


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:52:15Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406009" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406009</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>genetics</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Genetics</journal-id><journal-id journal-id-type="iso-abbrev">Genetics</journal-id><journal-id journal-id-type="pmc-domain-id">301</journal-id><journal-id journal-id-type="pmc-domain">genetics</journal-id><journal-id journal-id-type="publisher-id">genetics</journal-id><journal-title-group><journal-title>Genetics</journal-title></journal-title-group><issn pub-type="ppub">0016-6731</issn><issn pub-type="epub">1943-2631</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406009</article-id><article-id pub-id-type="pmcid-ver">PMC12406009.1</article-id><article-id pub-id-type="pmcaid">12406009</article-id><article-id pub-id-type="pmcaiid">12406009</article-id><article-id pub-id-type="pmid">40796140</article-id><article-id pub-id-type="doi">10.1093/genetics/iyaf141</article-id><article-id pub-id-type="publisher-id">iyaf141</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/SCI01180</subject><subject>AcademicSubjects/SCI01140</subject></subj-group><subj-group subj-group-type="category-oup-series"><subject>Featured</subject></subj-group></article-categories><title-group><article-title>Drug screens using the nematode <italic toggle="yes">Caenorhabditis elegans</italic></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2959-2276</contrib-id><name name-style="western"><surname>Roy</surname><given-names initials="PJ">Peter J</given-names></name><aff>
<institution>Department of Molecular Genetics, University of Toronto</institution>, <addr-line>1 King's College Circle, Toronto, Ontario M5S 1A8</addr-line>, <country country="CA">Canada</country></aff><aff>
<institution>Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto</institution>, <addr-line>160 College St., Toronto, Ontario M5S 3E1</addr-line>, <country country="CA">Canada</country></aff><aff>
<institution>Department of Pharmacology and Toxicology, University of Toronto</institution>, <addr-line>1 King's College Circle, Toronto, Ontario M5S 1A8</addr-line>, <country country="CA">Canada</country></aff><xref rid="iyaf141-cor1" ref-type="corresp"/><xref rid="FN01" ref-type="author-notes"/></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Greenstein</surname><given-names initials="D">D</given-names></name><role>Editor</role></contrib></contrib-group><author-notes><corresp id="iyaf141-cor1">Corresponding author: Email: <email>peter.roy@utoronto.ca</email></corresp><fn id="FN01" fn-type="COI-statement"><p>Conflicts of interest: Many of the molecules that we discovered are available from commercial vendors using the tradenames we gave them. We make no money from these sales. We are named inventors on patents or patents pending related to cyprocide, nemacol, nementin, and selectivin. Any reference to commercial entities should not constitute endorsement.</p></fn></author-notes><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><pub-date pub-type="epub" iso-8601-date="2025-08-12"><day>12</day><month>8</month><year>2025</year></pub-date><volume>231</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">496124</issue-id><elocation-id>iyaf141</elocation-id><history><date date-type="received"><day>11</day><month>6</month><year>2025</year></date><date date-type="accepted"><day>11</day><month>7</month><year>2025</year></date><date date-type="corrected-typeset"><day>12</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025. Published by Oxford University Press on behalf of The Genetics Society of America.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#8212;for further information please contact journals.permissions@oup.com.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="iyaf141.pdf"/><self-uri xlink:href="iyaf141.pdf"/><abstract><title>Abstract</title><p>Since its inception as a model system, <italic toggle="yes">Caenorhabditis elegans</italic> has provided insight about the mechanism of action of drugs through genetic analyses. With the arrival of diverse drug-like small molecule libraries sometime later, the worm also became a platform for drug discovery that was previously inaccessible to academics. Here, the history of larger-scale drug screens using <italic toggle="yes">C. elegans</italic> is reviewed. The current approaches used to identify the targets and targeted pathways of the novel hits from these screens are also discussed. We focus on the development of small molecule tools for biological investigation, the discovery of novel candidate nematicides and anthelmintics, and touch on screens related to other areas of biology, including neurodegeneration. Finally, we draw attention to the fundamental aspects of <italic toggle="yes">C. elegans</italic> biology that lends itself to chemical genetic research. When combined with diverse small molecule libraries, the worm's tractability and genetic power make it an unparalleled whole-animal model system for early-stage drug discovery.</p></abstract><abstract abstract-type="teaser"><p>This invited review by Roy examines the use of <italic toggle="yes">Caenorhabditis</italic> elegans as a model organism in drug discovery and chemical genetics. Highlighting its advantages as a cost-effective, whole-animal drug-screening platform, it surveys over 9,600 published studies to identify key research trends. The article revisits Sydney Brenner&#8217;s seminal 1974 drug screen, reviews large-scale efforts that uncovered novel candidate drugs, anthelmintics, and nematicides, and shows how genetics can reveal drug targets. By integrating historical context with recent advances, the review underscores the enduring value of C. elegans as a small animal model for early-stage drug research.</p></abstract><kwd-group><kwd>small molecule</kwd><kwd>drugs</kwd><kwd>compounds</kwd><kwd>drug screens</kwd><kwd>genetic suppression</kwd><kwd><italic toggle="yes">Caenorhabditis elegans</italic></kwd><kwd>review</kwd><kwd>anthelmintics</kwd><kwd>nematicides</kwd><kwd>WormBase</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source><institution-wrap><institution>Canadian Institutes of Health Research</institution><institution-id institution-id-type="DOI">10.13039/501100000024</institution-id></institution-wrap></funding-source><award-id>68813</award-id><award-id>133526</award-id><award-id>153024</award-id><award-id>173448</award-id><award-id>186156</award-id></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>Canada Research Chairs Program</institution></institution-wrap></funding-source></award-group></funding-group><counts><page-count count="19"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="iyaf141-s1"><title>Introduction</title><p>Why would anyone want to screen drugs against the model nematode <italic toggle="yes">Caenorhabditis elegans</italic>? Especially nowadays, with such a diversity of biological systems that include human organoids, ingenious CRISPR screens with mice, and zebrafish models of disease aplenty. Despite the many options, biologists typically publish more <italic toggle="yes">C. elegans</italic> drug studies each year than the year before (<xref rid="iyaf141-F1" ref-type="fig">Fig. 1</xref>). There must be compelling reasons why investigators keep returning to the lowly worm. This review aims to provide insight and perspective into this question.</p><fig position="float" id="iyaf141-F1" fig-type="figure" orientation="portrait"><label>Fig. 1.</label><caption><p>The number of <italic toggle="yes">C. elegans</italic> drug studies at PubMed over time. In black are the numbers of publications identified on PubMed using keywords &#8220;<italic toggle="yes">Caenorhabditis elegans</italic>&#8221; or &#8220;<italic toggle="yes">C. elegans</italic>&#8221; and &#8220;drug,&#8221; &#8220;drugs,&#8221; &#8220;small molecule,&#8221; &#8220;small molecules,&#8221; &#8220;compound,&#8221; or &#8220;compounds&#8221; tracked on the left axis as a function of time on the <italic toggle="yes">x</italic> axis. There are a total of 9,620 papers of this type. In pink are those identified with keywords &#8220;<italic toggle="yes">Caenorhabditis elegans</italic>&#8221; or &#8220;<italic toggle="yes">C. elegans</italic>,&#8221; the numbers of which are tracked on the right axis. There are a total of 44,720 papers of this type, which include all 9,620 drug-related papers. In each search, the PubMed queries were phrased using appropriate Boolean syntax to yield nonredundant results. Note the dip in the number of <italic toggle="yes">C. elegans</italic> drug-related papers published after the onset of the COVID-19 pandemic, which is not reflected in the overall numbers of <italic toggle="yes">C. elegans</italic> papers. Over the past decade, more than 27% of <italic toggle="yes">C. elegans</italic> papers published included a drug study of some type.</p></caption><graphic position="float" orientation="portrait" xlink:href="iyaf141f1.jpg"/></fig><p>It might be useful to first understand the subject areas in which <italic toggle="yes">C. elegans</italic> is employed in the context of drug studies. Toward this end, the titles and abstracts of all 9,620 papers involving <italic toggle="yes">C. elegans</italic> drug studies were collected from PubMed and analyzed. The top 3 subjects focus on longevity, neurobiology, and antimicrobials (<xref rid="iyaf141-F2" ref-type="fig">Fig. 2</xref>). What each of these subjects has in common is that they require an intact whole animal for study. Linda Buck's screen for compounds that extend the life of animals (<xref rid="iyaf141-B133" ref-type="bibr">Petrascheck et al. 2007</xref>), our neuromuscular-based screen for candidate nematicides (<xref rid="iyaf141-B62" ref-type="bibr">Harrington et al. 2022</xref>), and Fred Ausubel's screen for compounds that defend <italic toggle="yes">C. elegans</italic> against <italic toggle="yes">Enterococcus faecalis</italic> (<xref rid="iyaf141-B116" ref-type="bibr">Moy et al. 2006</xref>) would be next to impossible without the ability to screen whole animals, and we all did so in a high-throughput manner.</p><fig position="float" id="iyaf141-F2" fig-type="figure" orientation="portrait"><label>Fig. 2.</label><caption><p>A keyword subject analysis from the titles and abstracts of the 9,620 <italic toggle="yes">C. elegans</italic> drug papers in PubMed. Titles and abstracts of the <italic toggle="yes">C. elegans</italic> drug papers described in <xref rid="iyaf141-F1" ref-type="fig">Fig. 1</xref> were downloaded and processed for the occurrence of all words using the Natural Language Toolkit (NLTK) library for Python programming language (<xref rid="iyaf141-B8" ref-type="bibr">Bird et al. 2009</xref>) (kindly processed by Matej Usaj from Charlie Boone's lab). A total of 213 common nonrelevant words (and, the, for, etc.), numbers, and bits shorter than 2 characters were automatically filtered. The resulting list of 78,432 terms was manually curated, and similar high-ranking terms were grouped together (eg brain, neuron, nervous system, neural, axon were grouped together into &#8220;nervous system&#8221;). The top 40 words are indicated with a few related groups color-coded as indicated.</p></caption><graphic position="float" orientation="portrait" xlink:href="iyaf141f2.jpg"/></fig><p>These examples capitalize on a key set of features that make <italic toggle="yes">C. elegans</italic> such an attractive option for drug studies. The worm's small size (it is &#8764;1&#8197;mm long as an adult), its ability to self-fertilize, and its quick three day life cycle allow us to probe its entire biological program over all life stages for small molecule sensitivities in 96, 384, and 1,532 well plates. This power is unparalleled with any other cell, tissue, or animal model system.</p><p>A second key feature of <italic toggle="yes">C. elegans</italic> is that the entire genetic program of 19,824 protein-coding genes is packaged within an exceptionally simple and transparent body plan. The laboratory wildtype strain is also isogenic. The implications are that phenotype is more readily observable, reproducible, and accessible with fluorescent markers compared to other animal models.</p><p>A third feature that makes <italic toggle="yes">C. elegans</italic> so tractable is that it is exceptionally fecund. Each hermaphrodite generates about 300 replacements in 3 d. With sufficient <italic toggle="yes">Escherichia coli</italic> food, it would take a single <italic toggle="yes">C. elegans</italic> parent about 42 d to generate enough progeny equivalent in mass to the Earth's moon. In other words, 100,000&#8197;s of animals can easily be generated for screens for drug-resistant mutants, which has repeatedly revealed the mechanism-of-action of drugs.</p><p>The final feature introduced here is that drug screens with <italic toggle="yes">C. elegans</italic> are inexpensive. First, growing worms costs a small fraction compared to culturing human cells, organoids, or zebrafish, for example. Second, worms can be cultured in volumes as little as 50&#8197;ml over many days, and unlike other animal model systems, the media does not require refreshment. This saves on both drug and media costs. Third, thousands of samples per week can be processed manually with an inexpensive dissection microscope, although more sophisticated data capture methods exist. Hence, drug studies with <italic toggle="yes">C. elegans</italic> are more accessible in general compared to many other systems.</p><p>Several reviews have been published about drug studies with <italic toggle="yes">C. elegans</italic>. These include reviews on the use of <italic toggle="yes">C. elegans</italic> to characterize the mechanism of action of anthelmintics and nematicides (<xref rid="iyaf141-B64" ref-type="bibr">Holden-Dye and Walker 2014</xref>; <xref rid="iyaf141-B59" ref-type="bibr">Hahnel et al. 2020</xref>; <xref rid="iyaf141-B119" ref-type="bibr">Nixon et al. 2020</xref>; <xref rid="iyaf141-B109" ref-type="bibr">Martin et al. 2021</xref>), reviews on high-throughput drug discovery and microfluidics (<xref rid="iyaf141-B14" ref-type="bibr">Buckingham et al. 2014</xref>; <xref rid="iyaf141-B125" ref-type="bibr">O'Reilly et al. 2014</xref>; <xref rid="iyaf141-B180" ref-type="bibr">Zamanian and Chan 2021</xref>; <xref rid="iyaf141-B179" ref-type="bibr">Yoon et al. 2024</xref>), reviews about antimicrobial drug discovery (<xref rid="iyaf141-B85" ref-type="bibr">Kim et al. 2017</xref>; <xref rid="iyaf141-B132" ref-type="bibr">Peterson and Pukkila-Worley 2018</xref>), and reviews on natural products (<xref rid="iyaf141-B46" ref-type="bibr">Garcia-Bustos et al. 2019</xref>; <xref rid="iyaf141-B58" ref-type="bibr">Ha et al. 2022</xref>). There is little point in repeating what has already been written. Instead, this review focuses on the roots of <italic toggle="yes">C. elegans</italic> chemical genetic analyses, large-scale screens of more than 400 molecules, and how <italic toggle="yes">C. elegans</italic> genetics has been useful in the characterization of novel hits from these screens.</p></sec><sec id="iyaf141-s2"><title>Brenner's drug screen raises the question of drug sensitivity</title><p>The first reported drug screen with <italic toggle="yes">C. elegans</italic> was performed by the late Nobel laureate Sydney Brenner and published in his seminal 1974 <italic toggle="yes">Genetics</italic> paper (<xref rid="iyaf141-B12" ref-type="bibr">Brenner 1974</xref>). In it, he provided no rationale for the screen. One can only speculate what his underlying motivation was. A decade earlier, Brenner, together with Francis Crick and others, exploited the prolific nature of phage to isolate mutagen-induced suppressors of the <italic toggle="yes">rII</italic> mutant phenotypes, and suppressors of these suppressors. With brilliant logic, the triplet nature of the genetic code was revealed by combining these suppressors (<xref rid="iyaf141-B25" ref-type="bibr">Crick et al. 1961</xref>). Perhaps inspired by this earlier work, Brenner might have sought to show that his new model system was also capable of genetically bending to selective pressure that a drug could provide and was prolific enough to allow the detection of mutants of a desired type. In his fervor to genetically characterize as many loci as possible with his new model organism, Brenner might have also wanted to explore alternative approaches to isolate distinct mutants that might not otherwise be revealed on plates without drugs.</p><p>Brenner screened roughly 100 unnamed compounds that were readily available to him and found only 2 molecules that elicited obvious <italic toggle="yes">C. elegans</italic> phenotypes. He commented that, &#8220;most are without effect on the worms, probably because they are not absorbed.&#8221; This statement assumes that all 100 molecules could in principle elicit a phenotype, which is likely not true for several reasons (eg target divergence, target redundancy, and target nonessentiality). Despite this caveat, our previous work showed that only a low percentage of molecules (96 of the 1027 surveyed) accumulate robustly within the worm, which is not inconsistent with the spirit of Brenner's statement (<xref rid="iyaf141-B16" ref-type="bibr">Burns et al. 2010</xref>).</p><p>The typical assumption that is made to explain Brenner's low hit rate or the low accumulation rate is that the cuticle is a major barrier to small molecule absorption. Cuticles do reduce drug sensitivity of the worm, but only modestly so. For example, mutants that disrupt either the exocuticle (eg <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00044621?doi=10.1093/genetics/iyaf141" ext-link-type="uri">bus-5</ext-link></italic> and <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00007210?doi=10.1093/genetics/iyaf141" ext-link-type="uri">agmo-1</ext-link></italic>) or the pharynx cuticle (eg <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00004008?doi=10.1093/genetics/iyaf141" ext-link-type="uri">pgp-14</ext-link></italic>) increase drug sensitivity only 2-fold (<xref rid="iyaf141-B178" ref-type="bibr">Xiong et al. 2017</xref>; <xref rid="iyaf141-B79" ref-type="bibr">Kamal et al. 2023</xref>; <xref rid="iyaf141-B140" ref-type="bibr">Rehborg et al. 2023</xref>). It turns out that the exocuticle covers a little less surface area than the luminal membrane of the intestine because the latter is covered in microvilli, each of which has a surface area of 0.47&#8197;&#956;m<sup>2</sup> (<xref rid="iyaf141-B182" ref-type="bibr">Zhu et al. 2022</xref>). We can estimate the total surface area of an adult hermaphrodite to be roughly 251,000&#8197;&#956;m<sup>2</sup> (1,000&#8197;&#956;m length &#215; 2&#960;r, with <italic toggle="yes">r</italic> = 40&#8197;&#956;m). By comparison, the surface area of the intestinal apical (luminal) membrane in an adult hermaphrodite is about 261,000&#8197;&#956;m<sup>2</sup> {(21,250&#8197;&#956;m<sup>2</sup> intestinal lumen surface area, assuming an intestinal length of 850&#8197;&#956;m and a luminal perimeter of 25&#8197;&#956;m) + [a surface area of 239,700&#8197;&#956;m<sup>2</sup> for the microvilli (24 microvilli/&#956;m<sup>2</sup> &#215; 21,250&#8197;&#956;m<sup>2</sup> intestinal lumen surface area = 510,000 microvilli, each with a surface area of 0.47 &#956;m<sup>2</sup>)]}. Given that the pharynx pumps liquid at 4&#8197;Hz (<xref rid="iyaf141-B6" ref-type="bibr">Avery and You 2012</xref>) and that the residence time in the gut is about 2&#8197;min (<xref rid="iyaf141-B48" ref-type="bibr">Ghafouri and McGhee 2007</xref>), there is ample opportunity for small molecule absorption via the intestine, regardless of the structural integrity of the cuticle. Another route of small molecule absorption is the 26 sensory neurons that are exposed to the environment through cuticular holes and readily take up hydrophobic molecules (<xref rid="iyaf141-B70" ref-type="bibr">Inglis et al. 2007</xref>). Hence, the post-embryonic animal is not encased within a fortress that is largely impenetrable to small molecule absorption.</p><p>Given the multiple routes for small molecule absorption, how can we rationalize the relatively low accumulation rate that we observed? <italic toggle="yes">C. elegans</italic> lives within the microbial world (<xref rid="iyaf141-B148" ref-type="bibr">Schulenburg and Felix 2017</xref>). It thrives in the environment of some microbial species and perishes in the presence of others who produce noxious natural products (<xref rid="iyaf141-B143" ref-type="bibr">Samuel et al. 2016</xref>). This selective pressure has likely driven the expansion of a robust small molecule detoxification system. The animal has a greatly expanded number of nuclear receptors (267) called nuclear hormone receptors in <italic toggle="yes">C. elegans</italic>, most of which are orphan receptors that are speculated to respond to environmental compounds (<xref rid="iyaf141-B163" ref-type="bibr">Sural and Hobert 2021</xref>) and other debilitating xenobiotics (<xref rid="iyaf141-B99" ref-type="bibr">Lindblom et al. 2001</xref>; <xref rid="iyaf141-B73" ref-type="bibr">Jones et al. 2015</xref>). By contrast, there are only 48 nuclear receptors in humans (<xref rid="iyaf141-B42" ref-type="bibr">Frigo et al. 2021</xref>). <italic toggle="yes">C. elegans</italic> encodes 76 cytochrome P450s (compared to 57 in humans), many of which have been shown to oxidize xenobiotics as part of phase I drug metabolism (<xref rid="iyaf141-B93" ref-type="bibr">Larigot et al. 2022</xref>). The worm also has a wide array of phase II detoxification enzymes (<xref rid="iyaf141-B160" ref-type="bibr">Stasiuk et al. 2019</xref>). Finally, <italic toggle="yes">C. elegans</italic> encodes 14 full P-glycoproteins (PGP) (compared to 4 in humans), many of which have been implicated in xenobiotic and metabolite export from cells (<xref rid="iyaf141-B96" ref-type="bibr">Lespine et al. 2024</xref>). Hence, the low hit rate in Brenner's screen and in the accumulation survey may have less to do with absorption than with a robust xenobiotic detoxification system.</p><p>At least 3 classes of mutants that compromise xenobiotic defense and increase <italic toggle="yes">C. elegans</italic> drug sensitivity have been discovered (<xref rid="iyaf141-T1" ref-type="table">Table 1</xref>). These include mutant genes that disrupt the exocuticle barrier (<xref rid="iyaf141-B53" ref-type="bibr">Gravato-Nobre et al. 2005</xref>; <xref rid="iyaf141-B127" ref-type="bibr">Partridge et al. 2008</xref>; <xref rid="iyaf141-B178" ref-type="bibr">Xiong et al. 2017</xref>), those discovered to disrupt the pharynx cuticle barrier (<xref rid="iyaf141-B76" ref-type="bibr">Kamal et al. 2019</xref>, <xref rid="iyaf141-B79" ref-type="bibr">2023</xref>), and others that reduce drug export (<xref rid="iyaf141-B4" ref-type="bibr">Ardelli and Prichard 2013</xref>; <xref rid="iyaf141-B73" ref-type="bibr">Jones et al. 2015</xref>; <xref rid="iyaf141-B115" ref-type="bibr">Menez et al. 2019</xref>; <xref rid="iyaf141-B56" ref-type="bibr">Guerrero et al. 2021</xref>). Creating strains that combine all 3 mutant classes might prove additionally useful. While these sensitized mutants might yield additional hits in drug screens, screens focused on identifying novel nematicides or anthelmintics would likely not employ a sensitized background because hits should be capable of circumventing the natural xenobiotic barriers of nematodes.</p><table-wrap position="float" id="iyaf141-T1" orientation="portrait"><label>Table 1.</label><caption><p>Mutant genes that confer drug sensitivity.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Drug-sensitizing mutant gene</th><th align="center" rowspan="1" colspan="1">Mechanism of drug sensitivity</th><th align="center" rowspan="1" colspan="1">Demonstrated hypersensitivity</th><th align="center" rowspan="1" colspan="1">Health on nondrug plates</th><th align="center" rowspan="1" colspan="1">Citations</th></tr></thead><tbody><tr><td colspan="5" rowspan="1">
<bold>Disruption of the exocuticle barrier</bold>
</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">acs-20</italic>; <italic toggle="yes">acs-22</italic></td><td rowspan="1" colspan="1">Disruption of the exocuticle</td><td rowspan="1" colspan="1">Bleach, clofiliuim, E-4031, Hoechst 33342, ibutilide, levamisole, osmotic imbalance</td><td rowspan="1" colspan="1">Small, dumpy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B75" ref-type="bibr">Kage-Nakadai et al. (2010)</xref>; <xref rid="iyaf141-B72" ref-type="bibr">Jiang et al. (2018)</xref></td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">agmo-1</italic>
</td><td rowspan="1" colspan="1">Disrupted production of cuticle lipids</td><td rowspan="1" colspan="1">Aldicarb, bleach, fenoxycarb, piperazine, 2-phenoxyethanol, toluene, valproic acid, warfarin</td><td rowspan="1" colspan="1">Slow growth, fragile cuticle</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B53" ref-type="bibr">Gravato-Nobre et al. (2005)</xref>; <xref rid="iyaf141-B103" ref-type="bibr">Loer et al. (2015)</xref>; <xref rid="iyaf141-B178" ref-type="bibr">Xiong et al. (2017)</xref></td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">bus-5</italic>
</td><td rowspan="1" colspan="1">Disruption of the exocuticle</td><td rowspan="1" colspan="1">Aldicarb, bleach, boric acid, fenoxycarb, 2-methoxyethanol, piperazine, 2-phenoxyethanol, toluene, valproic acid, warfarin</td><td rowspan="1" colspan="1">Skiddy movement and cuticle fragility, poor long-term survival</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B53" ref-type="bibr">Gravato-Nobre et al. (2005)</xref>; <xref rid="iyaf141-B178" ref-type="bibr">Xiong et al. (2017)</xref></td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">bus-8</italic>
</td><td rowspan="1" colspan="1">Disorganized cuticle and hypodermis</td><td rowspan="1" colspan="1">Bleach, ivermectin, nicotine, 1-phenoxypropan-2-ol</td><td rowspan="1" colspan="1">Slow growth; reduced fecundity</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B53" ref-type="bibr">Gravato-Nobre et al. (2005)</xref>; <xref rid="iyaf141-B127" ref-type="bibr">Partridge et al. (2008)</xref>; <xref rid="iyaf141-B178" ref-type="bibr">Xiong et al. (2017)</xref></td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">bus-16</italic>
</td><td rowspan="1" colspan="1">Likely disrupted cuticle organization; exact mechanism unknown</td><td rowspan="1" colspan="1">Aldicarb, piperazine, valproic acid</td><td rowspan="1" colspan="1">Skiddy movement, vulval rupture, poor long-term survival</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B53" ref-type="bibr">Gravato-Nobre et al. (2005)</xref>; <xref rid="iyaf141-B178" ref-type="bibr">Xiong et al. (2017)</xref></td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">bus-17</italic>
</td><td rowspan="1" colspan="1">Likely disrupted cuticle organization; exact mechanism unknown</td><td rowspan="1" colspan="1">Bleach</td><td rowspan="1" colspan="1">Reduced fecundity, poor long-term survival</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B53" ref-type="bibr">Gravato-Nobre et al. (2005)</xref>; <xref rid="iyaf141-B178" ref-type="bibr">Xiong et al. (2017)</xref></td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">dpy-2</italic>, <italic toggle="yes">dpy-3</italic>, <italic toggle="yes">dpy-7</italic>, <italic toggle="yes">dpy-8</italic>, <italic toggle="yes">dpy-9</italic>, and <italic toggle="yes">dpy-10</italic></td><td rowspan="1" colspan="1">Exocuticle integrity</td><td rowspan="1" colspan="1">Hoechst 33342, ivermectin, levamisole, paraquat</td><td rowspan="1" colspan="1">Shorter, some mutants roll, some mutants are uncoordinated</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B144" ref-type="bibr">Sandhu et al. (2021)</xref>
</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">cat-4</italic>, <italic toggle="yes">ptps-1</italic></td><td rowspan="1" colspan="1">Needed for synthesis of BH4, a cofactor for AGMO-1</td><td rowspan="1" colspan="1">Bleach, SDS, levamisole</td><td rowspan="1" colspan="1">Cuticle fragility</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B103" ref-type="bibr">Loer et al. (2015)</xref>
</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">ceh-60</italic>
</td><td rowspan="1" colspan="1">Disrupted exocuticle epicuticle structure</td><td rowspan="1" colspan="1">Acridine orange, hydrogen peroxide</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B168" ref-type="bibr">Van de Walle et al. (2019)</xref>
</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">gmap-1</italic>
</td><td rowspan="1" colspan="1">Reduced exocuticle lipid barrier</td><td rowspan="1" colspan="1">Levamisole, Na azide, Hoechst 33342, dehydration</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B120" ref-type="bibr">Njume et al. (2022)</xref>
</td></tr><tr><td colspan="5" rowspan="1">
<bold>Disruption of the Pharynx Cuticle Barrier</bold>
</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">pgp-14</italic>
</td><td rowspan="1" colspan="1">Reduced lipid barrier in pharynx cuticle</td><td rowspan="1" colspan="1">188 lethal molecules, Hoechst 33342</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B79" ref-type="bibr">Kamal et al. (2023)</xref>
</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">sms-5</italic>
</td><td rowspan="1" colspan="1">Reduced lipid barrier in pharynx cuticle</td><td rowspan="1" colspan="1">169 lethal molecules</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B76" ref-type="bibr">Kamal et al. (2019)</xref>
</td></tr><tr><td colspan="5" rowspan="1">
<bold>Disruption of Drug Efflux</bold>
</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">nhr-8</italic>
</td><td rowspan="1" colspan="1">Regulation of the expression of drug efflux pumps</td><td rowspan="1" colspan="1">Ivermectin, tunicamycin</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B115" ref-type="bibr">Menez et al. (2019)</xref>; <xref rid="iyaf141-B56" ref-type="bibr">Guerrero et al. (2021)</xref></td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">pgp-1</italic>
</td><td rowspan="1" colspan="1">Likely drug efflux</td><td rowspan="1" colspan="1">Thiabendazole</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B73" ref-type="bibr">Jones et al. (2015)</xref>
</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">pgp-2</italic>
</td><td rowspan="1" colspan="1">Likely drug efflux</td><td rowspan="1" colspan="1">Ivermectin</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B4" ref-type="bibr">Ardelli and Prichard (2013)</xref>
</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">pgp-3</italic>
</td><td rowspan="1" colspan="1">Likely drug efflux</td><td rowspan="1" colspan="1">colchicine, chloroquine, thiabendazole</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B13" ref-type="bibr">Broeks et al. (1995)</xref>; <xref rid="iyaf141-B73" ref-type="bibr">Jones et al. (2015)</xref></td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">pgp-5</italic>
</td><td rowspan="1" colspan="1">Likely drug efflux</td><td rowspan="1" colspan="1">Ivermectin, tunicamycin</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B4" ref-type="bibr">Ardelli and Prichard (2013)</xref>; <xref rid="iyaf141-B56" ref-type="bibr">Guerrero et al. (2021)</xref></td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">pgp-6</italic>
</td><td rowspan="1" colspan="1">Likely drug efflux</td><td rowspan="1" colspan="1">Ivermectin</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B4" ref-type="bibr">Ardelli and Prichard (2013)</xref>; <xref rid="iyaf141-B115" ref-type="bibr">Menez et al. (2019)</xref></td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">pgp-7</italic>
</td><td rowspan="1" colspan="1">Likely drug efflux</td><td rowspan="1" colspan="1">Ivermectin</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B4" ref-type="bibr">Ardelli and Prichard (2013)</xref>
</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">pgp-11</italic>
</td><td rowspan="1" colspan="1">likely drug efflux</td><td rowspan="1" colspan="1">Tunicamycin</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B56" ref-type="bibr">Guerrero et al. (2021)</xref>
</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">pgp-12</italic>
</td><td rowspan="1" colspan="1">Likely drug efflux</td><td rowspan="1" colspan="1">Ivermectin, tunicamycin</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B4" ref-type="bibr">Ardelli and Prichard (2013)</xref>; <xref rid="iyaf141-B56" ref-type="bibr">Guerrero et al. (2021)</xref></td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">pgp-13</italic>
</td><td rowspan="1" colspan="1">Likely drug efflux</td><td rowspan="1" colspan="1">Ivermectin</td><td rowspan="1" colspan="1">Healthy</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B4" ref-type="bibr">Ardelli and Prichard (2013)</xref>
</td></tr></tbody></table></table-wrap><p>Despite the above discussion, it would be a mistake to leave the impression that <italic toggle="yes">C. elegans</italic> is exceptionally resistant to small molecule perturbation compared to other model systems. Yeast have 16 drug efflux pumps (<xref rid="iyaf141-B23" ref-type="bibr">Celaj et al. 2020</xref>) and often require high drug concentrations for screens (<xref rid="iyaf141-B94" ref-type="bibr">Lee et al. 2014</xref>); uniform drug exposure with flies can be difficult to achieve (<xref rid="iyaf141-B169" ref-type="bibr">Vidal et al. 2024</xref>), and solubilizing hydrophobic molecules in zebrafish's purely aquatic media can be limiting (<xref rid="iyaf141-B29" ref-type="bibr">Dash and Patnaik 2023</xref>). Brenner's 2% hit rate is actually very impressive, especially because we do not know the identity of the other 98 tested molecules, whether those molecules have targets in nematodes, how far those targets have diverged in nematodes relative to their intended target, and what the potency, if any, those 98 substances have in biological systems. Similarly, the finding that fewer than 10% of small molecules accumulate to micromolar concentrations in the worm may seem limiting, but most human drugs have potency in the low nanomolar range [50&#8197;nM on average (<xref rid="iyaf141-B51" ref-type="bibr">Gleeson et al. 2011</xref>)], so robust accumulation is not a prerequisite for activity. Identifying good hits in any system is a challenge, and likely no more so in <italic toggle="yes">C. elegans</italic> than in other model systems.</p></sec><sec id="iyaf141-s3"><title>Brenner isolates the first <italic toggle="yes">C. elegans</italic> drug-resistant mutants</title><p>As introduced above, a key advantage of <italic toggle="yes">C. elegans</italic> as a model system is the ability to rear millions of animals in a short period of time. Given a sufficiently negative selection pressure, this allows for the identification of drug-resistant mutants through powerful <italic toggle="yes">selection</italic> schemes [see (<xref rid="iyaf141-B74" ref-type="bibr">Jorgensen and Mango 2002</xref>) for an excellent overview of genetic screens with <italic toggle="yes">C. elegans</italic>]. As described previously, mutant genes that confer resistance to a bioactive compound can reveal the target or targeted pathway, irrespective of whether the drug agonizes or antagonizes its target (<xref rid="iyaf141-B15" ref-type="bibr">Burns et al. 2006</xref>) (<xref rid="iyaf141-T2" ref-type="table">Table 2</xref>).</p><table-wrap position="float" id="iyaf141-T2" orientation="portrait"><label>Table 2.</label><caption><p>Compound classes and mutant targets that confer drug resistance.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Compound</th><th align="center" rowspan="1" colspan="1">Compound class</th><th align="center" rowspan="1" colspan="1">Exemplar gene and allele in target or pathway that confers resistance</th><th align="center" rowspan="1" colspan="1">Class of mutation that can yield resistance</th><th align="center" rowspan="1" colspan="1">Citation</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Amino-acetonitrile derivatives (monepantel)</td><td rowspan="1" colspan="1">Agonist</td><td rowspan="1" colspan="1">
<italic toggle="yes">acr-23(cb79)</italic>
</td><td rowspan="1" colspan="1">RoF or LoF</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B81" ref-type="bibr">Kaminsky et al. (2008)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Aminophenylamidines (tribendimine)</td><td rowspan="1" colspan="1">Agonist</td><td rowspan="1" colspan="1">
<italic toggle="yes">unc-29(e193)</italic>
</td><td rowspan="1" colspan="1">RoF or LoF</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B66" ref-type="bibr">Hu et al. (2009)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Apigenin</td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">
<italic toggle="yes">daf-16(mu86)</italic>
</td><td rowspan="1" colspan="1">RoF or LoF</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B82" ref-type="bibr">Kawasaki et al. (2010)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Avermectins (ivermectin)</td><td rowspan="1" colspan="1">Agonist</td><td rowspan="1" colspan="1">
<italic toggle="yes">avr-14(ad1305); avr-15(vu227); glc-1(pk54)</italic>
</td><td rowspan="1" colspan="1">RoF or LoF</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B32" ref-type="bibr">Dent et al. (2000)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Benzimidazoles (benomyl)</td><td rowspan="1" colspan="1">Antagonist</td><td rowspan="1" colspan="1">
<italic toggle="yes">ben-1(e1880)</italic>
</td><td rowspan="1" colspan="1">RoF or LoF</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B35" ref-type="bibr">Driscoll et al. (1989)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Carbomates/organophosphates (lannate, aldicarb)</td><td rowspan="1" colspan="1">Antagonist</td><td rowspan="1" colspan="1">
<italic toggle="yes">cha-1(p1152)</italic>
</td><td rowspan="1" colspan="1">RoF</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B12" ref-type="bibr">Brenner (1974)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Cyclooctadepsipeptides (emodepside)</td><td rowspan="1" colspan="1">Agonist</td><td rowspan="1" colspan="1">
<italic toggle="yes">slo-1(js379)</italic>
</td><td rowspan="1" colspan="1">RoF or LoF</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B57" ref-type="bibr">Guest et al. (2007)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Dihydropyridines (nemadipine)</td><td rowspan="1" colspan="1">Antagonist</td><td rowspan="1" colspan="1">
<italic toggle="yes">egl-19(tr92)</italic>
</td><td rowspan="1" colspan="1">Neomorphic</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B90" ref-type="bibr">Kwok et al. (2008)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Imidazothiazole (levamisole)</td><td rowspan="1" colspan="1">Agonist</td><td rowspan="1" colspan="1">
<italic toggle="yes">unc-29(x29)</italic>
</td><td rowspan="1" colspan="1">RoF or LoF</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B41" ref-type="bibr">Fleming et al. (1997)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Nemacol</td><td rowspan="1" colspan="1">Antagonist</td><td rowspan="1" colspan="1">
<italic toggle="yes">unc-17(md414)</italic>
</td><td rowspan="1" colspan="1">Neomorphic</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B63" ref-type="bibr">Harrington et al. (2023)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Succinate dehydrogenase inhibitors (fluopyram, wact-11)</td><td rowspan="1" colspan="1">Antagonist</td><td rowspan="1" colspan="1">
<italic toggle="yes">sdhc-1(tr393)</italic>
</td><td rowspan="1" colspan="1">Neomorphic</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B18" ref-type="bibr">Burns et al. (2015)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Tetrahydropyrimidines (pyrantel, morantel)</td><td rowspan="1" colspan="1">Agonist</td><td rowspan="1" colspan="1">
<italic toggle="yes">unc-29(e193)</italic>
</td><td rowspan="1" colspan="1">RoF or LoF</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B155" ref-type="bibr">Sleigh (2010)</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>Neomorphic mutations can confer resistance by altering the ability of the compound to interact with the target. Hypermorphic mutations can confer resistance by increasing the target's activity. RoF, reduction of function; LoF, loss of function; both of which can suppress phenotypes induced by an agonist if in the target or targeted pathway.</p></fn></table-wrap-foot></table-wrap><p>Despite the awesome power of <italic toggle="yes">C. elegans</italic> genetics, screens for resistant mutants can be fruitless in some scenarios. For example, a drug's target may not be mutable to a resistant state without the resulting mutation debilitating the animal (like the carbamates described below). In a second example, a drug may engage multiple targets simultaneously to yield a phenotype. Random mutagenesis is highly unlikely to yield resistant mutants in this case because all drug targets would have to be mutated simultaneously in 1 individual mutant. Given that the mechanism of action is not known in advance, it is impossible to predict whether a bioactive compound will yield informative drug-resistant mutants.</p><p>With each of the 2 bioactive compounds that Brenner identified in the first <italic toggle="yes">C. elegans</italic> drug screen, he was remarkably lucky to isolate resistant mutants for both. One of the 2 molecules, lannate (aka methomyl), is a carbamate. The mode of action of carbamates was discovered in 1921 by Otto Loewi, who showed that a natural product carbamate called physostigmine inhibits acetylcholinesterase (AChE) activity. Loewi won a Nobel Prize related to this discovery in 1936 (<xref rid="iyaf141-B114" ref-type="bibr">McCoy and Tan 2014</xref>). Brenner isolated multiple recessive lannate-resistant alleles of the <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00006756?doi=10.1093/genetics/iyaf141" ext-link-type="uri">unc-17</ext-link></italic> gene, which Jim Rand's group showed 19 years later to encode the nematode vesicular acetylcholine transporter (VAChT) (<xref rid="iyaf141-B3" ref-type="bibr">Alfonso et al. 1993</xref>). Given that carbamates increase acetylcholine levels at the synapse via AChE inhibition, it is easy to understand how reducing the loading of acetylcholine into presynaptic vesicles confers some level of resistance to this class of drugs. While Brenner's screen did not lead to the discovery of the lannate target, it did ultimately contribute to an understanding of neuronal function, which was the overarching motivation of Brenner's genetic characterization of <italic toggle="yes">C. elegans</italic>.</p><p>Brenner also isolated 2 classes of mutants that resist the paralytic effects of the anthelmintic tetramisole, which is a racemic mixture of 2 enantiomers, including the more potent and commonly used worm anesthetic levamisole. One class of mutants was twitchers that mapped to the <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00006759?doi=10.1093/genetics/iyaf141" ext-link-type="uri">unc-22</ext-link></italic> gene, which are thought to confer resistance through indirect mechanisms. Brenner mapped the other classes of nontwitching mutants to 4 different genes, including <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00006765?doi=10.1093/genetics/iyaf141" ext-link-type="uri">unc-29</ext-link></italic>, <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00006774?doi=10.1093/genetics/iyaf141" ext-link-type="uri">unc-38</ext-link></italic>, <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00006797?doi=10.1093/genetics/iyaf141" ext-link-type="uri">unc-63</ext-link></italic>, and a gene later named <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00002974?doi=10.1093/genetics/iyaf141" ext-link-type="uri">lev-1</ext-link></italic>. Of course, methodologies for identifying the sequence of these genes would not be invented until sometime later. Brenner disciple Jim Lewis would spend the better part of 2 decades isolating and characterizing additional levamisole-resistant mutants. In 1997, Lewis's group identified the genomic sequences of <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00002974?doi=10.1093/genetics/iyaf141" ext-link-type="uri">lev-1</ext-link></italic>, <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00006765?doi=10.1093/genetics/iyaf141" ext-link-type="uri">unc-29</ext-link></italic>, and <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00006774?doi=10.1093/genetics/iyaf141" ext-link-type="uri">unc-38</ext-link></italic>, showing them to be nicotinic acetylcholine receptor (nAChR) subunits (<xref rid="iyaf141-B41" ref-type="bibr">Fleming et al. 1997</xref>). The group expressed all 3 subunits together in <italic toggle="yes">Xenopus</italic> oocytes and demonstrated levamisole-induced current that was suppressible with known nAChR antagonists. The full levamisole receptor, including 5 distinct receptor subunits and 3 ancillary proteins, would later be functionally reconstituted by the Bessereau and Richmond groups 11 years later (<xref rid="iyaf141-B11" ref-type="bibr">Boulin et al. 2008</xref>). Hence, in the early days of <italic toggle="yes">C. elegans</italic> chemical genetics, it took 23 years to go from isolating the first drug-resistant mutants to identifying the target components revealed by those mutants. As discussed below, this can now be done in about 60 d with the skills of an undergraduate student.</p></sec><sec id="iyaf141-s4"><title>The first large-scale small molecule screens in <italic toggle="yes">C. elegans</italic></title><p>The cloning revolution of yeast, worm, and fly genes gained steady momentum throughout the 1980s and 1990s. With it came the revelation that many of the genes in these simple organisms not only had orthologs in humans but controlled orthologous signaling pathways and analogous developmental programs. These organisms truly could be exploited to <italic toggle="yes">model</italic> our own biology. At around the same time, new techniques in the world of chemistry lowered the cost of synthesizing compounds while increasing structural diversity [ie combinatory chemistry methodology (<xref rid="iyaf141-B9" ref-type="bibr">Blackwell et al. 2001</xref>; <xref rid="iyaf141-B45" ref-type="bibr">Galloway et al. 2010</xref>)]. In 1997, it was also recognized that most successful drugs fall within a narrow range of physicochemical properties (<xref rid="iyaf141-B100" ref-type="bibr">Lipinski et al. 1997</xref>). The scope of chemical synthesis for new drug discovery could now be sharply focused, and libraries of small molecules with drug-like properties became commercially available at this time.</p><p>This new chemistry collided with model organism biology in the late 1990s with the founding of biotech startups DevGen, NemaPharm, Exelixis, and Elixir Pharma. These firms focused on drug development using model organisms that included <italic toggle="yes">C. elegans</italic> (eg <xref rid="iyaf141-B174" ref-type="bibr">Wells 1998</xref>; <xref rid="iyaf141-B113" ref-type="bibr">McCarthy 2005</xref>). Academic papers describing small molecule screens performed at these companies do not exist, but screens were central to their business model. Beyond these private efforts, there were no published large-scale <italic toggle="yes">C. elegans</italic> screens of small molecule libraries between the time of Brenner's inaugural screen and papers published 3 decades later.</p><p>In the early 2000s, a colleague asked if we were interested in screening their library of 10,000 uncharacterized molecules from ChemBridge Corporation against the worm so that we could compare notes with their screen being carried out against <italic toggle="yes">Arabidopsis</italic> (<xref rid="iyaf141-B181" ref-type="bibr">Zhao et al. 2007</xref>). The idea was exciting. We fantasized about identifying a suite of molecules that would yield obvious &#8220;Brenner phenotypes.&#8221; These molecules would disrupt the key developmental signaling pathways and might be powerful tools for chemical genetic analyses, not just in <italic toggle="yes">C. elegans</italic> but in other systems as well.</p><p>Given that the vast majority of <italic toggle="yes">C. elegans</italic> investigations are performed on solid agar substrate, we felt it important to screen the compounds by co-culturing them with animals reared on solid agar substrate in 24-well plates so that we could visualize the emergence of any obvious plate phenotypes. This would also avoid any of the biological peculiarities of worms cultured in liquid (<xref rid="iyaf141-B98" ref-type="bibr">Lev et al. 2019</xref>). We ended up screening 14,100 molecules that included other libraries. Through manual inspection of the cultures using a dissection microscope, we identified 308 compounds that induced obvious phenotypes in the worm (<xref rid="iyaf141-B89" ref-type="bibr">Kwok et al. 2006</xref>). The majority of hits induced slow growth, embryonic lethality, or larval lethality. At the time, we did not investigate these types of hits further, but some were later included in our worm active (aka wactive) collection that we explored for years.</p><p>Among the 308 hits, there was only 1 molecule that elicited an obvious set of post-embryonic phenotypes initially described by Brenner. In addition to slow growth, the hit that we renamed &#8220;nemadipine&#8221; induced <underline>v</underline>ariable morphological <underline>ab</underline>normalities (aka Vab) in young larvae and an <underline>eg</underline>g-<underline>l</underline>aying <underline>d</underline>efective (aka Egl-d) phenotype in adults (<xref rid="iyaf141-T3" ref-type="table">Table 3</xref>). Nemadipine is discussed in more detail below in the context of using phenotype to uncover a drug's target.</p><table-wrap position="float" id="iyaf141-T3" orientation="portrait"><label>Table 3.</label><caption><p>Large-scale small molecule screens with <italic toggle="yes">C. elegans</italic> and key resulting compounds.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Main molecule of interest</th><th align="center" rowspan="1" colspan="1">Phenotype</th><th align="center" rowspan="1" colspan="1">Mode of action and target</th><th align="center" rowspan="1" colspan="1">Potential utility</th><th align="center" rowspan="1" colspan="1"># of molecules in initial screen (and primary vendor)</th><th align="center" rowspan="1" colspan="1">Citation</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Nemadipine</td><td rowspan="1" colspan="1">Egg retention (Egl-d), slow growth (Gro), morphological abnormalities (Vab)</td><td rowspan="1" colspan="1">Inhibits CaV1 ion channels (EGL-19)</td><td rowspan="1" colspan="1">Tool compound</td><td rowspan="1" colspan="1">14,100 (ChemBridge Diverset)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B89" ref-type="bibr">Kwok et al. (2006)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Mianserin</td><td rowspan="1" colspan="1">Lifespan extension</td><td rowspan="1" colspan="1">Suppression of transcriptional drift via modulation of serotonergic signaling</td><td rowspan="1" colspan="1">Lifespan extension</td><td rowspan="1" colspan="1">88,000 (ChemBridge CNS, ChemBridge Diverset)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B133" ref-type="bibr">Petrascheck et al. (2007)</xref>; <xref rid="iyaf141-B139" ref-type="bibr">Rangaraju et al. (2015)</xref></td></tr><tr><td rowspan="1" colspan="1">Dafadine</td><td rowspan="1" colspan="1">Constituative Dauer (Daf-c); distal tip cell migration defects (Mig); lifespan extension</td><td rowspan="1" colspan="1">Inhibits cytochrome P450 (DAF-9, aka CYP-22A1)</td><td rowspan="1" colspan="1">Tool compound</td><td rowspan="1" colspan="1">4,710 (yeast bioactives)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B106" ref-type="bibr">Luciani et al. (2011)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Migrazole</td><td rowspan="1" colspan="1">Distal tip cell migration defects (Mig); bivulva (Biv); axon extension defects</td><td rowspan="1" colspan="1">Unknown target; chemical genetic interactions with multiple developmental signaling pathways</td><td rowspan="1" colspan="1">Tool compound</td><td rowspan="1" colspan="1">1,570 (yeast bioactives)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B91" ref-type="bibr">Kwok (2011)</xref>
</td></tr><tr><td rowspan="1" colspan="1">HBAC-B</td><td rowspan="1" colspan="1">Uncoordination (Unc); premature starvation-induced death (Sid)</td><td rowspan="1" colspan="1">Unknown target; chemical genetic interactions with metabotropic glutamate receptor</td><td rowspan="1" colspan="1">Tool compound</td><td rowspan="1" colspan="1">4,000 (clickable library assembled by Sean Cutler)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B17" ref-type="bibr">Burns (2013)</xref>
</td></tr><tr><td rowspan="1" colspan="1">ML358</td><td rowspan="1" colspan="1">Decreased transcription of SKN-1 targets</td><td rowspan="1" colspan="1">Inhibition of SKN-1 pathway</td><td rowspan="1" colspan="1">Nematicide</td><td rowspan="1" colspan="1">36,4000 (NIH Molecular Libraries Small Molecule Repository)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B97" ref-type="bibr">Leung et al. (2013)</xref>; <xref rid="iyaf141-B131" ref-type="bibr">Peddibhotla et al. (2015)</xref></td></tr><tr><td rowspan="1" colspan="1">NH125</td><td rowspan="1" colspan="1">Suppresses microbial-induced killing of <italic toggle="yes">C. elegans</italic> by MRSA persisters</td><td rowspan="1" colspan="1">Disruption of MRSA biofilms</td><td rowspan="1" colspan="1">Antimicrobial</td><td rowspan="1" colspan="1">85,000 (ICCB Harvard Collection)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B84" ref-type="bibr">Kim et al. (2015)</xref>
</td></tr><tr><td rowspan="1" colspan="1">wact-11</td><td rowspan="1" colspan="1">Lethal (Let)</td><td rowspan="1" colspan="1">inhibits nematode complex II (succinate dehydrogenase)</td><td rowspan="1" colspan="1">Nematicide/anthelmintic</td><td rowspan="1" colspan="1">67,012 (ChemBridge NovaCore and Diversets)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B18" ref-type="bibr">Burns et al. (2015)</xref>
</td></tr><tr><td rowspan="1" colspan="1">CID 2747322</td><td rowspan="1" colspan="1">Lethal (Let)</td><td rowspan="1" colspan="1">Inhibits nematode complex II (succinate dehydrogenase)</td><td rowspan="1" colspan="1">Nematicide/anthelmintic</td><td rowspan="1" colspan="1">25,986 (ChemBridge and Maybridge)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B111" ref-type="bibr">Mathew et al. (2016)</xref>
</td></tr><tr><td rowspan="1" colspan="1">NP1</td><td rowspan="1" colspan="1">Lifespan extension</td><td rowspan="1" colspan="1">Promotion of glutamate signaling</td><td rowspan="1" colspan="1">Tool compound</td><td rowspan="1" colspan="1">30,000 (unknown origin)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B104" ref-type="bibr">Lucanic et al. (2016)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Auranofin</td><td rowspan="1" colspan="1">Suppresses microbial-induced killing of <italic toggle="yes">C. elegans</italic></td><td rowspan="1" colspan="1">Inhibition of the mia40-Erv1 pathway</td><td rowspan="1" colspan="1">Antimicrobial</td><td rowspan="1" colspan="1">640 (Biomol 4 library, Enzo Life Sciences)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B43" ref-type="bibr">Fuchs et al. (2016)</xref>; <xref rid="iyaf141-B165" ref-type="bibr">Thangamani et al. (2017)</xref></td></tr><tr><td rowspan="1" colspan="1">C22</td><td rowspan="1" colspan="1">Embryonic lethality (Emb)</td><td rowspan="1" colspan="1">Dependent on LET-607 activity</td><td rowspan="1" colspan="1">Tool compound</td><td rowspan="1" colspan="1">37,000 (Yale Pilot library, MicroSource Gen-Plus and Natural Products, ChemBridge and Maybridge Diversets)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B173" ref-type="bibr">Weicksel et al. (2016)</xref>
</td></tr><tr><td rowspan="1" colspan="1">wact-86</td><td rowspan="1" colspan="1">Lethal (Let); synergistic with aldicarb</td><td rowspan="1" colspan="1">Unknown target; synergy is mediated through GES-1 inhibition</td><td rowspan="1" colspan="1">Nematicide</td><td rowspan="1" colspan="1">67,012 (ChemBridge NovaCore and Diversets)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B19" ref-type="bibr">Burns et al. (2017)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Pimozide</td><td rowspan="1" colspan="1">Suppression of motor defects induced by heterologous expression of human TDP-43</td><td rowspan="1" colspan="1">T-type calcium channels</td><td rowspan="1" colspan="1">Treatment of ALS</td><td rowspan="1" colspan="1">3,750 (LOPAC 1280, Spectrum, Biomol, and Prestwick)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B130" ref-type="bibr">Patten et al. (2017)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Prostratin and ingenol-3,20-dibenzoate (repurposed)</td><td rowspan="1" colspan="1">Suppression of trafficking-induced suppression of motor defects induced by heterologous expression of a human-worm chimeric hERG potassium channel</td><td rowspan="1" colspan="1">Agonism of protein kinase C epsilon</td><td rowspan="1" colspan="1">Treatment of long-QT syndrome (LQTS)</td><td rowspan="1" colspan="1">10,600 (Prestwick Chemical Library, Spectrum Collection, the Natural Products Library, the ICCB Known Bioactives Library, the IB screening Library, the NIH Clinical Collection, the FDA-Approved Drug Library, the Simga-Aldrich LOPAC, and the AnalytiCon Discovery)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B72" ref-type="bibr">Jiang et al. (2018)</xref>
</td></tr><tr><td rowspan="1" colspan="1">TRVA242</td><td rowspan="1" colspan="1">Suppression of motor defects induced by heterologous expression of human TDP-43</td><td rowspan="1" colspan="1">Unknown or not public; possibly inhibition of T-type calcium channels</td><td rowspan="1" colspan="1">Treatment of ALS</td><td rowspan="1" colspan="1">3,765 (Treventis, Zalicus)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B10" ref-type="bibr">Bose et al. (2019)</xref>
</td></tr><tr><td rowspan="1" colspan="1">wact-190</td><td rowspan="1" colspan="1">Larval lethal (Lvl)</td><td rowspan="1" colspan="1">SMS-5, PGP-14-dependent Crystallization in the pharynx cuticle</td><td rowspan="1" colspan="1">Tool compound</td><td rowspan="1" colspan="1">67,012 (ChemBridge NovaCore and Diversets)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B76" ref-type="bibr">Kamal et al. (2019)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Rifabutin (repurposed)</td><td rowspan="1" colspan="1">Suppression of motor defects induced by heterologous expression of human &#945;-synuclein</td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">Treatment of Parkinson's</td><td rowspan="1" colspan="1">620 (characterized drugs predicted by IBM Watson for Drug Discovery; Predictive Analytics for inhibiting &#945;-synuclein aggregation)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B24" ref-type="bibr">Chen et al. (2021)</xref>
</td></tr><tr><td rowspan="1" colspan="1">HF-00014 (aka UMW-9729)</td><td rowspan="1" colspan="1">Lethal against <italic toggle="yes">C. elegans</italic> and <italic toggle="yes">H. contortus</italic></td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">Nematicide/anthelmintic</td><td rowspan="1" colspan="1">14,400 (HitFinder, Maybridge)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B164" ref-type="bibr">Taki et al. (2021)</xref>; <xref rid="iyaf141-B151" ref-type="bibr">Shanley et al. (2024b)</xref></td></tr><tr><td rowspan="1" colspan="1">GSK306886A</td><td rowspan="1" colspan="1">Larval arrest (Lva); internal hatchlings of animals (Bag)</td><td rowspan="1" colspan="1">LET-23 (EGFR)</td><td rowspan="1" colspan="1">Nematicide/anthelmintic</td><td rowspan="1" colspan="1">2,040 (GSK Published Kinase Inhibitor Sets 1 and 2, APExBIO DiscoveryProbe Kinase Inhibitor Library; Sigma-Aldrich LOPAC; PICR Kinase Inhibitor Library)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B86" ref-type="bibr">Knox et al. (2021)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Trametinib</td><td rowspan="1" colspan="1">Sterile (Ste)</td><td rowspan="1" colspan="1">MEK-2 (MEK1/2)</td><td rowspan="1" colspan="1">Nematicide/anthelmintic</td><td rowspan="1" colspan="1">2,040 (custom Kinase Inhibitor Collection&#8212;details above)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B86" ref-type="bibr">Knox et al. (2021)</xref>
</td></tr><tr><td rowspan="1" colspan="1">GSK1520489A</td><td rowspan="1" colspan="1">sterile (Ste); embryonic lethality (Emb)</td><td rowspan="1" colspan="1">PLK-1 (polo-like kinase 1)</td><td rowspan="1" colspan="1">Nematicide/anthelmintic</td><td rowspan="1" colspan="1">2,040 (custom Kinase Inhibitor Collection&#8212;details above)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B86" ref-type="bibr">Knox et al. (2021)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Crotamiton and JM03 derivative</td><td rowspan="1" colspan="1">Lifespan extension, stress resistance</td><td rowspan="1" colspan="1">OSM-9</td><td rowspan="1" colspan="1">Tool compound</td><td rowspan="1" colspan="1">1,027 (clinically used drugs)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B7" ref-type="bibr">Bao et al. (2022)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Nementin (aka wact-55)</td><td rowspan="1" colspan="1">Lethal (Let); hyperactive; convulsions; potently synergistic with aldicarb</td><td rowspan="1" colspan="1">Unknown target; agonizes dense core and synaptic vesicle release</td><td rowspan="1" colspan="1">Nematicide</td><td rowspan="1" colspan="1">486 (wactive library)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B62" ref-type="bibr">Harrington et al. (2022)</xref>
</td></tr><tr><td rowspan="1" colspan="1">MMV1581032 (aka ABX464)</td><td rowspan="1" colspan="1">Lethal (Let)</td><td rowspan="1" colspan="1">Tentatively HCON_00074590</td><td rowspan="1" colspan="1">Nematicide/anthelmintic</td><td rowspan="1" colspan="1">400 [Pandemic Response Box from Medicines for Malaria Venture (MMV)]</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B149" ref-type="bibr">Shanley et al. (2022)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Dexrazoxane</td><td rowspan="1" colspan="1">Inhibition of proliferation of multiple microsporidia species in <italic toggle="yes">C. elegans</italic></td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">Antimicrosporidia</td><td rowspan="1" colspan="1">2,560 (MicroSource Spectrum Library)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B117" ref-type="bibr">Murareanu et al. (2022)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Nemacol (aka wact-45)</td><td rowspan="1" colspan="1">Uncoordinated; coiler; paralysis</td><td rowspan="1" colspan="1">Vesicular acetylcholine transporter (VAChT) (UNC-17)</td><td rowspan="1" colspan="1">Nematicide</td><td rowspan="1" colspan="1">486 (wactive library)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B63" ref-type="bibr">Harrington et al. (2023)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Selectivin (aka wact-1)</td><td rowspan="1" colspan="1">Lethal (Let)</td><td rowspan="1" colspan="1">Bioactivated into lethal reactive product by CYP-35C1</td><td rowspan="1" colspan="1">Nematicide</td><td rowspan="1" colspan="1">67,012 (ChemBridge NovaCore and Diversets)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B20" ref-type="bibr">Burns et al. (2023)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Closantel</td><td rowspan="1" colspan="1">pharynx crystal suppressor and amyloid disruptor</td><td rowspan="1" colspan="1">Inhibits secondary a-beta filament formation in vitro</td><td rowspan="1" colspan="1">Amyloid disruption</td><td rowspan="1" colspan="1">2,560 (MicroSource Spectrum Library)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B80" ref-type="bibr">Kamal et al. (2024)</xref>
</td></tr><tr><td rowspan="1" colspan="1">NPD8790</td><td rowspan="1" colspan="1">Hypoxia-dependent lethality</td><td rowspan="1" colspan="1">Inhibits nematode complex I (NADH-ubiquinone oxidoreductase)</td><td rowspan="1" colspan="1">Anthelmintic</td><td rowspan="1" colspan="1">480 (RIKEN Natural Product Depository)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B30" ref-type="bibr">Davie et al. (2024)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Cyprocide (aka wact-4-5)</td><td rowspan="1" colspan="1">Lethal (Let)</td><td rowspan="1" colspan="1">Bioactivated into lethal reactive product by CYP-35D1</td><td rowspan="1" colspan="1">Nematicide</td><td rowspan="1" colspan="1">846 (custom library of disubstituted oxodiazoles)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B87" ref-type="bibr">Knox et al. (2024)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Avocatin A (aka avocado fatty alcohols/acetates)</td><td rowspan="1" colspan="1">Lethal (Let)</td><td rowspan="1" colspan="1">inhibition of acetyl-CoA carboxylase (ACC, aka POD-2)</td><td rowspan="1" colspan="1">Nematicide/anthelmintic</td><td rowspan="1" colspan="1">2,320 (MicroSource, Sigma-Aldrich, Cayman)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B38" ref-type="bibr">Fahs et al. (2025)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Benzene-sulfonamides</td><td rowspan="1" colspan="1">Inhibition of proliferation of multiple microsporidia species in <italic toggle="yes">C. elegans</italic></td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">Antimicrosporidia</td><td rowspan="1" colspan="1">2,900 (ChemBridge Diverset, Pandemic Response Box)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B68" ref-type="bibr">Huang et al. (2023)</xref>; <xref rid="iyaf141-B67" ref-type="bibr">Huang et al. (2025)</xref></td></tr></tbody></table><table-wrap-foot><fn id="tblfn2"><p>Included are screens of 400 molecules or more that have revealed a previously uncharacterized hit or a previously characterized hit with novel function, and where at least one of the hits was characterized in detail with respect to its mechanism-of-action or structural constraints.</p></fn></table-wrap-foot></table-wrap><p>While nemadipine induced an exciting set of phenotypes, the fact that we obtained only 1 hit that induced a nonlethal post-embryonic phenotype was a disappointment. To achieve our goal of assembling a suite of molecules that induce Brenner phenotypes by screening only 14,100 compounds was obviously na&#239;ve in retrospect. Over time and with several different screening approaches, however, the community has established a collection of small molecule tools that not only facilitate biological analyses but also have potential commercial utility (<xref rid="iyaf141-T3" ref-type="table">Table 3</xref>).</p><p>At about the same time as our 2006 publication, Fred Ausubel's group published their screen of 7,136 molecules and extracts for novel antimicrobial candidates using their pioneering <italic toggle="yes">C. elegans</italic> model of <italic toggle="yes">E. faecalis</italic> infection (<xref rid="iyaf141-B116" ref-type="bibr">Moy et al. 2006</xref>). Their screen was innovative on multiple fronts, including that it was performed in liquid media in 96-well plate format. A year later, Linda Buck's group published their screen of 88,000 compounds for those that extend <italic toggle="yes">C. elegans</italic> lifespan and identified a series of antidepressants that can do so (<xref rid="iyaf141-B133" ref-type="bibr">Petrascheck et al. 2007</xref>). In addition to screening an impressive 6-fold more compounds than anyone before, the group showed that <italic toggle="yes">C. elegans</italic> screens could be performed in 384-well plate format. Later, Keith Choe's group published the largest <italic toggle="yes">C. elegans</italic> drug screen to date. They screened 364,000 compounds for those that inhibit the transcription factor <ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00004804?doi=10.1093/genetics/iyaf141" ext-link-type="uri">SKN-1</ext-link>, which is a key mediator of nematode oxidative stress and a potential anthelmintic target (<xref rid="iyaf141-B97" ref-type="bibr">Leung et al. 2013</xref>). Impressively, they used 1,536-well plates and a fluorescent readout to achieve ultrahigh-throughput processivity. The group identified a selective inhibitor of nematode <ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00004804?doi=10.1093/genetics/iyaf141" ext-link-type="uri">SKN-1</ext-link> called ML358 that fails to inhibit the human ortholog NRF2 and serves as an anthelmintic candidate (<xref rid="iyaf141-B131" ref-type="bibr">Peddibhotla et al. 2015</xref>) (<xref rid="iyaf141-T3" ref-type="table">Table 3</xref>).</p></sec><sec id="iyaf141-s5"><title>Specific phenotypes can suggest specific drug targets</title><p>
<italic toggle="yes">C. elegans</italic> has a relatively simple body plan for an animal (<xref rid="iyaf141-B161" ref-type="bibr">Sulston and Horvitz 1977</xref>; <xref rid="iyaf141-B162" ref-type="bibr">Sulston et al. 1983</xref>) and has been genetically and phenotypically characterized extensively. Hence, there are many obvious phenotypes that are highly indicative of the underlying biochemical pathway perturbed. In the case of nemadipine, a limited number of genes can be mutated to an Egl-d phenotype, and we knew of only 1 Egl-d mutant that also had a Vab phenotype: reduction of function mutants in the <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00001187?doi=10.1093/genetics/iyaf141" ext-link-type="uri">egl-19</ext-link></italic> gene that encodes the sole <italic toggle="yes">C. elegans</italic> L-type calcium channel &#945;<sub>1</sub>-subunit ortholog (<xref rid="iyaf141-B95" ref-type="bibr">Lee et al. 1997</xref>). We therefore had a good hypothesis that nemadipine inhibits <ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00001187?doi=10.1093/genetics/iyaf141" ext-link-type="uri">EGL-19</ext-link> function. In parallel to chemical genetic tests with existing <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00001187?doi=10.1093/genetics/iyaf141" ext-link-type="uri">egl-19</ext-link></italic> alleles, we carried out a forward genetic screen for resistant mutants and identified multiple dominant alleles of <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00001187?doi=10.1093/genetics/iyaf141" ext-link-type="uri">egl-19</ext-link></italic> as anticipated (<xref rid="iyaf141-B89" ref-type="bibr">Kwok et al. 2006</xref>, <xref rid="iyaf141-B90" ref-type="bibr">2008</xref>; <xref rid="iyaf141-B69" ref-type="bibr">Hui et al. 2009</xref>). Nemadipine belongs to the well-characterized dihydropyridine (DHP) class of L-type calcium channel (Ca<sub>v</sub>1) inhibitors (<xref rid="iyaf141-F3" ref-type="fig">Fig. 3</xref>). What is useful about nemadipine is that it was the only known DHP that could inhibit <ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00001187?doi=10.1093/genetics/iyaf141" ext-link-type="uri">EGL-19</ext-link> within whole animals; other DHPs only work when dissected animals are bathed in the compounds, indicating that nemadipine escapes the ADME (absorption, distribution, metabolism, and excretion) liabilities of other DHPs in <italic toggle="yes">C. elegans</italic>.</p><fig position="float" id="iyaf141-F3" fig-type="figure" orientation="portrait"><label>Fig. 3.</label><caption><p>Hits that resemble characterized molecules. Hits are on the left (ordered according to their discovery and/or publication date), and previously characterized molecules are on the right. The Jaccard&#8211;Tanimoto similarity score between the left and right molecules is in brackets after the names on the left. The score was calculated using RDKFingerprints on the NovoPro online tool. A score of 1.0 is a perfect match, and a score of 0 indicates no structural similarity.</p></caption><graphic position="float" orientation="portrait" xlink:href="iyaf141f3.jpg"/></fig><p>This phenotype-driven hypothesis approach has been repeatedly useful in identifying the target of small molecule hits from our screens. For example, we discovered a new structure called dafadine that induces a constitutive dauer formation (Daf-c) phenotype and a defect in the migration of the distal tip cell (Mig), which results in a clear patch on the ventral side of animals. Mutations in only 2 genes were known to yield that combination of penetrant phenotypes: <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00000905?doi=10.1093/genetics/iyaf141" ext-link-type="uri">daf-9</ext-link></italic> and <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00000908?doi=10.1093/genetics/iyaf141" ext-link-type="uri">daf-12</ext-link></italic> (<xref rid="iyaf141-B47" ref-type="bibr">Gerisch et al. 2001</xref>). We went on to provide evidence that supports the hypothesis that dafadine inhibits the cytochrome P450 <ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00000905?doi=10.1093/genetics/iyaf141" ext-link-type="uri">DAF-9</ext-link>, which makes the hormone that regulates the <ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00000908?doi=10.1093/genetics/iyaf141" ext-link-type="uri">DAF-12</ext-link> nuclear receptor (<xref rid="iyaf141-B106" ref-type="bibr">Luciani et al. 2011</xref>). Dafadine also extends <italic toggle="yes">C. elegans</italic>' lifespan. In another example, a novel structure that we discovered called nemacol induces a tight coiling phenotype highly reminiscent of reduction-of-function mutants in the aforementioned <ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00006756?doi=10.1093/genetics/iyaf141" ext-link-type="uri">UNC-17</ext-link> VAChT and the <ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00000481?doi=10.1093/genetics/iyaf141" ext-link-type="uri">CHA-1</ext-link> choline <italic toggle="yes">O</italic>-acetyltransferase that produces acetylcholine. Again, we went on to provide multiple lines of evidence that supports the hypothesis that nemacol inhibits <ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00006756?doi=10.1093/genetics/iyaf141" ext-link-type="uri">UNC-17</ext-link> (<xref rid="iyaf141-B63" ref-type="bibr">Harrington et al. 2023</xref>).</p><p>The phenotype-to-hypothesis-to-target approach has been successful, but not always so. Through a screen of 1,570 molecules that were found to be bioactive in the yeast <italic toggle="yes">Saccharomyces cerevisiae</italic>, we identified 1 molecule that we called migrazole that induced distal tip cell migration defects, a bivulva phenotype, and axon extension defects (<xref rid="iyaf141-B91" ref-type="bibr">Kwok 2011</xref>). Despite this specific combination of post-embryonic phenotypes, extensive chemical genetic analyses, and genetic screens for resistant mutants, we failed to identify a candidate target that could satisfactorily explain migrazole's suite of phenotypes. In a similar example, we found 1 molecule from a screen for egg-laying modulators that we call nementin that also induces hyperactivity and convulsions (<xref rid="iyaf141-B62" ref-type="bibr">Harrington et al. 2022</xref>). This suite of phenotypes led us to the realization that nementin agonizes dense core and synaptic vesicle release, but despite the robust phenotypes and genetic screens for resistance, we could not identify a specific target. A similar theme emerged for HBAC-B (<xref rid="iyaf141-T3" ref-type="table">Table 3</xref>) (<xref rid="iyaf141-B17" ref-type="bibr">Burns 2013</xref>). We speculate that in all of these cases, the bioactive small molecule may have multiple targets, which confounds the use of genetics to reveal the target. Hence, phenotype can lead to target but, in just as many cases, can also leave the researcher empty-handed.</p></sec><sec id="iyaf141-s6"><title>Screens for novel nematicides</title><p>Some have argued that <italic toggle="yes">C. elegans</italic> is an imperfect model for anthelmintic/nematicide discovery because it lacks several evolutionary innovations adopted by parasitic species. Indeed, if one can screen against the parasite itself, then they should do so. Several groups have provided beautiful examples of this direct approach (<xref rid="iyaf141-B110" ref-type="bibr">Marxer et al. 2012</xref>; <xref rid="iyaf141-B135" ref-type="bibr">Preston et al. 2016</xref>, <xref rid="iyaf141-B136" ref-type="bibr">2017a</xref>, <xref rid="iyaf141-B137" ref-type="bibr">2017b</xref>; <xref rid="iyaf141-B128" ref-type="bibr">Pasche et al. 2018</xref>; <xref rid="iyaf141-B108" ref-type="bibr">Maccesi et al. 2019</xref>; <xref rid="iyaf141-B129" ref-type="bibr">Pasche et al. 2019</xref>; <xref rid="iyaf141-B175" ref-type="bibr">Wheeler et al. 2023</xref>; <xref rid="iyaf141-B36" ref-type="bibr">Elfawal et al. 2025</xref>). However, it is undeniable that <italic toggle="yes">C. elegans</italic> genetics has been instrumental in revealing the molecular mechanisms of some of the most important broad-spectrum nematicidal molecules ever discovered, including the Nobel Prize-winning ivermectin (<xref rid="iyaf141-B27" ref-type="bibr">Cully et al. 1994</xref>; <xref rid="iyaf141-B32" ref-type="bibr">Dent et al. 2000</xref>), the amino-acetonitrile derivatives (aka AADs, aka monpantel) (<xref rid="iyaf141-B81" ref-type="bibr">Kaminsky et al. 2008</xref>), benzimidazole (<xref rid="iyaf141-B35" ref-type="bibr">Driscoll et al. 1989</xref>), levamisole (<xref rid="iyaf141-B12" ref-type="bibr">Brenner 1974</xref>; <xref rid="iyaf141-B41" ref-type="bibr">Fleming et al. 1997</xref>; <xref rid="iyaf141-B11" ref-type="bibr">Boulin et al. 2008</xref>), and emodepside (<xref rid="iyaf141-B57" ref-type="bibr">Guest et al. 2007</xref>; <xref rid="iyaf141-B26" ref-type="bibr">Crisford et al. 2011</xref>). Other nematicidal molecules also have demonstrable activity against <italic toggle="yes">C. elegans</italic>, including the derquantel precursor (<xref rid="iyaf141-B124" ref-type="bibr">Ondeyka et al. 1990</xref>; <xref rid="iyaf141-B142" ref-type="bibr">Ruiz-Lancheros et al. 2011</xref>; <xref rid="iyaf141-B88" ref-type="bibr">Koizumi et al. 2023</xref>) and the spiroindolines (<xref rid="iyaf141-B156" ref-type="bibr">Sluder et al. 2012</xref>). One can easily make the argument that each of these molecules could have been discovered using <italic toggle="yes">C. elegans</italic>.</p><p>In the early 2010s, we embarked on a large screening campaign that would dominate our focus for some time. Colleagues gave us access to 2 of their 50,000-molecule ChemBridge libraries. We prescreened one of these libraries in <italic toggle="yes">S. cerevisiae</italic> yeast at a high concentration to identify those with bioactivity and then screened the resulting bioactives against <italic toggle="yes">C. elegans</italic> (<xref rid="iyaf141-B170" ref-type="bibr">Wallace 2011</xref>; <xref rid="iyaf141-B107" ref-type="bibr">Luciani 2014</xref>). We screened the remaining 50,000-molecule library and molecules from a few other sources directly against worms (<xref rid="iyaf141-B107" ref-type="bibr">Luciani 2014</xref>). In total, we screened 67,012 distinct structures against <italic toggle="yes">C. elegans</italic> in 96-well plate liquid culture manually and identified 627 molecules that induced obvious phenotypes. We re-purchased these hits from vendors to assemble our custom worm active (wactive) library and gave each molecule a trivial name with a &#8220;wact&#8221; prefix followed by a unique number. We then screened the wactive library against other nematodes, parasitic or not, as well as cultured human cells and zebrafish to determine which molecules might have nematode selectivity. We ended up with 30 structurally distinct scaffolds as candidate nematicides/anthelmintics (<xref rid="iyaf141-B18" ref-type="bibr">Burns et al. 2015</xref>).</p><p>We reasoned that the most efficient approach to prioritize which of our hits could be understood mechanistically was by determining which might yield resistant mutants. Systematic genome-wide RNAi screens have previously been employed to reveal potential drug targets (<xref rid="iyaf141-B145" ref-type="bibr">Saur et al. 2013</xref>), but RNAi's low-throughput relative to forward genetic <italic toggle="yes">selection</italic> screens, together with RNAi's inability to generate hypermorphic or neomorphic mutations, which are important for revealing the target of inhibitors, made RNAi screens a less desirable option.</p><p>We carried out a large-scale campaign of forward genetic selection screens against our lethal hits and by 2015, completed screens against 39 molecules with a minimum of 50,000 mutant genomes screened, typically in both F1 and F2 screens, against each molecule (<xref rid="iyaf141-B18" ref-type="bibr">Burns et al. 2015</xref>). An additional 56 molecules were screened against thereafter (<xref rid="iyaf141-B138" ref-type="bibr">Pyche 2019</xref>; <xref rid="iyaf141-B61" ref-type="bibr">Harrington 2021</xref>). Screens were attempted with an additional 25, but the lethality of these molecules did not fully translate onto the solid substrate format that was used for genetic screens. In the end, robustly resistant mutants were isolated against 8 molecules, which included dafadine (<xref rid="iyaf141-B106" ref-type="bibr">Luciani et al. 2011</xref>), wact-86 (<xref rid="iyaf141-B19" ref-type="bibr">Burns et al. 2017</xref>), 2 crystal-forming compounds (<xref rid="iyaf141-B76" ref-type="bibr">Kamal et al. 2019</xref>; <xref rid="iyaf141-B79" ref-type="bibr">Kamal et al. 2023</xref>), and 4 wact-11 family members (<xref rid="iyaf141-B18" ref-type="bibr">Burns et al. 2015</xref>) (<xref rid="iyaf141-T3" ref-type="table">Table 3</xref>).</p><p>Our wact-11 study provides a good example of the power of genetic screens to provide mechanistic insight. A total of 33 wact-11 resistant mutants were isolated, and their whole genomes were sequenced. Astonishingly, 32 of the 33 mutants had mutations in 3 different components of the same complex; 10 had missense mutations in succinate dehydrogenase complex subunit B (<italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00006433?doi=10.1093/genetics/iyaf141" ext-link-type="uri">sdhb-1</ext-link></italic>); 16 had missense mutations in <italic toggle="yes">sdhc-1</italic>; and 6 had missense mutations in <italic toggle="yes"><ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00009353?doi=10.1093/genetics/iyaf141" ext-link-type="uri">sdhd-1</ext-link></italic>. Together, they defined the ubiquinone binding pocket within complex II of the electron transport chain (ETC). The mutations also revealed the likely binding site of the wact-11 molecule (<xref rid="iyaf141-B18" ref-type="bibr">Burns et al. 2015</xref>). Furthermore, several of the nematode residues that can be mutated to confer strong resistance to wact-11 are divergent in mammals, thereby explaining wact-11's nematode selectivity. A few years earlier, Bayer patented a highly related scaffold for nematicidal use and marketed it as fluopyram (<xref rid="iyaf141-F3" ref-type="fig">Fig. 3</xref>) (<xref rid="iyaf141-B54" ref-type="bibr">Greul et al. 2013</xref>). Hence, the wact-11 narrative illustrates the power of <italic toggle="yes">C. elegans</italic> to reveal molecules with real-world utility.</p><p>When chemical genetic screens work, whole genome sequencing of a large collection of resistant strains will often reveal multiple alleles within the same genes, which circumvents the laborious mapping of traits. Our experience indicates that these genes typically encode either the target or the components of the targeted pathway. Examples of this include nemadipine, wact-11, and wact-190 (<xref rid="iyaf141-T3" ref-type="table">Table 3</xref>). These experiments can be executed over the course of about 2 months and are so simple that we have adapted the approach to undergraduate lab classes. It is a testament to the progress of the field of genetics that we went from taking 2 decades of work by experienced geneticists to a couple of months of experimentation by inexperienced undergraduates to uncover the target of a small molecule.</p><p>Despite the success of wact-11, our genetic screening campaign yielded resistant mutants for only 8 of 120 bioactive molecules. This is a far cry from Brenner's 100% success rate. While all 8 led to exciting stories, it was clear that approaches beyond genetic screens are needed to understand how most bioactive compounds perturb <italic toggle="yes">C. elegans</italic> biology.</p></sec><sec id="iyaf141-s7"><title>Second generation screens for candidate nematicides and anthelmintics</title><p>After exhausting forward genetic screens, my group developed alternative strategies to characterize the wactives that resisted the genetic screen approach.</p><sec id="iyaf141-s7.1"><title>The Egl modulator screen</title><p>We hypothesized that some of our molecules that kill larvae over 6 d might induce other phenotypes when assayed in different contexts. Identifying those that induce specific motor phenotypes could lead to better hypotheses about their mechanism of action. We therefore established a collaboration with an engineering colleague to build an imaging instrument that measures the ability of <italic toggle="yes">C. elegans</italic> to lay eggs (aka embryos) (<xref rid="iyaf141-B5" ref-type="bibr">Au et al. 2025</xref>). The neuromuscular system that governs egg-laying is controlled by cholinergic, serotoninergic, GABAergic, and peptidergic inputs (<xref rid="iyaf141-B146" ref-type="bibr">Schafer 2006</xref>) and is therefore sensitive to a wide variety of perturbations. A screen of our wactive library revealed 58 egg-laying (Egl) modulators, about half of which also induced other motor phenotypes including convulsions, shaking, and coiling (<xref rid="iyaf141-B62" ref-type="bibr">Harrington et al. 2022</xref>).</p><p>Returning to our &#8220;phenotype to hypothesis to target&#8221; mantra, the convulsions induced by wact-55 led to an understanding that the molecule agonizes presynaptic vesicle release and has potential utility in selectively enhancing the killing of nematodes by the nonselective acetylcholine esterase inhibitors (<xref rid="iyaf141-B62" ref-type="bibr">Harrington et al. 2022</xref>). Similarly, the coiling phenotype induced by the wact-45 family directly led to its vesicular acetylcholine transporter target (<xref rid="iyaf141-B63" ref-type="bibr">Harrington et al. 2023</xref>), which is an established anthelmintic target (<xref rid="iyaf141-B156" ref-type="bibr">Sluder et al. 2012</xref>). Fruit remains on the Egl-modulator tree, including several molecules that induce convulsions.</p></sec><sec id="iyaf141-s7.2"><title>The P450 bioactivation screen</title><p>Inspired by our earlier work on drug metabolism in the worm (<xref rid="iyaf141-B16" ref-type="bibr">Burns et al. 2010</xref>) and the structural similarities of one of our wactive molecules (wact-1) to cytochrome P450-bioactivated molecules, we investigated whether wact-1 is metabolized into a lethal product by one or more of the worm's 76 P450s (<xref rid="iyaf141-B93" ref-type="bibr">Larigot et al. 2022</xref>). The oxidation of small molecules by P450&#8197;s can pull electrons away from neighboring atoms, making them electrophilic and reactive, which in turn can incapacitate the cell through their interaction with essential nucleophiles (<xref rid="iyaf141-B55" ref-type="bibr">Guengerich 2006</xref>). We showed this to be true for wact-1, and together with the support of collaborators, we demonstrated real-world nematicidal potential for the molecule, which we renamed selectivin (<xref rid="iyaf141-B20" ref-type="bibr">Burns et al. 2023</xref>).</p><p>Our early results inspired us to rescreen the wactive library for other molecules whose lethal effects might be dependent on P450 bioactivation. We did this using established methods to incapacitate the cofactor needed for all microsomal P450 activity (<xref rid="iyaf141-B60" ref-type="bibr">Harlow et al. 2018</xref>) and asked whether the wactive lost killing potency. The screen revealed additional P450-bioactivated molecules, including wact-4, which we developed into cyprocide (<xref rid="iyaf141-B87" ref-type="bibr">Knox et al. 2024</xref>), and others that we continue to work on.</p></sec><sec id="iyaf141-s7.3"><title>The crystal screen</title><p>From our very first drug screens, we noticed that worms co-incubated with select small molecules develop dark objects near the lumen of the pharynx. Others have reported this phenotype as well [see Fig. 6c in <xref rid="iyaf141-B141" ref-type="bibr">Risi et al. (2019)</xref> and <xref rid="iyaf141-B44" ref-type="bibr">Galford and Jose (2020)</xref>]. Our curiosity about the dark objects was reignited upon finding that we were able to isolate mutants that resisted both the lethality and the object formation, one of the object-inducing molecules called wact-190 (<xref rid="iyaf141-B76" ref-type="bibr">Kamal et al. 2019</xref>). We showed that the dark objects are crystalline in nature (ie they are birefringent in vivo and can form a crystal lattice in vitro), are at least partially composed of the exogenous small molecule, and are seeded within the pharynx cuticle and grow to pierce the underlying epithelium, which is at least in part responsible for their ability to kill young larvae (<xref rid="iyaf141-B76" ref-type="bibr">Kamal et al. 2019</xref>, <xref rid="iyaf141-B79" ref-type="bibr">2023</xref>).</p><p>At the genetic level, the activity of a sphingomyelin synthesis pathway and the <ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00004008?doi=10.1093/genetics/iyaf141" ext-link-type="uri">PGP-14</ext-link> export pump, expressed specifically by the myoepithelium beneath the pharynx cuticle, are necessary for the deposition of polar lipids into the cuticle, which is in turn necessary for the accumulation of the hydrophobic crystalizing molecules (<xref rid="iyaf141-B77" ref-type="bibr">Kamal et al. 2022</xref>, <xref rid="iyaf141-B79" ref-type="bibr">2023</xref>).</p><p>A detailed screen of 197 wactives revealed that 48 form birefringent crystals. The lethality and crystal formation of 23 of these is suppressed upon mutating the <ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00004008?doi=10.1093/genetics/iyaf141" ext-link-type="uri">PGP-14</ext-link> pump (<xref rid="iyaf141-B76" ref-type="bibr">Kamal et al. 2019</xref>, <xref rid="iyaf141-B79" ref-type="bibr">2023</xref>). We infer that the remaining 25 crystal-forming wactives have multiple mechanisms by which they can kill the worm.</p><p>While we continue to exploit the crystal-forming molecules as tools, the nematicidal utility of crystalizing wactives has yet to be fully explored. In preliminary analyses, we find that wact-190 can form crystals in the pharynx cuticle of some species but not others (<xref rid="iyaf141-B78" ref-type="bibr">Kamal 2023</xref>). Nematicidal utility will likely depend on the molecular composition of the species' pharynx cuticle.</p></sec><sec id="iyaf141-s7.4"><title>The kinase inhibitor screen</title><p>In parallel to our work on the wactive library, we assembled a collection of 2040 molecules targeting vertebrate kinases for the purpose of identifying small molecule scaffolds that might be modified to generate selectivity against essential nematode kinases. The pipeline consisted of first identifying vertebrate kinase inhibitors that induced phenotypes in <italic toggle="yes">C. elegans</italic> that are consistent with the reduction-of-function phenotype of the respective orthologous kinase in <italic toggle="yes">C. elegans</italic>. We then asked whether the corresponding worm kinase might have a drug-binding pocket that is different in some way from the vertebrate kinase and whether these differences are conserved among parasitic nematodes. With these types of hits, we could in principle modify the initial hit to generate nematode selectivity. We identified nematode EGFR (<ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00002299?doi=10.1093/genetics/iyaf141" ext-link-type="uri">LET-23</ext-link>), MEK1/2 (<ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00003186?doi=10.1093/genetics/iyaf141" ext-link-type="uri">MEK-2</ext-link>), and PLK1 (<ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00004042?doi=10.1093/genetics/iyaf141" ext-link-type="uri">PLK-1</ext-link>) kinases as not only being druggable in the worm but also having distinct differences in their drug-binding pockets that make them good candidate targets for anthelmintic development (<xref rid="iyaf141-T3" ref-type="table">Table 3</xref>) (<xref rid="iyaf141-B86" ref-type="bibr">Knox et al. 2021</xref>).</p></sec></sec><sec id="iyaf141-s8"><title>Novel approaches to identify candidate nematicides and anthelmintics</title><p>Several technologies have been developed or employed to advance high-throughput small molecule screening with <italic toggle="yes">C. elegans</italic> [see <xref rid="iyaf141-T4" ref-type="table">Table 4</xref> in <xref rid="iyaf141-B59" ref-type="bibr">Hahnel et al. (2020)</xref> with additional highlights shown in <xref rid="iyaf141-T4" ref-type="table">Table 4</xref>]. Those that have been exploited to screen 400 or more molecules for nematicidal potential and yielded hits that were characterized in detail are described here.</p><table-wrap position="float" id="iyaf141-T4" orientation="portrait"><label>Table 4.</label><caption><p>Technologies and protocols that aid throughput of <italic toggle="yes">C. elegans</italic> small molecule screens.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Technology or protocol</th><th align="center" rowspan="1" colspan="1">Innovation</th><th align="center" rowspan="1" colspan="1">Notable publications related to higher-throughput <italic toggle="yes">C. elegans</italic> drug assays</th></tr></thead><tbody><tr><td colspan="3" rowspan="1">
<bold>Animal preparation for screens</bold>
</td></tr><tr><td rowspan="1" colspan="1">Vital dyes</td><td rowspan="1" colspan="1">The use of vital dyes to measure the percentage of worms alive in a well</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B49" ref-type="bibr">Gill et al. (2003)</xref>; <xref rid="iyaf141-B71" ref-type="bibr">James and Davey (2007)</xref>; <xref rid="iyaf141-B40" ref-type="bibr">Ferreira et al. (2015)</xref>; <xref rid="iyaf141-B134" ref-type="bibr">Phiri et al. (2017)</xref></td></tr><tr><td rowspan="1" colspan="1">COPAS Biosort</td><td rowspan="1" colspan="1">a worm analyzer and dispenser with multiple utilities, including dispensing worms into multiwell plates for high-throughput screens</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B89" ref-type="bibr">Kwok et al. (2006)</xref>; <xref rid="iyaf141-B111" ref-type="bibr">Mathew et al. (2016)</xref>; <xref rid="iyaf141-B33" ref-type="bibr">Dilks et al. (2021)</xref>; <xref rid="iyaf141-B176" ref-type="bibr">Wit et al. (2021)</xref>; <xref rid="iyaf141-B123" ref-type="bibr">O'Brien et al. (2025)</xref></td></tr><tr><td rowspan="1" colspan="1">Live-animal FACS (aka, laFACS)</td><td rowspan="1" colspan="1">The use of FACS to sort fluorescently labeled (eg, GFP-expressing) animals based on particular properties (eg genotype) for small molecule screens</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B39" ref-type="bibr">Fernandez et al. (2010)</xref>
</td></tr><tr><td rowspan="1" colspan="1">BioTek MicroFlo</td><td rowspan="1" colspan="1">Rapid deposition of animals into wells</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B97" ref-type="bibr">Leung et al. (2013)</xref>
</td></tr><tr><td colspan="3" rowspan="1">
<bold>Innovative screening methodologies</bold>
</td></tr><tr><td rowspan="1" colspan="1">Lifespan Extension Assay</td><td rowspan="1" colspan="1">High-throughput analysis of lifespan extension in 96-well plate format</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B157" ref-type="bibr">Solis and Petrascheck (2011)</xref>; <xref rid="iyaf141-B105" ref-type="bibr">Lucanic et al. (2018)</xref></td></tr><tr><td rowspan="1" colspan="1">Bacterial Ghosts (using dead <italic toggle="yes">E. coli</italic> to Feed <italic toggle="yes">C. elegans</italic>)</td><td rowspan="1" colspan="1">allows for more reproducible results in high-throughput assays because worm phenotypes are not confounded by overgrowth of <italic toggle="yes">E. coli</italic></td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B34" ref-type="bibr">Dranchak et al. (2023)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Custom Microfluidic Devices</td><td rowspan="1" colspan="1">Lower throughput, but innovations allow for unparalleled analyses of single animals over time</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B22" ref-type="bibr">Carr et al. (2011)</xref>; reviewed in <xref rid="iyaf141-B179" ref-type="bibr">Yoon et al. (2024)</xref></td></tr><tr><td colspan="3" rowspan="1">
<bold>Microscope-Based Imaging and Data Capture</bold>
</td></tr><tr><td rowspan="1" colspan="1">Phenalysis Microplate Imaging</td><td rowspan="1" colspan="1">A high-throughput imager for the analysis of various traits, including movement</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B159" ref-type="bibr">Spensley et al. (2018)</xref>; <xref rid="iyaf141-B30" ref-type="bibr">Davie et al. (2024)</xref></td></tr><tr><td rowspan="1" colspan="1">INVAPP/Paragon Imager</td><td rowspan="1" colspan="1">Measures movement of animals in the wells of a 96-well plate at a rate of 100 plates per hour</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B126" ref-type="bibr">Partridge et al. (2018)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Microscope in a Box (eg Molecular Devices ImageXpress Nano microscope)</td><td rowspan="1" colspan="1">One of several versatile systems for high-throughput and high-content image collection and analyses</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B52" ref-type="bibr">Gosai et al. (2010)</xref>; <xref rid="iyaf141-B153" ref-type="bibr">Shaver et al. (2023)</xref>; <xref rid="iyaf141-B38" ref-type="bibr">Fahs et al. (2025)</xref></td></tr><tr><td colspan="3" rowspan="1">
<bold>Other Data Capture Methods</bold>
</td></tr><tr><td rowspan="1" colspan="1">PhylumTech's WMicrotracker</td><td rowspan="1" colspan="1">A multiwell plate reader that measures movement based on infrared signal disruption</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B154" ref-type="bibr">Simonetta and Golombek (2007)</xref>; <xref rid="iyaf141-B147" ref-type="bibr">Schmeisser et al. (2017)</xref>; <xref rid="iyaf141-B141" ref-type="bibr">Risi et al. (2019)</xref>; <xref rid="iyaf141-B177" ref-type="bibr">World Health Organization (2020)</xref>; <xref rid="iyaf141-B164" ref-type="bibr">Taki et al. (2021)</xref>; <xref rid="iyaf141-B2" ref-type="bibr">Alberich et al. (2025)</xref></td></tr><tr><td rowspan="1" colspan="1">WormScan</td><td rowspan="1" colspan="1">a flatbed line scan imager exploited to measure lethality, reduced fecundity, slow growth, and immobility</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B112" ref-type="bibr">Mathew et al. (2012)</xref>; <xref rid="iyaf141-B111" ref-type="bibr">Mathew et al. (2016)</xref></td></tr><tr><td rowspan="1" colspan="1">InVivo Biosystems Electropharyngeogram Microfluidic Chip</td><td rowspan="1" colspan="1">Rapid determination of a compound&#8217;s effect on the neuromuscular activity of the pharynx of free-living and parasitic nematodes</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B102" ref-type="bibr">Lockery et al. (2012)</xref>; <xref rid="iyaf141-B172" ref-type="bibr">Weeks et al. (2018)</xref></td></tr><tr><td rowspan="1" colspan="1">2020 Imager</td><td rowspan="1" colspan="1">Rapid higher resolution line scanning instrument</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B62" ref-type="bibr">Harrington et al. (2022)</xref>; <xref rid="iyaf141-B5" ref-type="bibr">Au et al. 2025</xref> (in review)</td></tr><tr><td rowspan="1" colspan="1">Gustatory Microplate</td><td rowspan="1" colspan="1">A microfluidic device that reveals compounds that are attractive and noxious to free-living and parasitic nematodes in a high-throughput manner</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B121" ref-type="bibr">Nunn et al. (2023)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Laser-Scanning Cytometry</td><td rowspan="1" colspan="1">Rapid high-content screening with fluorescently labeled (GFP reporters, etc.) <italic toggle="yes">C. elegans</italic> samples</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B34" ref-type="bibr">Dranchak et al. (2023)</xref>
</td></tr></tbody></table></table-wrap><p>While most <italic toggle="yes">C. elegans</italic> drug screens had previously focused on long-term effects of compounds after several days of drug treatment, Andy Fraser's group developed a system to measure acute effects on the scale of minutes to hours. The approach, called Phenalysis Microplate Imaging (PMI), is carried out in 96-well plate format and measures worm movement (<xref rid="iyaf141-T4" ref-type="table">Table 4</xref>) (<xref rid="iyaf141-B159" ref-type="bibr">Spensley et al. 2018</xref>). Two successive images of a well are captured, separated by 500&#8197;ms, and pixel displacement from 1 image to the next is measured. Data from 96 wells can be captured in &#8764;5&#8197;min. This allows the user to determine the acute impact of molecules on worm movement in a relatively high-throughput manner. Using this technology, the group discovered that <italic toggle="yes">C. elegans</italic> employs a rhodoquinone-dependent electron transport chain (ETC) to thrive in little to no oxygen, which is conveniently mimicked by cyanide treatment that blocks the ETC from using oxygen as an electron acceptor (<xref rid="iyaf141-B31" ref-type="bibr">Del Borrello et al. 2019</xref>). This alternative to a ubiquinone-dependent ETC allows the use of diverse electron acceptors such as fumarate and is an architectural solution for dealing with hypoxic stress that is shared by only a few types of animals, including soil-transmitted helminth (STH) (nematode) parasites but not their mammalian hosts. Hence, cyanide-treated <italic toggle="yes">C. elegans</italic> serves as a model for STH viability within the hypoxic milieu of their mammalian hosts. The group went on to use their technology to screen 480 structurally distinct small molecule scaffolds for those able to selectively kill cyanide-tolerant <italic toggle="yes">C. elegans</italic> (<xref rid="iyaf141-B30" ref-type="bibr">Davie et al. 2024</xref>). They identified a novel class of compounds that contain a benzimidazole core and are species-selective inhibitors of complex I of the ETC (<xref rid="iyaf141-T3" ref-type="table">Table 3</xref>). Excitingly, their lead molecules translated to adult nematode parasites and serve as candidate anthelmintics.</p><p>Using an inexpensive flatbed scanner, Don Moerman and colleagues were able to screen roughly 26,000 compounds for their ability to kill, paralyze, or reduce the brood size of <italic toggle="yes">C. elegans</italic> in a high-throughput manner (<xref rid="iyaf141-B111" ref-type="bibr">Mathew et al. 2016</xref>). Their approach, called WormScan (<xref rid="iyaf141-T4" ref-type="table">Table 4</xref>), relies on 2 successive scans of the wells of a 96-well plate over a total of 2.5&#8197;min. Changes in the images for a particular well, or lack thereof, over successive scans reveal phenotype (<xref rid="iyaf141-B112" ref-type="bibr">Mathew et al. 2012</xref>). The first WormScan screen yielded 5 compounds with IC50s in the low micromolar range, including one (2747322) that likely inhibits complex II of the electron transport chain as revealed through a forward genetic screen for resistant mutants (<xref rid="iyaf141-T3" ref-type="table">Table 3</xref>). 2747322 is similar in structure to the aforementioned wact-11 and fluopyram complex II inhibitors. Other hits from the screen have yet to be investigated in detail and remain good nematicidal candidates.</p><p>The WMicroTracker instrument, which measures the ability of sample content to interrupt infrared light, has been employed to identify compounds that perturb <italic toggle="yes">C. elegans</italic> development and movement (eg <xref rid="iyaf141-B101" ref-type="bibr">Liu et al. 2018</xref>; <xref rid="iyaf141-B141" ref-type="bibr">Risi et al. 2019</xref>). For example, Robin Gasser's group has used the WMicroTracker to screen 14,400 synthetic small molecules in 384-well plate format at a reported throughput of &#8764;10,000 compounds per week (<xref rid="iyaf141-B164" ref-type="bibr">Taki et al. 2021</xref>). A total of 40 hits were identified that reduce adult motility by 70% or more. One of these hits was characterized in detail and was found to translate to the ruminant parasitic nematode <italic toggle="yes">Haemonchus contortus</italic> (<xref rid="iyaf141-B164" ref-type="bibr">Taki et al. 2021</xref>; <xref rid="iyaf141-B151" ref-type="bibr">Shanley et al. 2024b</xref>). The Gasser group used the same technology to screen the 400 drug-like compounds from the Pandemic Response Box simultaneously against <italic toggle="yes">C. elegans</italic> and <italic toggle="yes">H. contortus</italic> (<xref rid="iyaf141-B149" ref-type="bibr">Shanley et al. 2022</xref>). Three hits had low micromolar activity against both species, one of which was characterized in detail including the identification of an aldo-keto reductase (HCON_00074590) as a candidate target in <italic toggle="yes">H. contortus</italic> (<xref rid="iyaf141-T3" ref-type="table">Table 3</xref>) using proteomics-based methodology (<xref rid="iyaf141-B150" ref-type="bibr">Shanley et al. 2024a</xref>).</p><p>There are many excellent options for microscope-in-a-box technologies that come with powerful software for high-content high-throughput analyses of samples in multiwell plate format. The Piano and Gunsalus groups employed one of these, the Cellinsight CX5 instrument from Thermo Fisher Scientific, to screen 2320 compounds from MicroSource Discovery Systems Inc against <italic toggle="yes">C. elegans</italic> and another free-living nematode species <italic toggle="yes">Pristionchus pacificus</italic> in parallel (<xref rid="iyaf141-T4" ref-type="table">Table 4</xref>) (<xref rid="iyaf141-B38" ref-type="bibr">Fahs et al. 2025</xref>). The groups discovered a family of molecules derived from avocados, called avocado-derived fatty alcohols/acetates (AFAs), that induce a suite of detrimental phenotypes against both nematode species at low micromolar concentrations while doing little against cultured human cells (U2-OS) or mice (<xref rid="iyaf141-T3" ref-type="table">Table 3</xref>). A series of chemical genetic experiments indicated that the <ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00004076?doi=10.1093/genetics/iyaf141" ext-link-type="uri">POD-2</ext-link> acetyl-CoA carboxylase is likely a key target of the AVAs and its disruption is at least partially responsible for the observed phenotypes. Remarkably, the molecules translate well against multiple parasitic species, <italic toggle="yes">H. contortus</italic>, <italic toggle="yes">Teladorsagia circumcincta</italic>, and <italic toggle="yes">Heligmosomoides polygyrus</italic>. Given that 1 representative structure (Avocatin B) has a favorable safety profile in humans (<xref rid="iyaf141-B1" ref-type="bibr">Ahmed et al. 2019</xref>), the AFAs are a promising class of candidate anthelmintics.</p><p>While the new screening technologies described above drive discovery and can dramatically increase throughput, the technology's expense can also be a barrier to entry for some. It is important for those without extensive resources to note that with an obvious phenotype, a simple dissection microscope, a multichannel pipette, access to a library of compounds, and a manual drug pinning tool, a throughput of thousands of molecules per week per person can still be achieved.</p></sec><sec id="iyaf141-s9"><title>Beyond nematicides</title><p>The investigation of small molecule crystal formation within the pharynx of <italic toggle="yes">C. elegans</italic>, as strange as crystals may be, led us down a surprising path. In addition to the forward genetic screen that revealed the role of <ext-link xlink:href="https://identifiers.org/bioentitylink/WB:WBGene00004008?doi=10.1093/genetics/iyaf141" ext-link-type="uri">PGP-14</ext-link> and a sphingomyelin synthesis pathway, we performed a screen of characterized drugs and natural products from the Spectrum library (MicroSource Inc) for molecules that could also suppress crystal-induced death.</p><p>Screening molecules with characterized modes of action can sometimes reveal information about a process beyond that which can provided by genetic screens. For example, a small molecule may agonize a target that cannot be mutated to a gain of function or may simultaneously disrupt a family of paralogous proteins that are highly unlikely to be mutated coincidentally in a founding suppressor mutant. Identifying compounds with known mechanisms of action that can suppress a process of interest, like crystal formation within the pharynx cuticle, can immediately lead to hypotheses about how the suppression is occurring and, in turn, lead to new biological insights.</p><p>Of the 2,560 spectrum molecules screened, we identified 85 that suppressed crystal-induced death. A search of chemoinformatic databases revealed that 33% of the unique scaffolds from the 85 molecules were known amyloid disruptors, which was 10-fold more than expected by random chance (<xref rid="iyaf141-B80" ref-type="bibr">Kamal et al. 2024</xref>). Additional experiments in our lab and that of our collaborators supported the idea that amyloid-like material within the pharynx cuticle was important for seeding crystal formation. This very unexpected result suggested that other molecules identified in the screen might have amyloid-disrupting potential as well, which our collaborators showed to be true (<xref rid="iyaf141-B80" ref-type="bibr">Kamal et al. 2024</xref>). Hence, the strange phenomenon of crystal formation fortuitously led to the discovery of a facile in vivo pipeline that yields candidate amyloid suppressors. Given the prevalence of amyloid-based diseases, this work has the potential to lead to real-world utility.</p><p>Obviously, we stumbled onto this neurodegeneration-related story. As illustrated in <xref rid="iyaf141-F2" ref-type="fig">Fig. 2</xref>, neurodegeneration-based drug studies are one of <italic toggle="yes">C. elegans</italic>' most popular uses. A good example of how <italic toggle="yes">C. elegans</italic> can be exploited in this regard comes from Alex Parker's and Pierre Drapeau's labs. The Parker group generated a worm model of ALS by expressing human mutant TDP-43 in GABAergic motor neurons, which induced age-dependent paralysis (<xref rid="iyaf141-B167" ref-type="bibr">Vaccaro et al. 2012</xref>). A set of 3,850 drugs and natural products was then screened for their ability to suppress the paralysis of their model. Hits were tested by the Drapeau group for their ability to suppress fish and mouse models of ALS, and it was found that the neuroleptic pimozide provided significant neuroprotective effects (<xref rid="iyaf141-B130" ref-type="bibr">Patten et al. 2017</xref>). Encouragingly, the compound prevented the decline in some measures of motor function in a small trial of 24 human ALS patients (<xref rid="iyaf141-B130" ref-type="bibr">Patten et al. 2017</xref>). Efforts are ongoing to optimize pimozide and its analogs (<xref rid="iyaf141-B10" ref-type="bibr">Bose et al. 2019</xref>) as a treatment for ALS (Drapeau, personal communication). Similarly, Lorraine Kalia's group found small molecule suppressors of alpha-synuclein-induced motor phenotypes in the worm that translated to a mammalian model (<xref rid="iyaf141-B24" ref-type="bibr">Chen et al. 2021</xref>). These examples typify how <italic toggle="yes">C. elegans</italic> can be used to screen for novel or repurposed drugs against human targets in so-called humanized strains. Other <italic toggle="yes">C. elegans</italic> models of neurodegeneration are highlighted in recent reviews (<xref rid="iyaf141-B50" ref-type="bibr">Giunti et al. 2021</xref>; <xref rid="iyaf141-B21" ref-type="bibr">Caldero-Escudero et al. 2024</xref>).</p></sec><sec id="iyaf141-s10"><title>Mining hits for biological and structural insight</title><sec id="iyaf141-s10.1"><title>Exploring SciFinder</title><p>Small molecule vendors like ChemBridge and ChemDiv sell molecules that have physicochemical properties that make them good drug candidates [ie they largely follow Lipinski's rules (<xref rid="iyaf141-B100" ref-type="bibr">Lipinski et al. 1997</xref>)]. The majority of their stocks have not been extensively characterized in biological assays, making them ripe for discovery. Yet some fraction of the vendors' offerings are structurally similar to well-characterized molecules. This is presumably because of the limitations of synthetic chemistry combined with the physicochemical limitations imposed by Lipinski's rules. Hence, upon identifying a hit, a key question to ask is whether the hit is likely new in terms of biological activity or whether it is a close structural analog of a previously characterized molecule. If the latter, might the hit still have potential value as a tool compound or as a candidate nematicide? To answer these questions, SciFinder Scholar is an excellent tool with which to explore what is known about hits of interest and their close structural analogs (<xref rid="iyaf141-B158" ref-type="bibr">Somerville 1998</xref>) (<xref rid="iyaf141-T5" ref-type="table">Table 5</xref>).</p><table-wrap position="float" id="iyaf141-T5" orientation="portrait"><label>Table 5.</label><caption><p>Computational-related resources used for hit analyses.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Tool</th><th align="center" rowspan="1" colspan="1">Utility</th><th align="center" rowspan="1" colspan="1">Academic citation</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">CFM-ID</td><td rowspan="1" colspan="1">Predictor of fragments generated in tandem mass spectrometry (used for drug metabolite analyses in the Roy lab)</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B171" ref-type="bibr">Wang et al. (2022)</xref>
</td></tr><tr><td rowspan="1" colspan="1">ChemDraw</td><td rowspan="1" colspan="1">visualization of small molecules in specific formats</td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">Cytoscape</td><td rowspan="1" colspan="1">Visualization of small molecule similarity networks</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B152" ref-type="bibr">Shannon et al. (2003)</xref>
</td></tr><tr><td rowspan="1" colspan="1">MolPort</td><td rowspan="1" colspan="1">Sourcing hits and structural analogs</td><td rowspan="1" colspan="1">None</td></tr><tr><td rowspan="1" colspan="1">Open Babel</td><td rowspan="1" colspan="1">Accepts small molecule names in different formats and generates extensive physicochemical properties for inputed molecules</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B122" ref-type="bibr">O'Boyle et al. (2011)</xref>
</td></tr><tr><td rowspan="1" colspan="1">SciFinder Scholar</td><td rowspan="1" colspan="1">Identifying similar molecules in the academic and patent literature, sourcing hits and structural analogs</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B158" ref-type="bibr">Somerville (1998)</xref>
</td></tr><tr><td rowspan="1" colspan="1">SwissADME</td><td rowspan="1" colspan="1">Facile SMILES visualizer provides downloadable physicochemical properties of inputed list of molecules</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B28" ref-type="bibr">Daina et al. (2017)</xref>
</td></tr><tr><td rowspan="1" colspan="1">Zinc</td><td rowspan="1" colspan="1">Sourcing hits and structural analogs</td><td rowspan="1" colspan="1">
<xref rid="iyaf141-B166" ref-type="bibr">Tingle et al. (2023)</xref>
</td></tr></tbody></table></table-wrap><p>SciFinder uses the Jaccard&#8211;Tanimoto scoring system (<xref rid="iyaf141-B118" ref-type="bibr">Nikolova and Jaworska 2004</xref>) to measure how similar a query is to molecules within the academic and patent literature, as well as to any molecule available from vendors around the globe. Small changes in atom composition, side groups, or ring size can decrease the similarity score. Hence, molecules that look similar to the human eye may have low similarity scores and be far down on the similarity list [eg selectivin and levamisole (<xref rid="iyaf141-F3" ref-type="fig">Fig. 3</xref>)]. Spending time inspecting as many analogs as possible on SciFinder can be revealing. Beyond SciFinder, we and others also take an experimental approach to determine whether a nematicidal hit may have a known mechanism of action by testing whether its associated phenotype can be suppressed by mutants that suppress the lethality induced by established nematicides and anthelmintics (<xref rid="iyaf141-T2" ref-type="table">Table 2</xref>).</p><p>My group has pursued hits that have different degrees of similarity to previously characterized molecules (<xref rid="iyaf141-F3" ref-type="fig">Fig. 3</xref>). Dafadine (<xref rid="iyaf141-B106" ref-type="bibr">Luciani et al. 2011</xref>), nementin (<xref rid="iyaf141-B62" ref-type="bibr">Harrington et al. 2022</xref>), wact-86 (<xref rid="iyaf141-B19" ref-type="bibr">Burns et al. 2017</xref>), wact-190 (<xref rid="iyaf141-B76" ref-type="bibr">Kamal et al. 2019</xref>), and cyprocide (<xref rid="iyaf141-B87" ref-type="bibr">Knox et al. 2024</xref>) appear to be &#8220;first-in-class&#8221; molecules. By contrast, nemadipine is similar to the characterized L-type calcium channel inhibitors dihydropyridines but has the unique property in <italic toggle="yes">C. elegans</italic> of not being rapidly detoxified (<xref rid="iyaf141-B89" ref-type="bibr">Kwok et al. 2006</xref>). Nemacol is similar to the VAChT inhibitor vesamicol but has greater selectivity for the nematode ortholog (<xref rid="iyaf141-B63" ref-type="bibr">Harrington et al. 2023</xref>). Wact-11 (<xref rid="iyaf141-B18" ref-type="bibr">Burns et al. 2015</xref>) and Don Moerman's CID 2747322 (<xref rid="iyaf141-B111" ref-type="bibr">Mathew et al. 2016</xref>) are similar to fluopyram, but the 2 molecules led to a better understanding of how these molecules interact with complex II and what residues confer nematode selectivity. Selectivin is similar to levamisole but has a completely different mechanism of action (<xref rid="iyaf141-B20" ref-type="bibr">Burns et al. 2023</xref>). Migrazole induces a set of phenotypes in <italic toggle="yes">C. elegans</italic> that are not induced by the closely related analog fatostatin (<xref rid="iyaf141-B91" ref-type="bibr">Kwok 2011</xref>). Hence, there can be value in pursuing hits even if they share some structural similarity with characterized molecules.</p></sec><sec id="iyaf141-s10.2"><title>Exploring structural analogs</title><p>Upon identifying a hit of interest, it can be useful to investigate what parts of the molecule are essential for its activity, what parts can vary without effect, and what changes can be made to improve its potency and, if relevant, its species selectivity. These structure&#8211;activity relationships (SARs) can be investigated in a few ways. First, pairwise Jaccard&#8211;Tanimoto similarity scores can be calculated for all molecules within a screened library. The resulting structural similarity network can be visualized using Cytoscape network software, and any analogs already screened can be easily visualized (eg <xref rid="iyaf141-B80" ref-type="bibr">Kamal et al. 2024</xref>). Second, SciFinder Scholar, Zinc (<xref rid="iyaf141-B166" ref-type="bibr">Tingle et al. 2023</xref>), and MolPort can be exploited to identify analogs that are commercially available (<xref rid="iyaf141-T5" ref-type="table">Table 5</xref>). Third, collaborations with academic chemists can be fruitful in generating useful and unique structural analogs of hits. The analysis of analogs can reveal the key structural features of a hit of interest, and additional rounds of structural optimization can then be carried out. In some projects, activity is only modestly improved [see selectivin (<xref rid="iyaf141-B20" ref-type="bibr">Burns et al. 2023</xref>), nementin (<xref rid="iyaf141-B62" ref-type="bibr">Harrington et al. 2022</xref>), nemacol (<xref rid="iyaf141-B63" ref-type="bibr">Harrington et al. 2023</xref>), UMW-9729 (<xref rid="iyaf141-B151" ref-type="bibr">Shanley et al. 2024b</xref>), and ABX464 (<xref rid="iyaf141-B150" ref-type="bibr">Shanley et al. 2024a</xref>) for examples]. In others, activity has been dramatically improved [see wact-11 (<xref rid="iyaf141-B18" ref-type="bibr">Burns et al. 2015</xref>), cyprocide (<xref rid="iyaf141-B87" ref-type="bibr">Knox et al. 2024</xref>), and NPD8790 (<xref rid="iyaf141-B30" ref-type="bibr">Davie et al. 2024</xref>) for examples].</p></sec></sec><sec id="iyaf141-s11"><title>Some limitations of <italic toggle="yes">C. elegans</italic>' utility in drug studies</title><p>No one model system is perfect, and <italic toggle="yes">C. elegans</italic> is no exception. One limitation is that a few commercial nematicides and anthelmintics are ineffective against <italic toggle="yes">C. elegans</italic> [eg albendazole, fluazaindolizine, and pyrantel (<xref rid="iyaf141-B65" ref-type="bibr">Hu et al. 2013</xref>; <xref rid="iyaf141-B92" ref-type="bibr">Lahm et al. 2017</xref>)]. Hence, using <italic toggle="yes">elegans</italic> to identify novel broad-spectrum nematicides will undoubtedly miss some potentially great hits. However, this point is likely true for any single screening platform. For example, the anthelmintics ivermectin and oxibendazole are ineffective in in vitro assays against the <italic toggle="yes">Trichuris muris</italic> whipworm parasitic model (<xref rid="iyaf141-B83" ref-type="bibr">Keiser et al. 2016</xref>; <xref rid="iyaf141-B37" ref-type="bibr">Elfawal et al. 2019</xref>). A second issue is that there has yet to be a novel or repurposed hit discovered from a <italic toggle="yes">C. elegans</italic> screen that has made it to the clinic or market as far as we are aware. The same can be said for academic efforts using nematode parasites in de novo drug screens (J. Keiser, personal communication). Regardless, some molecules from humanized <italic toggle="yes">C. elegans</italic> drug screens show promise (<xref rid="iyaf141-B130" ref-type="bibr">Patten et al. 2017</xref>; <xref rid="iyaf141-B10" ref-type="bibr">Bose et al. 2019</xref>; <xref rid="iyaf141-B24" ref-type="bibr">Chen et al. 2021</xref>), and some of our nematicidal molecules are being evaluated by agrochemical companies, which is encouraging. Given the growing intensity of drug studies in <italic toggle="yes">C. elegans</italic> (<xref rid="iyaf141-F1" ref-type="fig">Fig. 1</xref>), there is hope that something will soon be born of the worm with utility beyond academia.</p></sec><sec id="iyaf141-s12"><title>Conclusion</title><p>The study of <italic toggle="yes">C. elegans</italic> has yielded foundational insights that have rippled to most corners of the biomedical world. The earliest of investigations with the worm sought an understanding of the mechanism of action of a single small molecule (levamisole) that laid the groundwork for thousands of drug studies that followed. This review has focused on the largest of <italic toggle="yes">C. elegans</italic> drug screens and how the resulting hits were characterized by exploiting the worm's awesome genetic power. We hope this review will inspire others to exploit <italic toggle="yes">C. elegans</italic> for early-stage drug discovery and uncover new molecules with potential utility. It is hard to imagine a more genetically tractable and economically accessible model organism with which to do so.</p></sec></body><back><ack id="ack1"><title>Acknowledgments</title><p>We thank <italic toggle="yes">Genetics</italic> for providing us with the opportunity to discuss our perspective on this subject. We are grateful to Lindy Holden-Dye for reviewing a draft of this manuscript and to Matej Usaj from Charlie Boone's lab who helped with <xref rid="iyaf141-F2" ref-type="fig">Fig. 2</xref>.</p></ack><sec id="iyaf141-s13"><title>Funding</title><p>The work from my group discussed here has been supported by Canadian Institutes of Health Research grants 68813, 133526, 153024, 173448, and 186156.</p></sec><ref-list id="ref1"><title>Literature cited</title><ref id="iyaf141-B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ahmed</surname> &#160;<given-names>N</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2019</year>. <article-title>Avocatin B protects against lipotoxicity and improves insulin sensitivity in diet-induced obesity</article-title>. <source>Mol Nutr Food Res</source>. <volume>63</volume>:<fpage>e1900688</fpage>. <pub-id pub-id-type="doi">10.1002/mnfr.201900688</pub-id>.<pub-id pub-id-type="pmid">31609072</pub-id></mixed-citation></ref><ref id="iyaf141-B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Alberich</surname> &#160;<given-names>M</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2025</year>. <article-title>Evaluation of nematode susceptibility and resistance to anthelmintic drugs with a WMicrotracker motility assay</article-title>. <source>Sci Rep</source>. <volume>15</volume>(<issue>17968</issue>). <pub-id pub-id-type="doi">10.1038/s41598-025-02866-3</pub-id>.<pub-id pub-id-type="pmcid">PMC12102259</pub-id><pub-id pub-id-type="pmid">40410413</pub-id></mixed-citation></ref><ref id="iyaf141-B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Alfonso</surname> &#160;<given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Grundahl</surname> &#160;<given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Duerr</surname> &#160;<given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Han</surname> &#160;<given-names>HP</given-names></string-name>, <string-name name-style="western"><surname>Rand</surname> &#160;<given-names>JB</given-names></string-name></person-group>. <year>1993</year>. <article-title>The <italic toggle="yes">Caenorhabditis elegans</italic> unc-17 gene: a putative vesicular acetylcholine transporter</article-title>. <source>Science</source>. <volume>261</volume>:<fpage>617</fpage>&#8211;<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1126/science.8342028</pub-id>.<pub-id pub-id-type="pmid">8342028</pub-id></mixed-citation></ref><ref id="iyaf141-B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ardelli</surname> &#160;<given-names>BF</given-names></string-name>, <string-name name-style="western"><surname>Prichard</surname> &#160;<given-names>RK</given-names></string-name></person-group>. <year>2013</year>. <article-title>Inhibition of P-glycoprotein enhances sensitivity of <italic toggle="yes">Caenorhabditis elegans</italic> to ivermectin</article-title>. <source>Vet Parasitol</source>. <volume>191</volume>:<fpage>264</fpage>&#8211;<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetpar.2012.09.021</pub-id>.<pub-id pub-id-type="pmid">23062691</pub-id></mixed-citation></ref><ref id="iyaf141-B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Au</surname> &#160;<given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Giuliani</surname> &#160;<given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Harrington</surname> &#160;<given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Roy</surname> &#160;<given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Yip</surname> &#160;<given-names>CM</given-names></string-name></person-group>. <year>2025</year>. <article-title>Low-cost line-scan imaging for real-time phenotypic screening of <italic toggle="yes">C. elegans</italic></article-title>. <source>Rev Sci Instrum</source>. <volume>96</volume>(<issue>063705</issue>). <pub-id pub-id-type="doi">10.1063/5.0238824</pub-id>.<pub-id pub-id-type="pmid">40525927</pub-id></mixed-citation></ref><ref id="iyaf141-B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Avery</surname> &#160;<given-names>L</given-names></string-name>, <string-name name-style="western"><surname>You</surname> &#160;<given-names>YJ</given-names></string-name></person-group>. <year>2012</year>. <article-title><italic toggle="yes">C. elegans</italic> feeding</article-title>. In: <source>WormBook</source>. p. <fpage>1</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1895/wormbook.1.150.1</pub-id>.<pub-id pub-id-type="pmcid">PMC3590810</pub-id><pub-id pub-id-type="pmid">22628186</pub-id></mixed-citation></ref><ref id="iyaf141-B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bao</surname> &#160;<given-names>K</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2022</year>. <article-title>Crotamiton derivative JM03 extends lifespan and improves oxidative and hypertonic stress resistance in <italic toggle="yes">Caenorhabditis elegans</italic> via inhibiting OSM-9</article-title>. <source>Elife</source>. <volume>11</volume>:<fpage>e72410</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.72410</pub-id>.<pub-id pub-id-type="pmid">35510610</pub-id><pub-id pub-id-type="pmcid">PMC9071264</pub-id></mixed-citation></ref><ref id="iyaf141-B8"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Bird</surname> &#160;<given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Loper</surname> &#160;<given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Klein</surname> &#160;<given-names>E</given-names></string-name></person-group>. <year>2009</year>. <source>Natural language processing with Python</source>. <publisher-name>O&#8217;Reilly Media Inc</publisher-name>.</mixed-citation></ref><ref id="iyaf141-B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Blackwell</surname> &#160;<given-names>HE</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2001</year>. <article-title>A one-bead, one-stock solution approach to chemical genetics: part 1</article-title>. <source>Chem Biol</source>. <volume>8</volume>:<fpage>1167</fpage>&#8211;<lpage>1182</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-5521(01)00085-0</pub-id>.<pub-id pub-id-type="pmid">11755396</pub-id></mixed-citation></ref><ref id="iyaf141-B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bose</surname> &#160;<given-names>P</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2019</year>. <article-title>The novel small molecule TRVA242 stabilizes neuromuscular junction defects in multiple animal models of amyotrophic lateral sclerosis</article-title>. <source>Neurotherapeutics</source>. <volume>16</volume>:<fpage>1149</fpage>&#8211;<lpage>1166</lpage>. <pub-id pub-id-type="doi">10.1007/s13311-019-00765-w</pub-id>.<pub-id pub-id-type="pmid">31342410</pub-id><pub-id pub-id-type="pmcid">PMC6985319</pub-id></mixed-citation></ref><ref id="iyaf141-B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Boulin</surname> &#160;<given-names>T</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2008</year>. <article-title>Eight genes are required for functional reconstitution of the <italic toggle="yes">Caenorhabditis elegans</italic> levamisole-sensitive acetylcholine receptor</article-title>. <source>Proc Natl Acad Sci U S A</source>. <volume>105</volume>:<fpage>18590</fpage>&#8211;<lpage>18595</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0806933105</pub-id>.<pub-id pub-id-type="pmid">19020092</pub-id><pub-id pub-id-type="pmcid">PMC2587545</pub-id></mixed-citation></ref><ref id="iyaf141-B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Brenner</surname> &#160;<given-names>S</given-names></string-name></person-group>. <year>1974</year>. <article-title>The genetics of <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Genetics</source>. <volume>77</volume>:<fpage>71</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1093/genetics/77.1.71</pub-id>.<pub-id pub-id-type="pmid">4366476</pub-id><pub-id pub-id-type="pmcid">PMC1213120</pub-id></mixed-citation></ref><ref id="iyaf141-B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Broeks</surname> &#160;<given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Janssen</surname> &#160;<given-names>HW</given-names></string-name>, <string-name name-style="western"><surname>Calafat</surname> &#160;<given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Plasterk</surname> &#160;<given-names>RH</given-names></string-name></person-group>. <year>1995</year>. <article-title>A P-glycoprotein protects <italic toggle="yes">Caenorhabditis elegans</italic> against natural toxins</article-title>. <source>EMBO J</source>. <volume>14</volume>:<fpage>1858</fpage>&#8211;<lpage>1866</lpage>. <pub-id pub-id-type="doi">10.1002/j.1460-2075.1995.tb07178.x</pub-id>.<pub-id pub-id-type="pmid">7743993</pub-id><pub-id pub-id-type="pmcid">PMC398285</pub-id></mixed-citation></ref><ref id="iyaf141-B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Buckingham</surname> &#160;<given-names>SD</given-names></string-name>, <string-name name-style="western"><surname>Partridge</surname> &#160;<given-names>FA</given-names></string-name>, <string-name name-style="western"><surname>Sattelle</surname> &#160;<given-names>DB</given-names></string-name></person-group>. <year>2014</year>. <article-title>Automated, high-throughput, motility analysis in <italic toggle="yes">Caenorhabditis elegans</italic> and parasitic nematodes: applications in the search for new anthelmintics</article-title>. <source>Int J Parasitol Drugs Drug Resist</source>. <volume>4</volume>:<fpage>226</fpage>&#8211;<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2014.10.004</pub-id>.<pub-id pub-id-type="pmid">25516833</pub-id><pub-id pub-id-type="pmcid">PMC4266775</pub-id></mixed-citation></ref><ref id="iyaf141-B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Burns</surname> &#160;<given-names>A</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2006</year>. <article-title>High-throughput screening of small molecules for bioactivity and target identification in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Nat Protocols</source>. <volume>1</volume>:<fpage>1906</fpage>&#8211;<lpage>1914</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2006.283</pub-id>.<pub-id pub-id-type="pmid">17487175</pub-id></mixed-citation></ref><ref id="iyaf141-B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Burns</surname> &#160;<given-names>AR</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2010</year>. <article-title>A predictive model for drug bioaccumulation and bioactivity in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Nat Chem Biol</source>. <volume>6</volume>:<fpage>549</fpage>&#8211;<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.380</pub-id>.<pub-id pub-id-type="pmid">20512140</pub-id></mixed-citation></ref><ref id="iyaf141-B17"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Burns</surname> &#160;<given-names>AR</given-names></string-name></person-group>. <year>2013</year>. <part-title>Mapping worm-bioavailable chemical space for improved probe discovery and characterization with <italic toggle="yes">Caenorhabditis elegans</italic></part-title>. In: <source>Molecular genetics</source>. <publisher-name>The University of Toronto</publisher-name>. p. <fpage>170</fpage>.</mixed-citation></ref><ref id="iyaf141-B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Burns</surname> &#160;<given-names>AR</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2015</year>. <article-title><italic toggle="yes">Caenorhabditis elegans</italic> is a useful model for anthelmintic discovery</article-title>. <source>Nat Commun</source>. <volume>6</volume>:<fpage>7485</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms8485</pub-id>.<pub-id pub-id-type="pmid">26108372</pub-id><pub-id pub-id-type="pmcid">PMC4491176</pub-id></mixed-citation></ref><ref id="iyaf141-B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Burns</surname> &#160;<given-names>AR</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2017</year>. <article-title>The novel nematicide wact-86 interacts with aldicarb to kill nematodes</article-title>. <source>PLoS Negl Trop Dis</source>. <volume>11</volume>:<fpage>e0005502</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0005502</pub-id>.<pub-id pub-id-type="pmid">28379972</pub-id><pub-id pub-id-type="pmcid">PMC5393889</pub-id></mixed-citation></ref><ref id="iyaf141-B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Burns</surname> &#160;<given-names>AR</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2023</year>. <article-title>Selective control of parasitic nematodes using bioactivated nematicides</article-title>. <source>Nature</source>. <volume>618</volume>:<fpage>102</fpage>&#8211;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-023-06105-5</pub-id>.<pub-id pub-id-type="pmid">37225985</pub-id></mixed-citation></ref><ref id="iyaf141-B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Caldero-Escudero</surname> &#160;<given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Romero-Sanz</surname> &#160;<given-names>S</given-names></string-name>, <string-name name-style="western"><surname>De la Fuente</surname> &#160;<given-names>S</given-names></string-name></person-group>. <year>2024</year>. <article-title>Using <italic toggle="yes">C. elegans</italic> as a model for neurodegenerative diseases: methodology and evaluation</article-title>. <source>Animal Models of Disease-Part B</source>. <volume>188</volume>:<fpage>1</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/bs.mcb.2024.03.004</pub-id>.<pub-id pub-id-type="pmid">38880519</pub-id></mixed-citation></ref><ref id="iyaf141-B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Carr</surname> &#160;<given-names>JA</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2011</year>. <article-title>A microfluidic platform for high-sensitivity, real-time drug screening on <italic toggle="yes">C. elegans</italic> and parasitic nematodes</article-title>. <source>Lab Chip</source>. <volume>11</volume>:<fpage>2385</fpage>&#8211;<lpage>2396</lpage>. <pub-id pub-id-type="doi">10.1039/c1lc20170k</pub-id>.<pub-id pub-id-type="pmid">21647497</pub-id><pub-id pub-id-type="pmcid">PMC3645292</pub-id></mixed-citation></ref><ref id="iyaf141-B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Celaj</surname> &#160;<given-names>A</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2020</year>. <article-title>Highly combinatorial genetic interaction analysis reveals a multi-drug transporter influence network</article-title>. <source>Cell Syst</source>. <volume>10</volume>:<fpage>25</fpage>&#8211;<lpage>38.e10</lpage>. <pub-id pub-id-type="doi">10.1016/j.cels.2019.09.009</pub-id>.<pub-id pub-id-type="pmid">31668799</pub-id><pub-id pub-id-type="pmcid">PMC6989212</pub-id></mixed-citation></ref><ref id="iyaf141-B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chen</surname> &#160;<given-names>KS</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2021</year>. <article-title>Small molecule inhibitors of alpha-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in <italic toggle="yes">C. elegans</italic></article-title>. <source>Mol Neurodegener</source>. <volume>16</volume>:<fpage>77</fpage>. <pub-id pub-id-type="doi">10.1186/s13024-021-00497-6</pub-id>.<pub-id pub-id-type="pmid">34772429</pub-id><pub-id pub-id-type="pmcid">PMC8588601</pub-id></mixed-citation></ref><ref id="iyaf141-B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Crick</surname> &#160;<given-names>FH</given-names></string-name>, <string-name name-style="western"><surname>Barnett</surname> &#160;<given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Brenner</surname> &#160;<given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Watts-Tobin</surname> &#160;<given-names>RJ</given-names></string-name></person-group>. <year>1961</year>. <article-title>General nature of the genetic code for proteins</article-title>. <source>Nature</source>. <volume>192</volume>:<fpage>1227</fpage>&#8211;<lpage>1232</lpage>. <pub-id pub-id-type="doi">10.1038/1921227a0</pub-id>.<pub-id pub-id-type="pmid">13882203</pub-id></mixed-citation></ref><ref id="iyaf141-B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Crisford</surname> &#160;<given-names>A</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2011</year>. <article-title>Selective toxicity of the anthelmintic emodepside revealed by heterologous expression of human KCNMA1 in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Mol Pharmacol</source>. <volume>79</volume>:<fpage>1031</fpage>&#8211;<lpage>1043</lpage>. <pub-id pub-id-type="doi">10.1124/mol.111.071043</pub-id>.<pub-id pub-id-type="pmid">21415309</pub-id><pub-id pub-id-type="pmcid">PMC3102553</pub-id></mixed-citation></ref><ref id="iyaf141-B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cully</surname> &#160;<given-names>DF</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>1994</year>. <article-title>Cloning of an avermectin-sensitive glutamate-gated chloride channel from <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Nature</source>. <volume>371</volume>:<fpage>707</fpage>&#8211;<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1038/371707a0</pub-id>.<pub-id pub-id-type="pmid">7935817</pub-id></mixed-citation></ref><ref id="iyaf141-B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Daina</surname> &#160;<given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Michielin</surname> &#160;<given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Zoete</surname> &#160;<given-names>V</given-names></string-name></person-group>. <year>2017</year>. <article-title>SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules</article-title>. <source>Sci Rep</source>. <volume>7</volume>:<fpage>42717</fpage>. <pub-id pub-id-type="doi">10.1038/srep42717</pub-id>.<pub-id pub-id-type="pmid">28256516</pub-id><pub-id pub-id-type="pmcid">PMC5335600</pub-id></mixed-citation></ref><ref id="iyaf141-B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dash</surname> &#160;<given-names>SN</given-names></string-name>, <string-name name-style="western"><surname>Patnaik</surname> &#160;<given-names>L</given-names></string-name></person-group>. <year>2023</year>. <article-title>Flight for fish in drug discovery: a review of zebrafish-based screening of molecules</article-title>. <source>Biol Lett</source>. <volume>19</volume>:<fpage>20220541</fpage>. <pub-id pub-id-type="doi">10.1098/rsbl.2022.0541</pub-id>.<pub-id pub-id-type="pmid">37528729</pub-id><pub-id pub-id-type="pmcid">PMC10394424</pub-id></mixed-citation></ref><ref id="iyaf141-B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Davie</surname> &#160;<given-names>T</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2024</year>. <article-title>Identification of a family of species-selective complex I inhibitors as potential anthelmintics</article-title>. <source>Nat Commun</source>. <volume>15</volume>:<fpage>3367</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-024-47331-3</pub-id>.<pub-id pub-id-type="pmid">38719808</pub-id><pub-id pub-id-type="pmcid">PMC11079024</pub-id></mixed-citation></ref><ref id="iyaf141-B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Del Borrello</surname> &#160;<given-names>S</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2019</year>. <article-title>Rhodoquinone biosynthesis in <italic toggle="yes">C. elegans</italic> requires precursors generated by the kynurenine pathway</article-title>. <source>Elife</source>. <volume>8</volume>:<fpage>e48165</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.48165</pub-id>.<pub-id pub-id-type="pmid">31232688</pub-id><pub-id pub-id-type="pmcid">PMC6656428</pub-id></mixed-citation></ref><ref id="iyaf141-B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dent</surname> &#160;<given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname> &#160;<given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Vassilatis</surname> &#160;<given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Avery</surname> &#160;<given-names>L</given-names></string-name></person-group>. <year>2000</year>. <article-title>The genetics of ivermectin resistance in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Proc Natl Acad Sci U S A</source>. <volume>97</volume>:<fpage>2674</fpage>&#8211;<lpage>2679</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.97.6.2674</pub-id>.<pub-id pub-id-type="pmid">10716995</pub-id><pub-id pub-id-type="pmcid">PMC15988</pub-id></mixed-citation></ref><ref id="iyaf141-B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dilks</surname> &#160;<given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Koury</surname> &#160;<given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Buchanan</surname> &#160;<given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Andersen</surname> &#160;<given-names>EC</given-names></string-name></person-group>. <year>2021</year>. <article-title>Newly identified parasitic nematode beta-tubulin alleles confer resistance to benzimidazoles</article-title>. <source>Int J Parasitol Drugs Drug Resist</source>. <volume>17</volume>:<fpage>168</fpage>&#8211;<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2021.09.006</pub-id>.<pub-id pub-id-type="pmid">34637983</pub-id><pub-id pub-id-type="pmcid">PMC8503852</pub-id></mixed-citation></ref><ref id="iyaf141-B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dranchak</surname> &#160;<given-names>PK</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2023</year>. <article-title>In vivo quantitative high-throughput screening for drug discovery and comparative toxicology</article-title>. <source>Dis Model Mech</source>. <volume>16</volume>:<fpage>dmm049863</fpage>. <pub-id pub-id-type="doi">10.1242/dmm.049863</pub-id>.<pub-id pub-id-type="pmid">36786055</pub-id><pub-id pub-id-type="pmcid">PMC10067442</pub-id></mixed-citation></ref><ref id="iyaf141-B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Driscoll</surname> &#160;<given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dean</surname> &#160;<given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Reilly</surname> &#160;<given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Bergholz</surname> &#160;<given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Chalfie</surname> &#160;<given-names>M</given-names></string-name></person-group>. <year>1989</year>. <article-title>Genetic and molecular analysis of a <italic toggle="yes">Caenorhabditis elegans</italic> beta-tubulin that conveys benzimidazole sensitivity</article-title>. <source>J Cell Biol</source>. <volume>109</volume>:<fpage>2993</fpage>&#8211;<lpage>3003</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.109.6.2993</pub-id>.<pub-id pub-id-type="pmid">2592410</pub-id><pub-id pub-id-type="pmcid">PMC2115974</pub-id></mixed-citation></ref><ref id="iyaf141-B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Elfawal</surname> &#160;<given-names>MA</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2025</year>. <article-title>High-throughput screening of more than 30,000 compounds for anthelmintics against gastrointestinal nematode parasites</article-title>. <source>ACS Infect Dis</source>. <volume>11</volume>:<fpage>104</fpage>&#8211;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.4c00327</pub-id>.<pub-id pub-id-type="pmid">39653369</pub-id><pub-id pub-id-type="pmcid">PMC11731298</pub-id></mixed-citation></ref><ref id="iyaf141-B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Elfawal</surname> &#160;<given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Savinov</surname> &#160;<given-names>SN</given-names></string-name>, <string-name name-style="western"><surname>Aroian</surname> &#160;<given-names>RV</given-names></string-name></person-group>. <year>2019</year>. <article-title>Drug screening for discovery of broad-spectrum agents for soil-transmitted Nematodes</article-title>. <source>Sci Rep</source>. <volume>9</volume>:<fpage>12347</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-48720-1</pub-id>.<pub-id pub-id-type="pmid">31451730</pub-id><pub-id pub-id-type="pmcid">PMC6710243</pub-id></mixed-citation></ref><ref id="iyaf141-B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fahs</surname> &#160;<given-names>HZ</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2025</year>. <article-title>A new class of natural anthelmintics targeting lipid metabolism</article-title>. <source>Nat Commun</source>. <volume>16</volume>:<fpage>305</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-024-54965-w</pub-id>.<pub-id pub-id-type="pmid">39746976</pub-id><pub-id pub-id-type="pmcid">PMC11695593</pub-id></mixed-citation></ref><ref id="iyaf141-B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fernandez</surname> &#160;<given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Mis</surname> &#160;<given-names>EK</given-names></string-name>, <string-name name-style="western"><surname>Bargmann</surname> &#160;<given-names>BO</given-names></string-name>, <string-name name-style="western"><surname>Birnbaum</surname> &#160;<given-names>KD</given-names></string-name>, <string-name name-style="western"><surname>Piano</surname> &#160;<given-names>F</given-names></string-name></person-group>. <year>2010</year>. <article-title>Automated sorting of live <italic toggle="yes">C. elegans</italic> using laFACS</article-title>. <source>Nat Methods</source>. <volume>7</volume>:<fpage>417</fpage>&#8211;<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.f.304</pub-id>.<pub-id pub-id-type="pmid">20436474</pub-id><pub-id pub-id-type="pmcid">PMC2896029</pub-id></mixed-citation></ref><ref id="iyaf141-B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ferreira</surname> &#160;<given-names>SR</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2015</year>. <article-title>A new methodology for evaluation of nematode viability</article-title>. <source>Biomed Res Int</source>. <volume>2015</volume>:<fpage>879263</fpage>. <pub-id pub-id-type="doi">10.1155/2015/879263</pub-id>.<pub-id pub-id-type="pmid">25866820</pub-id><pub-id pub-id-type="pmcid">PMC4383492</pub-id></mixed-citation></ref><ref id="iyaf141-B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fleming</surname> &#160;<given-names>JT</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>1997</year>. <article-title><italic toggle="yes">Caenorhabditis elegans</italic> levamisole resistance genes lev-1, unc-29, and unc-38 encode functional nicotinic acetylcholine receptor subunits</article-title>. <source>J Neurosci</source>. <volume>17</volume>:<fpage>5843</fpage>&#8211;<lpage>5857</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-15-05843.1997</pub-id>.<pub-id pub-id-type="pmid">9221782</pub-id><pub-id pub-id-type="pmcid">PMC6573193</pub-id></mixed-citation></ref><ref id="iyaf141-B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Frigo</surname> &#160;<given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Bondesson</surname> &#160;<given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname> &#160;<given-names>C</given-names></string-name></person-group>. <year>2021</year>. <article-title>Nuclear receptors: from molecular mechanisms to therapeutics</article-title>. <source>Essays Biochem</source>. <volume>65</volume>:<fpage>847</fpage>&#8211;<lpage>856</lpage>. <pub-id pub-id-type="doi">10.1042/EBC20210020</pub-id>.<pub-id pub-id-type="pmcid">PMC8628184</pub-id><pub-id pub-id-type="pmid">34825698</pub-id></mixed-citation></ref><ref id="iyaf141-B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fuchs</surname> &#160;<given-names>BB</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2016</year>. <article-title>Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin</article-title>. <source>Future Med Chem</source>. <volume>8</volume>:<fpage>117</fpage>&#8211;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.4155/fmc.15.182</pub-id>.<pub-id pub-id-type="pmid">26808006</pub-id><pub-id pub-id-type="pmcid">PMC4976847</pub-id></mixed-citation></ref><ref id="iyaf141-B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Galford</surname> &#160;<given-names>KF</given-names></string-name>, <string-name name-style="western"><surname>Jose</surname> &#160;<given-names>AM</given-names></string-name></person-group>. <year>2020</year>. <article-title>The FDA-approved drugs ticlopidine, sertaconazole, and dexlansoprazole can cause morphological changes in <italic toggle="yes">C. elegans</italic></article-title>. <source>Chemosphere</source>. <volume>261</volume>:<fpage>127756</fpage>. <pub-id pub-id-type="doi">10.1016/j.chemosphere.2020.127756</pub-id>.<pub-id pub-id-type="pmid">32731027</pub-id><pub-id pub-id-type="pmcid">PMC7606649</pub-id></mixed-citation></ref><ref id="iyaf141-B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Galloway</surname> &#160;<given-names>WRJD</given-names></string-name>, <string-name name-style="western"><surname>Isidro-Llobet</surname> &#160;<given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Spring</surname> &#160;<given-names>DR</given-names></string-name></person-group>. <year>2010</year>. <article-title>Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules</article-title>. <source>Nat Commun.</source> &#160;<volume>1</volume>:<fpage>80</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms1081</pub-id>.<pub-id pub-id-type="pmid">20865796</pub-id></mixed-citation></ref><ref id="iyaf141-B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Garcia-Bustos</surname> &#160;<given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Sleebs</surname> &#160;<given-names>BE</given-names></string-name>, <string-name name-style="western"><surname>Gasser</surname> &#160;<given-names>RB</given-names></string-name></person-group>. <year>2019</year>. <article-title>An appraisal of natural products active against parasitic nematodes of animals</article-title>. <source>Parasit Vectors</source>. <volume>12</volume>:<fpage>306</fpage>. <pub-id pub-id-type="doi">10.1186/s13071-019-3537-1</pub-id>.<pub-id pub-id-type="pmid">31208455</pub-id><pub-id pub-id-type="pmcid">PMC6580475</pub-id></mixed-citation></ref><ref id="iyaf141-B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gerisch</surname> &#160;<given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Weitzel</surname> &#160;<given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kober-Eisermann</surname> &#160;<given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Rottiers</surname> &#160;<given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Antebi</surname> &#160;<given-names>A</given-names></string-name></person-group>. <year>2001</year>. <article-title>A hormonal signaling pathway influencing <italic toggle="yes">C. elegans</italic> metabolism, reproductive development, and life span</article-title>. <source>Dev Cell</source>. <volume>1</volume>:<fpage>841</fpage>&#8211;<lpage>851</lpage>. <pub-id pub-id-type="doi">10.1016/S1534-5807(01)00085-5</pub-id>.<pub-id pub-id-type="pmid">11740945</pub-id></mixed-citation></ref><ref id="iyaf141-B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ghafouri</surname> &#160;<given-names>S</given-names></string-name>, <string-name name-style="western"><surname>McGhee</surname> &#160;<given-names>JD</given-names></string-name></person-group>. <year>2007</year>. <article-title>Bacterial residence time in the intestine of <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Nematology</source>. <volume>9</volume>:<fpage>87</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1163/156854107779969718</pub-id>.</mixed-citation></ref><ref id="iyaf141-B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gill</surname> &#160;<given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Olsen</surname> &#160;<given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sampayo</surname> &#160;<given-names>JN</given-names></string-name>, <string-name name-style="western"><surname>Lithgow</surname> &#160;<given-names>GJ</given-names></string-name></person-group>. <year>2003</year>. <article-title>An automated high-throughput assay for survival of the nematode <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Free Radic Biol Med</source>. <volume>35</volume>:<fpage>558</fpage>&#8211;<lpage>565</lpage>. <pub-id pub-id-type="doi">10.1016/S0891-5849(03)00328-9</pub-id>.<pub-id pub-id-type="pmid">12957648</pub-id></mixed-citation></ref><ref id="iyaf141-B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Giunti</surname> &#160;<given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Andersen</surname> &#160;<given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Rayes</surname> &#160;<given-names>D</given-names></string-name>, <string-name name-style="western"><surname>De Rosa</surname> &#160;<given-names>MJ</given-names></string-name></person-group>. <year>2021</year>. <article-title>Drug discovery: insights from the invertebrate <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Pharmacol Res Perspect</source>. <volume>9</volume>:<fpage>e00721</fpage>. <pub-id pub-id-type="doi">10.1002/prp2.721</pub-id>.<pub-id pub-id-type="pmid">33641258</pub-id><pub-id pub-id-type="pmcid">PMC7916527</pub-id></mixed-citation></ref><ref id="iyaf141-B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gleeson</surname> &#160;<given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Hersey</surname> &#160;<given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Montanari</surname> &#160;<given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Overington</surname> &#160;<given-names>J</given-names></string-name></person-group>. <year>2011</year>. <article-title>Probing the links between in vitro potency, ADMET and physicochemical parameters</article-title>. <source>Nat Rev Drug Discov</source>. <volume>10</volume>:<fpage>197</fpage>&#8211;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1038/nrd3367</pub-id>.<pub-id pub-id-type="pmid">21358739</pub-id><pub-id pub-id-type="pmcid">PMC6317702</pub-id></mixed-citation></ref><ref id="iyaf141-B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gosai</surname> &#160;<given-names>SJ</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2010</year>. <article-title>Automated high-content live animal drug screening using <italic toggle="yes">C. elegans</italic> expressing the aggregation prone serpin alpha1-antitrypsin Z</article-title>. <source>PLoS One</source>. <volume>5</volume>:<fpage>e15460</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0015460</pub-id>.<pub-id pub-id-type="pmid">21103396</pub-id><pub-id pub-id-type="pmcid">PMC2980495</pub-id></mixed-citation></ref><ref id="iyaf141-B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gravato-Nobre</surname> &#160;<given-names>MJ</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2005</year>. <article-title>Multiple genes affect sensitivity of <italic toggle="yes">Caenorhabditis elegans</italic> to the bacterial pathogen <italic toggle="yes">Microbacterium nematophilum</italic></article-title>. <source>Genetics</source>. <volume>171</volume>:<fpage>1033</fpage>&#8211;<lpage>1045</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.105.045716</pub-id>.<pub-id pub-id-type="pmid">16079230</pub-id><pub-id pub-id-type="pmcid">PMC1456810</pub-id></mixed-citation></ref><ref id="iyaf141-B54"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Greul</surname> &#160;<given-names>JN</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2013</year>. <part-title>PCT WO2014076015A1 Pyridyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides</part-title> &#160;<publisher-name>WIPO</publisher-name>. p. <fpage>1</fpage>&#8211;<lpage>121</lpage> &#160;<ext-link xlink:href="https://patentimages.storage.googleapis.com/73/0e/15/d99c8cd8991023/WO2014076015A1.pdf" ext-link-type="uri">https://patentimages.storage.googleapis.com/73/0e/15/d99c8cd8991023/WO2014076015A1.pdf</ext-link>.</mixed-citation></ref><ref id="iyaf141-B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Guengerich</surname> &#160;<given-names>FP</given-names></string-name></person-group>. <year>2006</year>. <article-title>Cytochrome P450s and other enzymes in drug metabolism and toxicity</article-title>. <source>AAPS J</source>. <volume>8</volume>:<fpage>E101</fpage>&#8211;<lpage>E111</lpage>. <pub-id pub-id-type="doi">10.1208/aapsj080112</pub-id>.<pub-id pub-id-type="pmid">16584116</pub-id><pub-id pub-id-type="pmcid">PMC2751428</pub-id></mixed-citation></ref><ref id="iyaf141-B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Guerrero</surname> &#160;<given-names>GA</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2021</year>. <article-title>NHR-8 and P-glycoproteins uncouple xenobiotic resistance from longevity in chemosensory <italic toggle="yes">C. elegans</italic> mutants</article-title>. <source>Elife</source>. <volume>10</volume>:<fpage>e53174</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.53174</pub-id>.<pub-id pub-id-type="pmid">34448454</pub-id><pub-id pub-id-type="pmcid">PMC8460253</pub-id></mixed-citation></ref><ref id="iyaf141-B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Guest</surname> &#160;<given-names>M</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2007</year>. <article-title>The calcium-activated potassium channel, SLO-1, is required for the action of the novel cyclo-octadepsipeptide anthelmintic, emodepside, in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Int J Parasitol</source>. <volume>37</volume>:<fpage>1577</fpage>&#8211;<lpage>1588</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpara.2007.05.006</pub-id>.<pub-id pub-id-type="pmid">17583712</pub-id></mixed-citation></ref><ref id="iyaf141-B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ha</surname> &#160;<given-names>NM</given-names></string-name>, <string-name name-style="western"><surname>Tran</surname> &#160;<given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Shim</surname> &#160;<given-names>YH</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname> &#160;<given-names>K</given-names></string-name></person-group>. <year>2022</year>. <article-title><italic toggle="yes">Caenorhabditis elegans</italic> as a powerful tool in natural product bioactivity research</article-title>. <source>Appl Biol Chem.</source> &#160;<volume>65</volume>:<fpage>18</fpage>. <pub-id pub-id-type="doi">10.1186/s13765-022-00685-y</pub-id>.</mixed-citation></ref><ref id="iyaf141-B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hahnel</surname> &#160;<given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Dilks</surname> &#160;<given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Heisler</surname> &#160;<given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Andersen</surname> &#160;<given-names>EC</given-names></string-name>, <string-name name-style="western"><surname>Kulke</surname> &#160;<given-names>D</given-names></string-name></person-group>. <year>2020</year>. <article-title><italic toggle="yes">Caenorhabditis elegans</italic> in anthelmintic research&#8212;old model, new perspectives</article-title>. <source>Int J Parasitol Drugs Drug Resist</source>. <volume>14</volume>:<fpage>237</fpage>&#8211;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2020.09.005</pub-id>.<pub-id pub-id-type="pmid">33249235</pub-id><pub-id pub-id-type="pmcid">PMC7704361</pub-id></mixed-citation></ref><ref id="iyaf141-B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Harlow</surname> &#160;<given-names>PH</given-names></string-name>, <string-name name-style="western"><surname>Perry</surname> &#160;<given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Stevens</surname> &#160;<given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Flemming</surname> &#160;<given-names>AJ</given-names></string-name></person-group>. <year>2018</year>. <article-title>Comparative metabolism of xenobiotic chemicals by cytochrome P450s in the nematode <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Sci Rep</source>. <volume>8</volume>:<fpage>13333</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-31215-w</pub-id>.<pub-id pub-id-type="pmid">30190484</pub-id><pub-id pub-id-type="pmcid">PMC6127299</pub-id></mixed-citation></ref><ref id="iyaf141-B61"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Harrington</surname> &#160;<given-names>SP</given-names></string-name></person-group>. <year>2021</year>. <part-title>Exploiting <italic toggle="yes">Caenorhabditis elegans</italic> as a discovery platform to identify nematode parasiticides that act through neuromuscular disruption</part-title>. In: <source>Pharmacology and toxicology</source>. <publisher-name>The University of Toronto</publisher-name>. p. <fpage>246</fpage>.</mixed-citation></ref><ref id="iyaf141-B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Harrington</surname> &#160;<given-names>S</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2022</year>. <article-title>Egg-laying and locomotory screens with <italic toggle="yes">C. elegans</italic> yield a nematode-selective small molecule stimulator of neurotransmitter release</article-title>. <source>Commun Biol</source>. <volume>5</volume>:<fpage>865</fpage>. <pub-id pub-id-type="doi">10.1038/s42003-022-03819-6</pub-id>.<pub-id pub-id-type="pmid">36002479</pub-id><pub-id pub-id-type="pmcid">PMC9402605</pub-id></mixed-citation></ref><ref id="iyaf141-B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Harrington</surname> &#160;<given-names>S</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2023</year>. <article-title>Nemacol is a small molecule inhibitor of <italic toggle="yes">C. elegans</italic> vesicular acetylcholine transporter with anthelmintic potential</article-title>. <source>Nat Commun</source>. <volume>14</volume>:<fpage>1816</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-023-37452-6</pub-id>.<pub-id pub-id-type="pmid">37002199</pub-id><pub-id pub-id-type="pmcid">PMC10066365</pub-id></mixed-citation></ref><ref id="iyaf141-B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Holden-Dye</surname> &#160;<given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Walker</surname> &#160;<given-names>RJ</given-names></string-name></person-group>. <year>2014</year>. <article-title>Anthelmintic drugs and nematicides: studies in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. In: <source>WormBook</source>. p. <fpage>1</fpage>&#8211;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1895/wormbook.1.143.2</pub-id>.<pub-id pub-id-type="pmcid">PMC5402214</pub-id><pub-id pub-id-type="pmid">25517625</pub-id></mixed-citation></ref><ref id="iyaf141-B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hu</surname> &#160;<given-names>Y</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2013</year>. <article-title>An extensive comparison of the effect of anthelmintic classes on diverse nematodes</article-title>. <source>PLoS One</source>. <volume>8</volume>:<fpage>e70702</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0070702</pub-id>.<pub-id pub-id-type="pmid">23869246</pub-id><pub-id pub-id-type="pmcid">PMC3712009</pub-id></mixed-citation></ref><ref id="iyaf141-B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hu</surname> &#160;<given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Xiao</surname> &#160;<given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Aroian</surname> &#160;<given-names>RV</given-names></string-name></person-group>. <year>2009</year>. <article-title>The new anthelmintic tribendimidine is an L-type (levamisole and pyrantel) nicotinic acetylcholine receptor agonist</article-title>. <source>PLoS Negl Trop Dis</source>. <volume>3</volume>:<fpage>e499</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0000499</pub-id>.<pub-id pub-id-type="pmid">19668355</pub-id><pub-id pub-id-type="pmcid">PMC2715879</pub-id></mixed-citation></ref><ref id="iyaf141-B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Huang</surname> &#160;<given-names>Q</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2025</year>. <article-title>Small-molecule screen in <italic toggle="yes">C. elegans</italic> identifies benzenesulfonamides as inhibitors of microsporidia spores</article-title>. <source>NPJ Antimicrob Resist</source>. <volume>3</volume>:<fpage>41</fpage>. <pub-id pub-id-type="doi">10.1038/s44259-025-00116-0</pub-id>.<pub-id pub-id-type="pmid">40399462</pub-id><pub-id pub-id-type="pmcid">PMC12095817</pub-id></mixed-citation></ref><ref id="iyaf141-B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Huang</surname> &#160;<given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname> &#160;<given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Pan</surname> &#160;<given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Reinke</surname> &#160;<given-names>AW</given-names></string-name></person-group>. <year>2023</year>. <article-title>Screening of the pandemic response box identifies anti-microsporidia compounds</article-title>. <source>PLoS Negl Trop Dis</source>. <volume>17</volume>:<fpage>e0011806</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0011806</pub-id>.<pub-id pub-id-type="pmid">38064503</pub-id><pub-id pub-id-type="pmcid">PMC10732440</pub-id></mixed-citation></ref><ref id="iyaf141-B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hui</surname> &#160;<given-names>K</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2009</year>. <article-title>Differential sensitivities of CaV1.2 IIS5-S6 mutants to 1,4-dihydropyridine analogs</article-title>. <source>Eur J Pharmacol</source>. <volume>602</volume>:<fpage>255</fpage>&#8211;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2008.11.051</pub-id>.<pub-id pub-id-type="pmid">19068212</pub-id></mixed-citation></ref><ref id="iyaf141-B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Inglis</surname> &#160;<given-names>PN</given-names></string-name>, <string-name name-style="western"><surname>Ou</surname> &#160;<given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Leroux</surname> &#160;<given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Scholey</surname> &#160;<given-names>JM</given-names></string-name></person-group>. <year>2007</year>. <article-title>The sensory cilia of <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. In: <source>WormBook</source>. p. <fpage>1</fpage>&#8211;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1895/wormbook.1.126.2</pub-id>.<pub-id pub-id-type="pmcid">PMC10083726</pub-id><pub-id pub-id-type="pmid">18050505</pub-id></mixed-citation></ref><ref id="iyaf141-B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>James</surname> &#160;<given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Davey</surname> &#160;<given-names>MW</given-names></string-name></person-group>. <year>2007</year>. <article-title>A rapid colorimetric assay for the quantitation of the viability of free-living larvae of nematodes in vitro</article-title>. <source>Parasitol Res</source>. <volume>101</volume>:<fpage>975</fpage>&#8211;<lpage>980</lpage>. <pub-id pub-id-type="doi">10.1007/s00436-007-0572-1</pub-id>.<pub-id pub-id-type="pmid">17492469</pub-id></mixed-citation></ref><ref id="iyaf141-B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jiang</surname> &#160;<given-names>Q</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2018</year>. <article-title>Identification of small-molecule ion channel modulators in <italic toggle="yes">C. elegans</italic> channelopathy models</article-title>. <source>Nat Commun</source>. <volume>9</volume>:<fpage>3941</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-06514-5</pub-id>.<pub-id pub-id-type="pmid">30258187</pub-id><pub-id pub-id-type="pmcid">PMC6158242</pub-id></mixed-citation></ref><ref id="iyaf141-B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jones</surname> &#160;<given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Flemming</surname> &#160;<given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Urwin</surname> &#160;<given-names>PE</given-names></string-name></person-group>. <year>2015</year>. <article-title>NHR-176 regulates cyp-35d1 to control hydroxylation-dependent metabolism of thiabendazole in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Biochem J</source>. <volume>466</volume>:<fpage>37</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20141296</pub-id>.<pub-id pub-id-type="pmid">25406993</pub-id></mixed-citation></ref><ref id="iyaf141-B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jorgensen</surname> &#160;<given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Mango</surname> &#160;<given-names>SE</given-names></string-name></person-group>. <year>2002</year>. <article-title>The art and design of genetic screens: <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Nat Rev Genet</source>. <volume>3</volume>:<fpage>356</fpage>&#8211;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1038/nrg794</pub-id>.<pub-id pub-id-type="pmid">11988761</pub-id></mixed-citation></ref><ref id="iyaf141-B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kage-Nakadai</surname> &#160;<given-names>E</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2010</year>. <article-title>Two very long chain fatty acid acyl-CoA synthetase genes, acs-20 and acs-22, have roles in the cuticle surface barrier in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>PLoS One</source>. <volume>5</volume>:<fpage>e8857</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0008857</pub-id>.<pub-id pub-id-type="pmid">20111596</pub-id><pub-id pub-id-type="pmcid">PMC2810326</pub-id></mixed-citation></ref><ref id="iyaf141-B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kamal</surname> &#160;<given-names>M</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2019</year>. <article-title>The marginal cells of the <italic toggle="yes">Caenorhabditis elegans</italic> pharynx scavenge cholesterol and other hydrophobic small molecules</article-title>. <source>Nat Commun</source>. <volume>10</volume>:<fpage>3938</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-11908-0</pub-id>.<pub-id pub-id-type="pmid">31477732</pub-id><pub-id pub-id-type="pmcid">PMC6718421</pub-id></mixed-citation></ref><ref id="iyaf141-B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kamal</surname> &#160;<given-names>M</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2022</year>. <article-title>A spatiotemporal reconstruction of the <italic toggle="yes">C. elegans</italic> pharyngeal cuticle reveals a structure rich in phase-separating proteins</article-title>. <source>Elife</source>. <volume>11</volume>:<fpage>e79396</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.79396</pub-id>.<pub-id pub-id-type="pmid">36259463</pub-id><pub-id pub-id-type="pmcid">PMC9629831</pub-id></mixed-citation></ref><ref id="iyaf141-B78"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Kamal</surname> &#160;<given-names>M</given-names></string-name></person-group>. <year>2023</year>. <part-title>Insights on the xenobiotic barrier function of the <italic toggle="yes">Caenorhabditis elegans</italic> pharynx cuticle</part-title>. In: <source>Molecular Genetics</source>. <publisher-name>The University of Toronoto</publisher-name>. p. <fpage>389</fpage>.</mixed-citation></ref><ref id="iyaf141-B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kamal</surname> &#160;<given-names>M</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2023</year>. <article-title>PGP-14 establishes a polar lipid permeability barrier within the <italic toggle="yes">C. elegans</italic> pharyngeal cuticle</article-title>. <source>PLoS Genet</source>. <volume>19</volume>:<fpage>e1011008</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1011008</pub-id>.<pub-id pub-id-type="pmid">37930961</pub-id><pub-id pub-id-type="pmcid">PMC10653525</pub-id></mixed-citation></ref><ref id="iyaf141-B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kamal</surname> &#160;<given-names>M</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2024</year>. <article-title>A rapid in vivo pipeline to identify small molecule inhibitors of amyloid aggregation</article-title>. <source>Nat Commun.</source> &#160;<volume>15</volume>:<fpage>8311</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-024-52480-6</pub-id>.<pub-id pub-id-type="pmid">39333123</pub-id><pub-id pub-id-type="pmcid">PMC11436953</pub-id></mixed-citation></ref><ref id="iyaf141-B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kaminsky</surname> &#160;<given-names>R</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2008</year>. <article-title>A new class of anthelmintics effective against drug-resistant nematodes</article-title>. <source>Nature</source>. <volume>452</volume>:<fpage>176</fpage>&#8211;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1038/nature06722</pub-id>.<pub-id pub-id-type="pmid">18337814</pub-id></mixed-citation></ref><ref id="iyaf141-B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kawasaki</surname> &#160;<given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Jeong</surname> &#160;<given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Oh</surname> &#160;<given-names>BK</given-names></string-name>, <string-name name-style="western"><surname>Shim</surname> &#160;<given-names>YH</given-names></string-name></person-group>. <year>2010</year>. <article-title>Apigenin inhibits larval growth of <italic toggle="yes">Caenorhabditis elegans</italic> through DAF-16 activation</article-title>. <source>FEBS Lett</source>. <volume>584</volume>:<fpage>3587</fpage>&#8211;<lpage>3591</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2010.07.026</pub-id>.<pub-id pub-id-type="pmid">20647014</pub-id></mixed-citation></ref><ref id="iyaf141-B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Keiser</surname> &#160;<given-names>J</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2016</year>. <article-title>Evaluation of an FDA approved library against laboratory models of human intestinal nematode infections</article-title>. <source>Parasit Vectors</source>. <volume>9</volume>:<fpage>376</fpage>. <pub-id pub-id-type="doi">10.1186/s13071-016-1616-0</pub-id>.<pub-id pub-id-type="pmid">27363703</pub-id><pub-id pub-id-type="pmcid">PMC4929775</pub-id></mixed-citation></ref><ref id="iyaf141-B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname> &#160;<given-names>W</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2015</year>. <article-title>Identification of an antimicrobial agent effective against methicillin-resistant Staphylococcus aureus persisters using a fluorescence-based screening strategy</article-title>. <source>PLoS One</source>. <volume>10</volume>:<fpage>e0127640</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0127640</pub-id>.<pub-id pub-id-type="pmid">26039584</pub-id><pub-id pub-id-type="pmcid">PMC4454602</pub-id></mixed-citation></ref><ref id="iyaf141-B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname> &#160;<given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Hendricks</surname> &#160;<given-names>GL</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname> &#160;<given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Mylonakis</surname> &#160;<given-names>E</given-names></string-name></person-group>. <year>2017</year>. <article-title>An update on the use of <italic toggle="yes">C. elegans</italic> for preclinical drug discovery: screening and identifying anti-infective drugs</article-title>. <source>Expert Opin Drug Discov</source>. <volume>12</volume>:<fpage>625</fpage>&#8211;<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1080/17460441.2017.1319358</pub-id>.<pub-id pub-id-type="pmid">28402221</pub-id></mixed-citation></ref><ref id="iyaf141-B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Knox</surname> &#160;<given-names>J</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2021</year>. <article-title>A survey of the kinome pharmacopeia reveals multiple scaffolds and targets for the development of novel anthelmintics</article-title>. <source>Sci Rep</source>. <volume>11</volume>:<fpage>9161</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-88150-6</pub-id>.<pub-id pub-id-type="pmid">33911106</pub-id><pub-id pub-id-type="pmcid">PMC8080662</pub-id></mixed-citation></ref><ref id="iyaf141-B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Knox</surname> &#160;<given-names>J</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2024</year>. <article-title>Cyprocide selectively kills nematodes via cytochrome P450 bioactivation</article-title>. <source>Nat Commun</source>. <volume>15</volume>:<fpage>5529</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-024-49738-4</pub-id>.<pub-id pub-id-type="pmid">38956039</pub-id><pub-id pub-id-type="pmcid">PMC11219838</pub-id></mixed-citation></ref><ref id="iyaf141-B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Koizumi</surname> &#160;<given-names>W</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2023</year>. <article-title>Determinants of subtype-selectivity of the anthelmintic paraherquamide A on <italic toggle="yes">Caenorhabditis elegans</italic> nicotinic acetylcholine receptors</article-title>. <source>Mol Pharmacol</source>. <volume>103</volume>:<fpage>299</fpage>&#8211;<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1124/molpharm.122.000601</pub-id>.<pub-id pub-id-type="pmid">36948535</pub-id></mixed-citation></ref><ref id="iyaf141-B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kwok</surname> &#160;<given-names>TC</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2006</year>. <article-title>A small-molecule screen in <italic toggle="yes">C. elegans</italic> yields a new calcium channel antagonist</article-title>. <source>Nature</source>. <volume>441</volume>:<fpage>91</fpage>&#8211;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1038/nature04657</pub-id>.<pub-id pub-id-type="pmid">16672971</pub-id></mixed-citation></ref><ref id="iyaf141-B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kwok</surname> &#160;<given-names>TC</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2008</year>. <article-title>A genetic screen for dihydropyridine (DHP)-resistant worms reveals new residues required for DHP-blockage of mammalian calcium channels</article-title>. <source>PLoS Genet</source>. <volume>4</volume>:<fpage>e1000067</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1000067</pub-id>.<pub-id pub-id-type="pmid">18464914</pub-id><pub-id pub-id-type="pmcid">PMC2362100</pub-id></mixed-citation></ref><ref id="iyaf141-B91"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Kwok</surname> &#160;<given-names>TCY</given-names></string-name></person-group>. <year>2011</year>. <part-title>The characterization of nemadipine and migrazole as small molecule tools for use in the nematode <italic toggle="yes">Caenorhabditis elegans</italic></part-title>. In: <source>Molecular Genetics</source>. <publisher-name>The University of Toronto</publisher-name>. p. <fpage>215</fpage>.</mixed-citation></ref><ref id="iyaf141-B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lahm</surname> &#160;<given-names>GP</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2017</year>. <article-title>The discovery of fluazaindolizine: a new product for the control of plant parasitic nematodes</article-title>. <source>Bioorg Med Chem Lett</source>. <volume>27</volume>:<fpage>1572</fpage>&#8211;<lpage>1575</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2017.02.029</pub-id>.<pub-id pub-id-type="pmid">28242274</pub-id></mixed-citation></ref><ref id="iyaf141-B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Larigot</surname> &#160;<given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Mansuy</surname> &#160;<given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Borowski</surname> &#160;<given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Coumoul</surname> &#160;<given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Dairou</surname> &#160;<given-names>J</given-names></string-name></person-group>. <year>2022</year>. <article-title>Cytochromes P450 of <italic toggle="yes">Caenorhabditis elegan</italic>s: implication in biological functions and metabolism of xenobiotics</article-title>. <source>Biomolecules</source>. <volume>12</volume>:<fpage>342</fpage>. <pub-id pub-id-type="doi">10.3390/biom12030342</pub-id>.<pub-id pub-id-type="pmid">35327534</pub-id><pub-id pub-id-type="pmcid">PMC8945457</pub-id></mixed-citation></ref><ref id="iyaf141-B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lee</surname> &#160;<given-names>AY</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2014</year>. <article-title>Mapping the cellular response to small molecules using chemogenomic fitness signatures</article-title>. <source>Science</source>. <volume>344</volume>:<fpage>208</fpage>&#8211;<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1126/science.1250217</pub-id>.<pub-id pub-id-type="pmid">24723613</pub-id><pub-id pub-id-type="pmcid">PMC4254748</pub-id></mixed-citation></ref><ref id="iyaf141-B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lee</surname> &#160;<given-names>RY</given-names></string-name>, <string-name name-style="western"><surname>Lobel</surname> &#160;<given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Hengartner</surname> &#160;<given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Horvitz</surname> &#160;<given-names>HR</given-names></string-name>, <string-name name-style="western"><surname>Avery</surname> &#160;<given-names>L</given-names></string-name></person-group>. <year>1997</year>. <article-title>Mutations in the alpha1 subunit of an L-type voltage-activated Ca<sup>2+</sup> channel cause myotonia in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Embo J</source>. <volume>16</volume>:<fpage>6066</fpage>&#8211;<lpage>6076</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/16.20.6066</pub-id>.<pub-id pub-id-type="pmid">9321386</pub-id><pub-id pub-id-type="pmcid">PMC1326290</pub-id></mixed-citation></ref><ref id="iyaf141-B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lespine</surname> &#160;<given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Blancfuney</surname> &#160;<given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Prichard</surname> &#160;<given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Alberich</surname> &#160;<given-names>M</given-names></string-name></person-group>. <year>2024</year>. <article-title>P-glycoproteins in anthelmintic safety, efficacy, and resistance</article-title>. <source>Trends Parasitol</source>. <volume>40</volume>:<fpage>896</fpage>&#8211;<lpage>913</lpage>. <pub-id pub-id-type="doi">10.1016/j.pt.2024.07.008</pub-id>.<pub-id pub-id-type="pmid">39168719</pub-id></mixed-citation></ref><ref id="iyaf141-B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Leung</surname> &#160;<given-names>CK</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2013</year>. <article-title>An ultra high-throughput, whole-animal screen for small molecule modulators of a specific genetic pathway in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>PLoS One</source>. <volume>8</volume>:<fpage>e62166</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0062166</pub-id>.<pub-id pub-id-type="pmid">23637990</pub-id><pub-id pub-id-type="pmcid">PMC3639262</pub-id></mixed-citation></ref><ref id="iyaf141-B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lev</surname> &#160;<given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Bril</surname> &#160;<given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname> &#160;<given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Cere</surname> &#160;<given-names>LI</given-names></string-name>, <string-name name-style="western"><surname>Rechavi</surname> &#160;<given-names>O</given-names></string-name></person-group>. <year>2019</year>. <article-title>Inter-generational consequences for growing <italic toggle="yes">Caenorhabditis elegans</italic> in liquid</article-title>. <source>Philos Trans R Soc Lond B Biol Sci</source>. <volume>374</volume>:<fpage>20180125</fpage>. <pub-id pub-id-type="doi">10.1098/rstb.2018.0125</pub-id>.<pub-id pub-id-type="pmid">30966881</pub-id><pub-id pub-id-type="pmcid">PMC6460074</pub-id></mixed-citation></ref><ref id="iyaf141-B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lindblom</surname> &#160;<given-names>TH</given-names></string-name>, <string-name name-style="western"><surname>Pierce</surname> &#160;<given-names>GJ</given-names></string-name>, <string-name name-style="western"><surname>Sluder</surname> &#160;<given-names>AE</given-names></string-name></person-group>. <year>2001</year>. <article-title>A <italic toggle="yes">C. elegans</italic> orphan nuclear receptor contributes to xenobiotic resistance</article-title>. <source>Curr Biol</source>. <volume>11</volume>:<fpage>864</fpage>&#8211;<lpage>868</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-9822(01)00236-6</pub-id>.<pub-id pub-id-type="pmid">11516648</pub-id></mixed-citation></ref><ref id="iyaf141-B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lipinski</surname> &#160;<given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Lombardo</surname> &#160;<given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Dominy</surname> &#160;<given-names>BW</given-names></string-name>, <string-name name-style="western"><surname>Feeney</surname> &#160;<given-names>PJ</given-names></string-name></person-group>. <year>1997</year>. <article-title>Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</article-title>. <source>Adv Drug Deliv Rev</source>. <volume>46</volume>:<fpage>3</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/S0169-409X(00)00129-0</pub-id>.<pub-id pub-id-type="pmid">11259830</pub-id></mixed-citation></ref><ref id="iyaf141-B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Liu</surname> &#160;<given-names>M</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2018</year>. <article-title>Bioassay-guided isolation of three anthelmintic compounds from <italic toggle="yes">Warburgia ugandensis</italic> Sprague subspecies <italic toggle="yes">ugandensis</italic>, and the mechanism of action of polygodial</article-title>. <source>Int J Parasitol</source>. <volume>48</volume>:<fpage>833</fpage>&#8211;<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpara.2017.11.009</pub-id>.<pub-id pub-id-type="pmid">30031002</pub-id></mixed-citation></ref><ref id="iyaf141-B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lockery</surname> &#160;<given-names>SR</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2012</year>. <article-title>A microfluidic device for whole-animal drug screening using electrophysiological measures in the nematode <italic toggle="yes">C. elegans</italic></article-title>. <source>Lab Chip</source>. <volume>12</volume>:<fpage>2211</fpage>&#8211;<lpage>2220</lpage>. <pub-id pub-id-type="doi">10.1039/c2lc00001f</pub-id>.<pub-id pub-id-type="pmid">22588281</pub-id><pub-id pub-id-type="pmcid">PMC3372093</pub-id></mixed-citation></ref><ref id="iyaf141-B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Loer</surname> &#160;<given-names>CM</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2015</year>. <article-title>Cuticle integrity and biogenic amine synthesis in <italic toggle="yes">Caenorhabditis elegans</italic> require the cofactor tetrahydrobiopterin (BH4)</article-title>. <source>Genetics</source>. <volume>200</volume>:<fpage>237</fpage>&#8211;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.114.174110</pub-id>.<pub-id pub-id-type="pmid">25808955</pub-id><pub-id pub-id-type="pmcid">PMC4423366</pub-id></mixed-citation></ref><ref id="iyaf141-B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lucanic</surname> &#160;<given-names>M</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2016</year>. <article-title>Chemical activation of a food deprivation signal extends lifespan</article-title>. <source>Aging Cell</source>. <volume>15</volume>:<fpage>832</fpage>&#8211;<lpage>841</lpage>. <pub-id pub-id-type="doi">10.1111/acel.12492</pub-id>.<pub-id pub-id-type="pmid">27220516</pub-id><pub-id pub-id-type="pmcid">PMC5013014</pub-id></mixed-citation></ref><ref id="iyaf141-B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lucanic</surname> &#160;<given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Garrett</surname> &#160;<given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Gill</surname> &#160;<given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Lithgow</surname> &#160;<given-names>GJ</given-names></string-name></person-group>. <year>2018</year>. <article-title>A simple method for high throughput chemical screening in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>J Vis Exp</source>. <volume>133</volume>:<fpage>56892</fpage>. <pub-id pub-id-type="doi">10.3791/56892</pub-id>.<pub-id pub-id-type="pmcid">PMC5933220</pub-id><pub-id pub-id-type="pmid">29630057</pub-id></mixed-citation></ref><ref id="iyaf141-B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Luciani</surname> &#160;<given-names>GM</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2011</year>. <article-title>Dafadine inhibits DAF-9 to promote dauer formation and longevity of <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Nat Chem Biol</source>. <volume>7</volume>:<fpage>891</fpage>&#8211;<lpage>893</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.698</pub-id>.<pub-id pub-id-type="pmid">22057127</pub-id></mixed-citation></ref><ref id="iyaf141-B107"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Luciani</surname> &#160;<given-names>GM</given-names></string-name></person-group>. <year>2014</year>. <part-title>Identification and characterization of novel small molecules using <italic toggle="yes">Caenorhabditis elegans</italic> as a model system</part-title>. In: <source>In molecular genetics</source>. <publisher-name>University of Toronto</publisher-name>. p. <fpage>214</fpage>.</mixed-citation></ref><ref id="iyaf141-B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Maccesi</surname> &#160;<given-names>M</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2019</year>. <article-title>Multi-center screening of the pathogen box collection for schistosomiasis drug discovery</article-title>. <source>Parasit Vectors</source>. <volume>12</volume>:<fpage>493</fpage>. <pub-id pub-id-type="doi">10.1186/s13071-019-3747-6</pub-id>.<pub-id pub-id-type="pmid">31640761</pub-id><pub-id pub-id-type="pmcid">PMC6805474</pub-id></mixed-citation></ref><ref id="iyaf141-B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Martin</surname> &#160;<given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Robertson</surname> &#160;<given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Choudhary</surname> &#160;<given-names>S</given-names></string-name></person-group>. <year>2021</year>. <article-title>Ivermectin: an anthelmintic, an insecticide, and much more</article-title>. <source>Trends Parasitol</source>. <volume>37</volume>:<fpage>48</fpage>&#8211;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.pt.2020.10.005</pub-id>.<pub-id pub-id-type="pmid">33189582</pub-id><pub-id pub-id-type="pmcid">PMC7853155</pub-id></mixed-citation></ref><ref id="iyaf141-B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Marxer</surname> &#160;<given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ingram</surname> &#160;<given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Keiser</surname> &#160;<given-names>J</given-names></string-name></person-group>. <year>2012</year>. <article-title>Development of an in vitro drug screening assay using <italic toggle="yes">Schistosoma haematobium</italic> schistosomula</article-title>. <source>Parasit Vectors</source>. <volume>5</volume>:<fpage>165</fpage>. <pub-id pub-id-type="doi">10.1186/1756-3305-5-165</pub-id>.<pub-id pub-id-type="pmid">22876861</pub-id><pub-id pub-id-type="pmcid">PMC3437206</pub-id></mixed-citation></ref><ref id="iyaf141-B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mathew</surname> &#160;<given-names>MD</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2016</year>. <article-title>Using <italic toggle="yes">C. elegans</italic> forward and reverse genetics to identify new compounds with anthelmintic activity</article-title>. <source>PLoS Negl Trop Dis</source>. <volume>10</volume>:<fpage>e0005058</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0005058</pub-id>.<pub-id pub-id-type="pmid">27755544</pub-id><pub-id pub-id-type="pmcid">PMC5068747</pub-id></mixed-citation></ref><ref id="iyaf141-B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mathew</surname> &#160;<given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Mathew</surname> &#160;<given-names>ND</given-names></string-name>, <string-name name-style="western"><surname>Ebert</surname> &#160;<given-names>PR</given-names></string-name></person-group>. <year>2012</year>. <article-title>WormScan: a technique for high-throughput phenotypic analysis of <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>PLoS One</source>. <volume>7</volume>:<fpage>e33483</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0033483</pub-id>.<pub-id pub-id-type="pmid">22457766</pub-id><pub-id pub-id-type="pmcid">PMC3311640</pub-id></mixed-citation></ref><ref id="iyaf141-B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McCarthy</surname> &#160;<given-names>AA</given-names></string-name></person-group>. <year>2005</year>. <article-title>Exelixis: integrated drug-discovery and development platform for human therapeutics</article-title>. <source>Chem Biol</source>. <volume>12</volume>:<fpage>407</fpage>&#8211;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2005.04.004</pub-id>.<pub-id pub-id-type="pmid">15850973</pub-id></mixed-citation></ref><ref id="iyaf141-B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McCoy</surname> &#160;<given-names>AN</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname> &#160;<given-names>SY</given-names></string-name></person-group>. <year>2014</year>. <article-title>Otto Loewi (1873&#8211;1961): dreamer and Nobel laureate</article-title>. <source>Singapore Med J</source>. <volume>55</volume>:<fpage>3</fpage>&#8211;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.11622/smedj.2014002</pub-id>.<pub-id pub-id-type="pmid">24452970</pub-id><pub-id pub-id-type="pmcid">PMC4291908</pub-id></mixed-citation></ref><ref id="iyaf141-B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Menez</surname> &#160;<given-names>C</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2019</year>. <article-title>The transcription factor NHR-8: a new target to increase ivermectin efficacy in nematodes</article-title>. <source>PLoS Pathog</source>. <volume>15</volume>:<fpage>e1007598</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1007598</pub-id>.<pub-id pub-id-type="pmid">30759156</pub-id><pub-id pub-id-type="pmcid">PMC6391013</pub-id></mixed-citation></ref><ref id="iyaf141-B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Moy</surname> &#160;<given-names>TI</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2006</year>. <article-title>Identification of novel antimicrobials using a live-animal infection model</article-title>. <source>Proc Natl Acad Sci U S A</source>. <volume>103</volume>:<fpage>10414</fpage>&#8211;<lpage>10419</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0604055103</pub-id>.<pub-id pub-id-type="pmid">16801562</pub-id><pub-id pub-id-type="pmcid">PMC1482800</pub-id></mixed-citation></ref><ref id="iyaf141-B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Murareanu</surname> &#160;<given-names>BM</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2022</year>. <article-title>High-throughput small molecule screen identifies inhibitors of microsporidia invasion and proliferation in <italic toggle="yes">C. elegans</italic></article-title>. <source>Nat Commun</source>. <volume>13</volume>:<fpage>5653</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-022-33400-y</pub-id>.<pub-id pub-id-type="pmid">36163337</pub-id><pub-id pub-id-type="pmcid">PMC9513054</pub-id></mixed-citation></ref><ref id="iyaf141-B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nikolova</surname> &#160;<given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Jaworska</surname> &#160;<given-names>J</given-names></string-name></person-group>. <year>2004</year>. <article-title>Approaches to measure chemical similarity&#8212;a review</article-title>. <source>QSAR Comb Sci.</source> &#160;<volume>22</volume>:<fpage>1006</fpage>&#8211;<lpage>1026</lpage>. <pub-id pub-id-type="doi">10.1002/qsar.200330831</pub-id>.</mixed-citation></ref><ref id="iyaf141-B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nixon</surname> &#160;<given-names>SA</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2020</year>. <article-title>Where are all the anthelmintics? Challenges and opportunities on the path to new anthelmintics</article-title>. <source>Int J Parasitol Drugs Drug Resist</source>. <volume>14</volume>:<fpage>8</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2020.07.001</pub-id>.<pub-id pub-id-type="pmid">32814269</pub-id><pub-id pub-id-type="pmcid">PMC7452592</pub-id></mixed-citation></ref><ref id="iyaf141-B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Njume</surname> &#160;<given-names>FN</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2022</year>. <article-title>A lipid transfer protein ensures nematode cuticular impermeability</article-title>. <source>iScience</source>. <volume>25</volume>:<fpage>105357</fpage>. <pub-id pub-id-type="doi">10.1016/j.isci.2022.105357</pub-id>.<pub-id pub-id-type="pmid">36339267</pub-id><pub-id pub-id-type="pmcid">PMC9626681</pub-id></mixed-citation></ref><ref id="iyaf141-B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nunn</surname> &#160;<given-names>LR</given-names></string-name>, <string-name name-style="western"><surname>Juang</surname> &#160;<given-names>TD</given-names></string-name>, <string-name name-style="western"><surname>Beebe</surname> &#160;<given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Wheeler</surname> &#160;<given-names>NJ</given-names></string-name>, <string-name name-style="western"><surname>Zamanian</surname> &#160;<given-names>M</given-names></string-name></person-group>. <year>2023</year>. <article-title>A high-throughput sensory assay for parasitic and free-living nematodes</article-title>. <source>Integr Biol (Camb)</source>. <volume>15</volume>:<fpage>zyad010</fpage>. <pub-id pub-id-type="doi">10.1093/intbio/zyad010</pub-id>.<pub-id pub-id-type="pmid">37555835</pub-id><pub-id pub-id-type="pmcid">PMC10752570</pub-id></mixed-citation></ref><ref id="iyaf141-B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>O'Boyle</surname> &#160;<given-names>NM</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2011</year>. <article-title>Open Babel: an open chemical toolbox</article-title>. <source>J Cheminform</source>. <volume>3</volume>:<fpage>33</fpage>. <pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id>.<pub-id pub-id-type="pmid">21982300</pub-id><pub-id pub-id-type="pmcid">PMC3198950</pub-id></mixed-citation></ref><ref id="iyaf141-B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>O'Brien</surname> &#160;<given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Barlow</surname> &#160;<given-names>IL</given-names></string-name>, <string-name name-style="western"><surname>Feriani</surname> &#160;<given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname> &#160;<given-names>AEX</given-names></string-name></person-group>. <year>2025</year>. <article-title>High-throughput tracking enables systematic phenotyping and drug repurposing in <italic toggle="yes">C. elegans</italic> disease models</article-title>. <source>Elife</source>. <volume>12</volume>:<fpage>e92491</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.92491.4</pub-id>.<pub-id pub-id-type="pmcid">PMC11709427</pub-id><pub-id pub-id-type="pmid">39773880</pub-id></mixed-citation></ref><ref id="iyaf141-B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ondeyka</surname> &#160;<given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Goegelman</surname> &#160;<given-names>RT</given-names></string-name>, <string-name name-style="western"><surname>Schaeffer</surname> &#160;<given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Kelemen</surname> &#160;<given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zitano</surname> &#160;<given-names>L</given-names></string-name></person-group>. <year>1990</year>. <article-title>Novel antinematodal and antiparasitic agents from <italic toggle="yes">Penicillium charlesii</italic>. I. Fermentation, isolation and biological activity</article-title>. <source>J Antibiot (Tokyo)</source>. <volume>43</volume>:<fpage>1375</fpage>&#8211;<lpage>1379</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.43.1375</pub-id>.<pub-id pub-id-type="pmid">2272914</pub-id></mixed-citation></ref><ref id="iyaf141-B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>O'Reilly</surname> &#160;<given-names>LP</given-names></string-name>, <string-name name-style="western"><surname>Luke</surname> &#160;<given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Perlmutter</surname> &#160;<given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Silverman</surname> &#160;<given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Pak</surname> &#160;<given-names>SC</given-names></string-name></person-group>. <year>2014</year>. <article-title><italic toggle="yes">C. elegans</italic> in high-throughput drug discovery</article-title>. <source>Adv Drug Deliv Rev</source>. <volume>69&#8211;70</volume>:<fpage>247</fpage>&#8211;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2013.12.001</pub-id>.<pub-id pub-id-type="pmcid">PMC4019719</pub-id><pub-id pub-id-type="pmid">24333896</pub-id></mixed-citation></ref><ref id="iyaf141-B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Partridge</surname> &#160;<given-names>FA</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2018</year>. <article-title>An automated high-throughput system for phenotypic screening of chemical libraries on <italic toggle="yes">C. elegans</italic> and parasitic nematodes</article-title>. <source>Int J Parasitol Drugs Drug Resist</source>. <volume>8</volume>:<fpage>8</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2017.11.004</pub-id>.<pub-id pub-id-type="pmid">29223747</pub-id><pub-id pub-id-type="pmcid">PMC5734697</pub-id></mixed-citation></ref><ref id="iyaf141-B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Partridge</surname> &#160;<given-names>FA</given-names></string-name>, <string-name name-style="western"><surname>Tearle</surname> &#160;<given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Gravato-Nobre</surname> &#160;<given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Schafer</surname> &#160;<given-names>WR</given-names></string-name>, <string-name name-style="western"><surname>Hodgkin</surname> &#160;<given-names>J</given-names></string-name></person-group>. <year>2008</year>. <article-title>The <italic toggle="yes">C. elegans</italic> glycosyltransferase BUS-8 has two distinct and essential roles in epidermal morphogenesis</article-title>. <source>Dev Biol</source>. <volume>317</volume>:<fpage>549</fpage>&#8211;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2008.02.060</pub-id>.<pub-id pub-id-type="pmid">18395708</pub-id></mixed-citation></ref><ref id="iyaf141-B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pasche</surname> &#160;<given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Laleu</surname> &#160;<given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Keiser</surname> &#160;<given-names>J</given-names></string-name></person-group>. <year>2018</year>. <article-title>Screening a repurposing library, the medicines for malaria venture stasis box, against <italic toggle="yes">Schistosoma mansoni</italic></article-title>. <source>Parasit Vectors</source>. <volume>11</volume>:<fpage>298</fpage>. <pub-id pub-id-type="doi">10.1186/s13071-018-2855-z</pub-id>.<pub-id pub-id-type="pmid">29764454</pub-id><pub-id pub-id-type="pmcid">PMC5952519</pub-id></mixed-citation></ref><ref id="iyaf141-B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pasche</surname> &#160;<given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Laleu</surname> &#160;<given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Keiser</surname> &#160;<given-names>J</given-names></string-name></person-group>. <year>2019</year>. <article-title>Early antischistosomal leads identified from in vitro and in vivo screening of the medicines for malaria venture pathogen box</article-title>. <source>ACS Infect Dis</source>. <volume>5</volume>:<fpage>102</fpage>&#8211;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.8b00220</pub-id>.<pub-id pub-id-type="pmid">30398059</pub-id></mixed-citation></ref><ref id="iyaf141-B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Patten</surname> &#160;<given-names>SA</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2017</year>. <article-title>Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis</article-title>. <source>JCI Insight</source>. <volume>2</volume>:<fpage>e97152</fpage>. <pub-id pub-id-type="doi">10.1172/jci.insight.97152</pub-id>.<pub-id pub-id-type="pmid">29202456</pub-id><pub-id pub-id-type="pmcid">PMC5752378</pub-id></mixed-citation></ref><ref id="iyaf141-B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Peddibhotla</surname> &#160;<given-names>S</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2015</year>. <article-title>Discovery of ML358, a selective small molecule inhibitor of the SKN-1 pathway involved in drug detoxification and resistance in nematodes</article-title>. <source>ACS Chem Biol</source>. <volume>10</volume>:<fpage>1871</fpage>&#8211;<lpage>1879</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.5b00304</pub-id>.<pub-id pub-id-type="pmid">25946346</pub-id></mixed-citation></ref><ref id="iyaf141-B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Peterson</surname> &#160;<given-names>ND</given-names></string-name>, <string-name name-style="western"><surname>Pukkila-Worley</surname> &#160;<given-names>R</given-names></string-name></person-group>. <year>2018</year>. <article-title><italic toggle="yes">Caenorhabditis elegans</italic> in high-throughput screens for anti-infective compounds</article-title>. <source>Curr Opin Immunol</source>. <volume>54</volume>:<fpage>59</fpage>&#8211;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2018.06.003</pub-id>.<pub-id pub-id-type="pmid">29935375</pub-id><pub-id pub-id-type="pmcid">PMC6463281</pub-id></mixed-citation></ref><ref id="iyaf141-B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Petrascheck</surname> &#160;<given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ye</surname> &#160;<given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Buck</surname> &#160;<given-names>LB</given-names></string-name></person-group>. <year>2007</year>. <article-title>An antidepressant that extends lifespan in adult <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Nature</source>. <volume>450</volume>:<fpage>553</fpage>&#8211;<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1038/nature05991</pub-id>.<pub-id pub-id-type="pmid">18033297</pub-id></mixed-citation></ref><ref id="iyaf141-B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Phiri</surname> &#160;<given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>DI</surname> &#160;<given-names>DEP</given-names></string-name>, <string-name name-style="western"><surname>Buttle</surname> &#160;<given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Behnke</surname> &#160;<given-names>JM</given-names></string-name></person-group>. <year>2017</year>. <article-title>A novel assay for the detection of anthelmintic activity mediated by cuticular damage to nematodes: validation on <italic toggle="yes">Caenorhabditis elegans</italic> exposed to cysteine proteinases</article-title>. <source>Parasitology</source>. <volume>144</volume>:<fpage>583</fpage>&#8211;<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1017/S0031182016002353</pub-id>.<pub-id pub-id-type="pmid">28134060</pub-id></mixed-citation></ref><ref id="iyaf141-B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Preston</surname> &#160;<given-names>S</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2016</year>. <article-title>Screening of the &#8216;pathogen box&#8217; identifies an approved pesticide with major anthelmintic activity against the barber's pole worm</article-title>. <source>Int J Parasitol Drugs Drug Resist</source>. <volume>6</volume>:<fpage>329</fpage>&#8211;<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2016.07.004</pub-id>.<pub-id pub-id-type="pmid">27524698</pub-id><pub-id pub-id-type="pmcid">PMC5196485</pub-id></mixed-citation></ref><ref id="iyaf141-B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Preston</surname> &#160;<given-names>S</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2017a</year>. <article-title>Screening of the &#8216;open scaffolds&#8217; collection from compounds Australia identifies a new chemical entity with anthelmintic activities against different developmental stages of the barber's pole worm and other parasitic nematodes</article-title>. <source>Int J Parasitol Drugs Drug Resist</source>. <volume>7</volume>:<fpage>286</fpage>&#8211;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2017.05.004</pub-id>.<pub-id pub-id-type="pmid">28732272</pub-id><pub-id pub-id-type="pmcid">PMC5517787</pub-id></mixed-citation></ref><ref id="iyaf141-B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Preston</surname> &#160;<given-names>S</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2017b</year>. <article-title>Deguelin exerts potent nematocidal activity via the mitochondrial respiratory chain</article-title>. <source>FASEB J</source>. <volume>31</volume>:<fpage>4515</fpage>&#8211;<lpage>4532</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201700288R</pub-id>.<pub-id pub-id-type="pmid">28687609</pub-id></mixed-citation></ref><ref id="iyaf141-B138"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Pyche</surname> &#160;<given-names>JE</given-names></string-name></person-group>. <year>2019</year>. <part-title>The characterization of wact-45, a novel small molecule tool that likely inhibits the vesicular acetylcholine transporter</part-title>. In: <source>Pharmacology and Toxicology</source>. <publisher-name>The University of Toronto</publisher-name>. p. <fpage>96</fpage>.</mixed-citation></ref><ref id="iyaf141-B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rangaraju</surname> &#160;<given-names>S</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2015</year>. <article-title>Suppression of transcriptional drift extends <italic toggle="yes">C. elegans</italic> lifespan by postponing the onset of mortality</article-title>. <source>Elife</source>. <volume>4</volume>:<fpage>e08833</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.08833</pub-id>.<pub-id pub-id-type="pmid">26623667</pub-id><pub-id pub-id-type="pmcid">PMC4720515</pub-id></mixed-citation></ref><ref id="iyaf141-B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rehborg</surname> &#160;<given-names>EG</given-names></string-name>, <string-name name-style="western"><surname>Wheeler</surname> &#160;<given-names>NJ</given-names></string-name>, <string-name name-style="western"><surname>Zamanian</surname> &#160;<given-names>M</given-names></string-name></person-group>. <year>2023</year>. <article-title>Mapping resistance-associated anthelmintic interactions in the model nematode <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>PLoS Negl Trop Dis</source>. <year>2023</year>;<volume>17</volume>:<fpage>e0011705</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0011705</pub-id>.<pub-id pub-id-type="pmid">37883578</pub-id><pub-id pub-id-type="pmcid">PMC10629664</pub-id></mixed-citation></ref><ref id="iyaf141-B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Risi</surname> &#160;<given-names>G</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2019</year>. <article-title><italic toggle="yes">Caenorhabditis elegans</italic> infrared-based motility assay identified new hits for nematicide drug development</article-title>. <source>Vet Sci</source>. <volume>6</volume>:<fpage>29</fpage>. <pub-id pub-id-type="doi">10.3390/vetsci6010029</pub-id>.<pub-id pub-id-type="pmid">30884899</pub-id><pub-id pub-id-type="pmcid">PMC6466232</pub-id></mixed-citation></ref><ref id="iyaf141-B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ruiz-Lancheros</surname> &#160;<given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Viau</surname> &#160;<given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Walter</surname> &#160;<given-names>TN</given-names></string-name>, <string-name name-style="western"><surname>Francis</surname> &#160;<given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Geary</surname> &#160;<given-names>TG</given-names></string-name></person-group>. <year>2011</year>. <article-title>Activity of novel nicotinic anthelmintics in cut preparations of <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Int J Parasitol</source>. <volume>41</volume>:<fpage>455</fpage>&#8211;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpara.2010.11.009</pub-id>.<pub-id pub-id-type="pmid">21195075</pub-id></mixed-citation></ref><ref id="iyaf141-B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Samuel</surname> &#160;<given-names>BS</given-names></string-name>, <string-name name-style="western"><surname>Rowedder</surname> &#160;<given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Braendle</surname> &#160;<given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Felix</surname> &#160;<given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Ruvkun</surname> &#160;<given-names>G</given-names></string-name></person-group>. <year>2016</year>. <article-title><italic toggle="yes">Caenorhabditis elegans</italic> responses to bacteria from its natural habitats</article-title>. <source>Proc Natl Acad Sci U S A</source>. <volume>113</volume>:<fpage>E3941</fpage>&#8211;<lpage>E3949</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1607183113</pub-id>.<pub-id pub-id-type="pmid">27317746</pub-id><pub-id pub-id-type="pmcid">PMC4941482</pub-id></mixed-citation></ref><ref id="iyaf141-B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sandhu</surname> &#160;<given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Badal</surname> &#160;<given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Sheokand</surname> &#160;<given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Tyagi</surname> &#160;<given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname> &#160;<given-names>V</given-names></string-name></person-group>. <year>2021</year>. <article-title>Specific collagens maintain the cuticle permeability barrier in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Genetics</source>. <volume>217</volume>:<fpage>iyaa047</fpage>. <pub-id pub-id-type="doi">10.1093/genetics/iyaa047</pub-id>.<pub-id pub-id-type="pmid">33789349</pub-id><pub-id pub-id-type="pmcid">PMC8045729</pub-id></mixed-citation></ref><ref id="iyaf141-B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Saur</surname> &#160;<given-names>T</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2013</year>. <article-title>A genome-wide RNAi screen in <italic toggle="yes">Caenorhabditis elegans</italic> identifies the nicotinic acetylcholine receptor subunit ACR-7 as an antipsychotic drug target</article-title>. <source>PLoS Genet</source>. <volume>9</volume>:<fpage>e1003313</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1003313</pub-id>.<pub-id pub-id-type="pmid">23468647</pub-id><pub-id pub-id-type="pmcid">PMC3585123</pub-id></mixed-citation></ref><ref id="iyaf141-B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Schafer</surname> &#160;<given-names>WF</given-names></string-name></person-group>. <year>2006</year>. <article-title>Genetics of egg-laying in worms</article-title>. <source>Annu Rev Genet</source>. <volume>40</volume>:<fpage>487</fpage>&#8211;<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.genet.40.110405.090527</pub-id>.<pub-id pub-id-type="pmid">17094742</pub-id></mixed-citation></ref><ref id="iyaf141-B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Schmeisser</surname> &#160;<given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Fardghassemi</surname> &#160;<given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Parker</surname> &#160;<given-names>JA</given-names></string-name></person-group>. <year>2017</year>. <article-title>A rapid chemical-genetic screen utilizing impaired movement phenotypes in <italic toggle="yes">C. elegans</italic>: input into genetics of neurodevelopmental disorders</article-title>. <source>Exp Neurol</source>. <volume>293</volume>:<fpage>101</fpage>&#8211;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2017.03.022</pub-id>.<pub-id pub-id-type="pmid">28373024</pub-id></mixed-citation></ref><ref id="iyaf141-B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Schulenburg</surname> &#160;<given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Felix</surname> &#160;<given-names>MA</given-names></string-name></person-group>. <year>2017</year>. <article-title>The natural biotic environment of <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Genetics</source>. <volume>206</volume>:<fpage>55</fpage>&#8211;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.116.195511</pub-id>.<pub-id pub-id-type="pmid">28476862</pub-id><pub-id pub-id-type="pmcid">PMC5419493</pub-id></mixed-citation></ref><ref id="iyaf141-B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shanley</surname> &#160;<given-names>HT</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2022</year>. <article-title>A high-throughput phenotypic screen of the &#8216;pandemic response box&#8217; identifies a quinoline derivative with significant anthelmintic activity</article-title>. <source>Pharmaceuticals (Basel)</source>. <volume>15</volume>:<fpage>257</fpage>. <pub-id pub-id-type="doi">10.3390/ph15020257</pub-id>.<pub-id pub-id-type="pmid">35215369</pub-id><pub-id pub-id-type="pmcid">PMC8874578</pub-id></mixed-citation></ref><ref id="iyaf141-B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shanley</surname> &#160;<given-names>HT</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2024a</year>. <article-title>Structure activity relationship and target prediction for ABX464 analogues in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Bioorg Med Chem</source>. <volume>98</volume>:<fpage>117540</fpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2023.117540</pub-id>.<pub-id pub-id-type="pmid">38134663</pub-id></mixed-citation></ref><ref id="iyaf141-B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shanley</surname> &#160;<given-names>HT</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2024b</year>. <article-title>Comparative structure activity and target exploration of 1,2-diphenylethynes in <italic toggle="yes">Haemonchus contortus</italic> and <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Int J Parasitol Drugs Drug Resist</source>. <volume>25</volume>:<fpage>100534</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2024.100534</pub-id>.<pub-id pub-id-type="pmid">38554597</pub-id><pub-id pub-id-type="pmcid">PMC10992699</pub-id></mixed-citation></ref><ref id="iyaf141-B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shannon</surname> &#160;<given-names>P</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2003</year>. <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>. <source>Genome Res</source>. <volume>13</volume>:<fpage>2498</fpage>&#8211;<lpage>2504</lpage>. <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>.<pub-id pub-id-type="pmid">14597658</pub-id><pub-id pub-id-type="pmcid">PMC403769</pub-id></mixed-citation></ref><ref id="iyaf141-B153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shaver</surname> &#160;<given-names>AO</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2023</year>. <article-title>Variation in anthelmintic responses are driven by genetic differences among diverse <italic toggle="yes">C. elegans</italic> wild strains</article-title>. <source>PLoS Pathog</source>. <volume>19</volume>:<fpage>e1011285</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1011285</pub-id>.<pub-id pub-id-type="pmid">37011090</pub-id><pub-id pub-id-type="pmcid">PMC10101645</pub-id></mixed-citation></ref><ref id="iyaf141-B154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Simonetta</surname> &#160;<given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Golombek</surname> &#160;<given-names>DA</given-names></string-name></person-group>. <year>2007</year>. <article-title>An automated tracking system for <italic toggle="yes">Caenorhabditis elegans</italic> locomotor behavior and circadian studies application</article-title>. <source>J Neurosci Methods</source>. <volume>161</volume>:<fpage>273</fpage>&#8211;<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2006.11.015</pub-id>.<pub-id pub-id-type="pmid">17207862</pub-id></mixed-citation></ref><ref id="iyaf141-B155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sleigh</surname> &#160;<given-names>JN</given-names></string-name></person-group>. <year>2010</year>. <article-title>Functional analysis of nematode nicotinic receptors</article-title>. <source>Biosci Horiz</source>. <volume>3</volume>:<fpage>11</fpage>. <pub-id pub-id-type="doi">10.1093/biohorizons/hzq005</pub-id>.</mixed-citation></ref><ref id="iyaf141-B156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sluder</surname> &#160;<given-names>A</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2012</year>. <article-title>Spiroindolines identify the vesicular acetylcholine transporter as a novel target for insecticide action</article-title>. <source>PLoS One</source>. <volume>7</volume>:<fpage>e34712</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0034712</pub-id>.<pub-id pub-id-type="pmid">22563457</pub-id><pub-id pub-id-type="pmcid">PMC3341389</pub-id></mixed-citation></ref><ref id="iyaf141-B157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Solis</surname> &#160;<given-names>GM</given-names></string-name>, <string-name name-style="western"><surname>Petrascheck</surname> &#160;<given-names>M</given-names></string-name></person-group>. <year>2011</year>. <article-title>Measuring <italic toggle="yes">Caenorhabditis elegans</italic> life span in 96 well microtiter plates</article-title>. <source>J Vis Exp</source>. <volume>49</volume>:<fpage>2496</fpage>. <pub-id pub-id-type="doi">10.3791/2496-v</pub-id>.<pub-id pub-id-type="pmcid">PMC3197298</pub-id><pub-id pub-id-type="pmid">21445049</pub-id></mixed-citation></ref><ref id="iyaf141-B158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Somerville</surname> &#160;<given-names>AN</given-names></string-name></person-group>. <year>1998</year>. <article-title>SciFinder Scholar</article-title>. <source>J Chem Educ.</source> &#160;<volume>75</volume>:<fpage>959</fpage>&#8211;<lpage>960</lpage>. <pub-id pub-id-type="doi">10.1021/ed075p959</pub-id>.</mixed-citation></ref><ref id="iyaf141-B159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Spensley</surname> &#160;<given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Del Borrello</surname> &#160;<given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Pajkic</surname> &#160;<given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Fraser</surname> &#160;<given-names>AG</given-names></string-name></person-group>. <year>2018</year>. <article-title>Acute effects of drugs on <italic toggle="yes">Caenorhabditis elegans</italic> movement reveal complex responses and plasticity</article-title>. <source>G3 (Bethesda)</source>. <volume>8</volume>:<fpage>2941</fpage>&#8211;<lpage>2952</lpage>. <pub-id pub-id-type="doi">10.1534/g3.118.200374</pub-id>.<pub-id pub-id-type="pmid">30061375</pub-id><pub-id pub-id-type="pmcid">PMC6118317</pub-id></mixed-citation></ref><ref id="iyaf141-B160"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Stasiuk</surname> &#160;<given-names>SJ</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2019</year>. <article-title>Similarities and differences in the biotransformation and transcriptomic responses of <italic toggle="yes">Caenorhabditis elegans</italic> and <italic toggle="yes">Haemonchus contortus</italic> to five different benzimidazole drugs</article-title>. <source>Int J Parasitol Drugs Drug Resist</source>. <volume>11</volume>:<fpage>13</fpage>&#8211;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2019.09.001</pub-id>.<pub-id pub-id-type="pmid">31542693</pub-id><pub-id pub-id-type="pmcid">PMC6796749</pub-id></mixed-citation></ref><ref id="iyaf141-B161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sulston</surname> &#160;<given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Horvitz</surname> &#160;<given-names>HR</given-names></string-name></person-group>. <year>1977</year>. <article-title>Post-embryonic cell lineages of the nematode, <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Dev Biol</source>. <volume>56</volume>:<fpage>110</fpage>&#8211;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1016/0012-1606(77)90158-0</pub-id>.<pub-id pub-id-type="pmid">838129</pub-id></mixed-citation></ref><ref id="iyaf141-B162"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sulston</surname> &#160;<given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Schierenberg</surname> &#160;<given-names>E</given-names></string-name>, <string-name name-style="western"><surname>White</surname> &#160;<given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Thomson</surname> &#160;<given-names>JN</given-names></string-name></person-group>. <year>1983</year>. <article-title>The embryonic cell lineage of the nematode <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Dev Biol</source>. <volume>100</volume>:<fpage>64</fpage>&#8211;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/0012-1606(83)90201-4</pub-id>.<pub-id pub-id-type="pmid">6684600</pub-id></mixed-citation></ref><ref id="iyaf141-B163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sural</surname> &#160;<given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hobert</surname> &#160;<given-names>O</given-names></string-name></person-group>. <year>2021</year>. <article-title>Nematode nuclear receptors as integrators of sensory information</article-title>. <source>Curr Biol.</source> &#160;<volume>31</volume>:<fpage>4361</fpage>&#8211;<lpage>4366.e2</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2021.07.019</pub-id>.<pub-id pub-id-type="pmid">34348120</pub-id></mixed-citation></ref><ref id="iyaf141-B164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Taki</surname> &#160;<given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Byrne</surname> &#160;<given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Boag</surname> &#160;<given-names>PR</given-names></string-name>, <string-name name-style="western"><surname>Jabbar</surname> &#160;<given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gasser</surname> &#160;<given-names>RB</given-names></string-name></person-group>. <year>2021</year>. <article-title>Practical high-throughput method to screen compounds for anthelmintic activity against <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>Molecules</source>. <volume>26</volume>:<fpage>4156</fpage>. <pub-id pub-id-type="doi">10.3390/molecules26144156</pub-id>.<pub-id pub-id-type="pmid">34299431</pub-id><pub-id pub-id-type="pmcid">PMC8305057</pub-id></mixed-citation></ref><ref id="iyaf141-B165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Thangamani</surname> &#160;<given-names>S</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2017</year>. <article-title>Repurposing approach identifies auranofin with broad spectrum antifungal activity that targets Mia40-erv1 pathway</article-title>. <source>Front Cell Infect Microbiol</source>. <volume>7</volume>:<fpage>4</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2017.00004</pub-id>.<pub-id pub-id-type="pmid">28149831</pub-id><pub-id pub-id-type="pmcid">PMC5241286</pub-id></mixed-citation></ref><ref id="iyaf141-B166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tingle</surname> &#160;<given-names>BI</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2023</year>. <article-title>ZINC-22&#8212;a free multi-billion-scale database of tangible compounds for ligand discovery</article-title>. <source>J Chem Inf Model</source>. <volume>63</volume>:<fpage>1166</fpage>&#8211;<lpage>1176</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.2c01253</pub-id>.<pub-id pub-id-type="pmid">36790087</pub-id><pub-id pub-id-type="pmcid">PMC9976280</pub-id></mixed-citation></ref><ref id="iyaf141-B167"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vaccaro</surname> &#160;<given-names>A</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2012</year>. <article-title>Mutant TDP-43 and FUS cause age-dependent paralysis and neurodegeneration in <italic toggle="yes">C. elegans</italic></article-title>. <source>PLoS One</source>. <volume>7</volume>:<fpage>e31321</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0031321</pub-id>.<pub-id pub-id-type="pmid">22363618</pub-id><pub-id pub-id-type="pmcid">PMC3283630</pub-id></mixed-citation></ref><ref id="iyaf141-B168"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Van de Walle</surname> &#160;<given-names>P</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2019</year>. <article-title>CEH-60/PBX regulates vitellogenesis and cuticle permeability through intestinal interaction with UNC-62/MEIS in <italic toggle="yes">Caenorhabditis elegans</italic></article-title>. <source>PLoS Biol</source>. <volume>17</volume>:<fpage>e3000499</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.3000499</pub-id>.<pub-id pub-id-type="pmid">31675356</pub-id><pub-id pub-id-type="pmcid">PMC6824563</pub-id></mixed-citation></ref><ref id="iyaf141-B169"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vidal</surname> &#160;<given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Arch</surname> &#160;<given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Fuentes</surname> &#160;<given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Cardona</surname> &#160;<given-names>PJ</given-names></string-name></person-group>. <year>2024</year>. <article-title><italic toggle="yes">Drosophila melanogaster</italic> experimental model to test new antimicrobials: a methodological approach</article-title>. <source>Front Microbiol.</source> &#160;<volume>15</volume>:<fpage>1478263</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2024.1478263</pub-id>.<pub-id pub-id-type="pmid">39568995</pub-id><pub-id pub-id-type="pmcid">PMC11576456</pub-id></mixed-citation></ref><ref id="iyaf141-B170"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wallace</surname> &#160;<given-names>IM</given-names></string-name></person-group> &#160;<year>2011</year>. <article-title>Compound prioritization methods increase rates of chemical probe discovery in model organisms</article-title>. <source>Chem Biol</source>. <volume>18</volume>:<fpage>1273</fpage>&#8211;<lpage>1283</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2011.07.018</pub-id>.<pub-id pub-id-type="pmid">22035796</pub-id><pub-id pub-id-type="pmcid">PMC4193902</pub-id></mixed-citation></ref><ref id="iyaf141-B171"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wang</surname> &#160;<given-names>F</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2022</year>. <article-title>CFM-ID 4.0&#8212;a web server for accurate MS-based metabolite identification</article-title>. <source>Nucleic Acids Res</source>. <volume>50</volume>:<fpage>W165</fpage>&#8211;<lpage>W174</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkac383</pub-id>.<pub-id pub-id-type="pmid">35610037</pub-id><pub-id pub-id-type="pmcid">PMC9252813</pub-id></mixed-citation></ref><ref id="iyaf141-B172"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Weeks</surname> &#160;<given-names>JC</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2018</year>. <article-title>Sertraline, paroxetine, and chlorpromazine are rapidly acting anthelmintic drugs capable of clinical repurposing</article-title>. <source>Sci Rep</source>. <volume>8</volume>:<fpage>975</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-18457-w</pub-id>.<pub-id pub-id-type="pmid">29343694</pub-id><pub-id pub-id-type="pmcid">PMC5772060</pub-id></mixed-citation></ref><ref id="iyaf141-B173"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Weicksel</surname> &#160;<given-names>SE</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2016</year>. <article-title>A novel small molecule that disrupts a key event during the oocyte-to-embryo transition in <italic toggle="yes">C. elegans</italic></article-title>. <source>Development</source>. <volume>143</volume>:<fpage>3540</fpage>&#8211;<lpage>3548</lpage>. <pub-id pub-id-type="doi">10.1242/dev.140046</pub-id>.<pub-id pub-id-type="pmid">27510972</pub-id><pub-id pub-id-type="pmcid">PMC5087616</pub-id></mixed-citation></ref><ref id="iyaf141-B174"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wells</surname> &#160;<given-names>WA</given-names></string-name></person-group>. <year>1998</year>. <article-title>High-throughput worms. NemaPharm, Inc</article-title>. <source>Chem Biol</source>. <volume>5</volume>:<fpage>R147</fpage>&#8211;<lpage>R148</lpage>. <pub-id pub-id-type="doi">10.1016/s1074-5521(98)90174-0</pub-id>.<pub-id pub-id-type="pmid">9653546</pub-id></mixed-citation></ref><ref id="iyaf141-B175"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wheeler</surname> &#160;<given-names>NJ</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2023</year>. <article-title>Multivariate chemogenomic screening prioritizes new macrofilaricidal leads</article-title>. <source>Commun Biol</source>. <volume>6</volume>:<fpage>44</fpage>. <pub-id pub-id-type="doi">10.1038/s42003-023-04435-8</pub-id>.<pub-id pub-id-type="pmid">36639423</pub-id><pub-id pub-id-type="pmcid">PMC9839782</pub-id></mixed-citation></ref><ref id="iyaf141-B176"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wit</surname> &#160;<given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Rodriguez</surname> &#160;<given-names>BC</given-names></string-name>, <string-name name-style="western"><surname>Andersen</surname> &#160;<given-names>EC</given-names></string-name></person-group>. <year>2021</year>. <article-title>Natural variation in <italic toggle="yes">Caenorhabditis elegans</italic> responses to the anthelmintic emodepside</article-title>. <source>Int J Parasitol Drugs Drug Resist</source>. <volume>16</volume>:<fpage>1</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2021.04.001</pub-id>.<pub-id pub-id-type="pmid">33878514</pub-id><pub-id pub-id-type="pmcid">PMC8079822</pub-id></mixed-citation></ref><ref id="iyaf141-B177"><mixed-citation publication-type="other"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>. <year>2020</year>. Vector-Borne Diseases. <ext-link xlink:href="https://www.who.int/news-room/fact-sheets/detail/vector-borne-diseases" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/vector-borne-diseases</ext-link>.</mixed-citation></ref><ref id="iyaf141-B178"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Xiong</surname> &#160;<given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Pears</surname> &#160;<given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Woollard</surname> &#160;<given-names>A</given-names></string-name></person-group>. <year>2017</year>. <article-title>An enhanced <italic toggle="yes">C. elegans</italic> based platform for toxicity assessment</article-title>. <source>Sci Rep</source>. <volume>7</volume>:<fpage>9839</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-10454-3</pub-id>.<pub-id pub-id-type="pmid">28852193</pub-id><pub-id pub-id-type="pmcid">PMC5575006</pub-id></mixed-citation></ref><ref id="iyaf141-B179"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yoon</surname> &#160;<given-names>S</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2024</year>. <article-title>Microfluidics in high-throughput drug screening: organ-on-a-chip and <italic toggle="yes">C. elegans</italic>-based innovations</article-title>. <source>Biosensors (Basel)</source>. <volume>14</volume>:<fpage>55</fpage>. <pub-id pub-id-type="doi">10.3390/bios14010055</pub-id>.<pub-id pub-id-type="pmid">38275308</pub-id><pub-id pub-id-type="pmcid">PMC10813408</pub-id></mixed-citation></ref><ref id="iyaf141-B180"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zamanian</surname> &#160;<given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname> &#160;<given-names>JD</given-names></string-name></person-group>. <year>2021</year>. <article-title>High-content approaches to anthelmintic drug screening</article-title>. <source>Trends Parasitol</source>. <volume>37</volume>:<fpage>780</fpage>&#8211;<lpage>789</lpage>. <pub-id pub-id-type="doi">10.1016/j.pt.2021.05.004</pub-id>.<pub-id pub-id-type="pmid">34092518</pub-id><pub-id pub-id-type="pmcid">PMC8364491</pub-id></mixed-citation></ref><ref id="iyaf141-B181"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhao</surname> &#160;<given-names>Y</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2007</year>. <article-title>Chemical genetic interrogation of natural variation uncovers a molecule that is glycoactivated</article-title>. <source>Nat Chem Biol</source>. <volume>3</volume>:<fpage>716</fpage>&#8211;<lpage>721</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.2007.32</pub-id>.<pub-id pub-id-type="pmid">17891152</pub-id></mixed-citation></ref><ref id="iyaf141-B182"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhu</surname> &#160;<given-names>H</given-names></string-name> &#160;<etal>et al</etal></person-group> &#160;<year>2022</year>. <article-title>In situ structure of intestinal apical surface reveals nanobristles on microvilli</article-title>. <source>Proc Natl Acad Sci U S A</source>. <volume>119</volume>:<fpage>e2122249119</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2122249119</pub-id>.<pub-id pub-id-type="pmid">35666862</pub-id><pub-id pub-id-type="pmcid">PMC9214534</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>